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1 SUMMARY 
 
The human stomatin protein family consists of 5 members, the prototype stomatin protein, 
stomatin-like protein 1 (SLP-1), SLP-2, SLP-3, and the kidney-specific podocin protein, 
whose precise functions have remained largely unknown up to now. This lack of knowledge 
may be explained by the hydrophobic nature and the tight membrane association of these 
proteins, which still pose a challenge for the biochemist and molecular cell biologist. 
Nevertheless, genetic data from C. elegans stomatin-like proteins UNC-1, UNC-24, and 
MEC-2 as well as knock-out experiments in mice (stomatin, SLP-2, SLP-3) and analysis of 
genetic data in human steroid-resistant nephrotic syndrome (podocin) indicate an important, 
but perhaps redundant function for these proteins in most tissues.  
In this work, the major focus was put on human SLP-1 protein, the least characterized family 
member. Due to the lack of an antibody against SLP-1, I prepared SLP-1 constructs fused to 
different tags (GFP, myc-epitope, HA-epitope) and exogenously expressed and characterized 
the tagged proteins with biochemical and molecular cell biological methods. Similar to 
stomatin, the tagged SLP-1 protein was localized to perinuclear vesicles, however, in contrast 
to stomatin it was not found on the plasma membrane by immunofluorescence and 
immunoelectron microscopy. Subcellular fractionation and biochemical analysis confirmed 
the endosomal localization. Comparison of the localization of SLP-1 with different organelle 
marker proteins by immunofluorescence studies revealed that these peri-nuclear vesicles are 
late endosomes/lysosomes. The degree of co-localization between SLP-1 and different late 
endosomal/lysosomal markers was variable and indicated a broad distribution of the protein 
over different late endosomal sub-compartments. Several truncation mutants and point 
mutants of the SLP-1 protein were constructed and led to the identification of a tyrosine-based 
N-terminal late endosomal/lysosomal targeting signal in the first 10 amino acids of the 
protein. In chimeric constructs, where the N-terminus of stomatin was replaced by the N-
terminus of SLP-1, this motif was found to be sufficient to direct the fusion protein to late 
endosomes/lysosomes and abolish the plasma membrane localization of stomatin. C-terminal 
deletions of SLP-1 also compromise the correct subcellular localization of this protein, as 
exemplified by one construct, which was found to be mis-targeted to cytoplasmic aggregates 
and tubular structures. This truncation was also analyzed by electron microscopy and the 
cytoplasmic aggregates were found to be small lipid bodies or droplets. Most likely, the over-
expression of the SLP-1 truncation mutant was the cause for the appearance of these 
characteristic structures.  
Our hypothesis that the human SLP-1 and stomatin proteins could form a complex like their 
C. elegans counterparts UNC-24 and UNC-1 was tested in this thesis and the interaction 
between endogenous stomatin and exogenously expressed, tagged SLP-1 was verified by co-
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immunoprecipitation analyses. These two proteins also showed co-localization in 
immunofluorescence experiments, and most importantly, over-expression of SLP-1 caused a 
re-distribution of endogenous stomatin from the plasma membrane to late endosomes. These 
data strongly support the notion that hetero-oligomeric complexes between stomatin and SLP-
1 are formed, whose functional properties might differ from the known stomatin homo-
oligomers. Biochemical and cell biological evidence indicates that SLP-1 forms an oligomeric 
structure. Like the prototype stomatin protein, SLP-1 is enriched in detergent-resistant 
membranes (DRMs), similar to lipid rafts, although it is not present at the plasma membrane. 
A major difference between stomatin and SLP-1 was found in respect to the targeting to lipid 
bodies/droplets. Wild-type SLP-1 was never detected on these neutral lipid storage organelles, 
whereas stomatin and a C-terminal truncation mutant of SLP-1 were readily detected there 
and showed the characteristic ring-shaped appearance.  
Based on the unique domain structure of SLP-1, containing a stomatin and a sterol carrier 
protein-2 (SCP-2) domain, and its enrichment in lipid rafts, we supposed that the protein 
could function in cholesterol/lipid transport. I used filipin staining to analyze the subcellular 
distribution of cholesterol in cells exogenously expressing SLP-1 and found no obvious 
differences to control cells. But when I blocked the transport of cholesterol from the late 
endosomal compartment to the plasma membrane with a synthetic aminosteroid, I 
encountered big differences between cells expressing SLP-1 and control cells. Over-
expression of SLP-1 caused the formation of enlarged, cholesterol-filled perinuclear 
structures. This means that the distribution of cholesterol in the late endosomal compartment 
can be modified by the expression of SLP-1. A truncation mutant in which the SCP-2 domain 
of SLP-1 was deleted did not show this effect, indicating that this domain is necessary to 
modify cholesterol distribution. Finally, live cell imaging of SLP-1-GFP revealed the 
dynamics of SLP-1 on perinuclear vesicles and led to the finding that the protein is 
inhomogeneously distributed on the surface of big endosomal structures and that smaller, 
rapidly diffusing vesicles are also positive for SLP-1-GFP. These small vesicles either 
transiently attach to the bigger structures or fuse and pinch off these structures as discrete 
entities. The precise nature of these transport intermediates remains to be clarified.  
In a second part of my work, I tried to expand our knowledge about the prototype family 
member, the stomatin protein. I established a fluorescence recovery after photobleaching 
(FRAP) assay and demonstrated that deletion of the outermost C-terminus of stomatin 
modifies the diffusion properties of this protein. The mobile fraction and the diffusion speed 
both increase when the outermost C-terminus, which is essential for oligomerization and lipid 
raft association, is deleted.  
To identify potential interaction partners and functional mechanisms where stomatin could 
play a role, I performed 2D PAGE analyses of platelet DRM fractions and identified the 
proteins and post-translational modifications (PTMs) of stomatin by mass spectrometry (at the 
Mass Spectrometry Unit). In resting platelets, the protein was detected in 3 separate spots, one 
close to the theoretical isoelectric point and two spots shifted towards the acidic end, which 
may correspond to one and two additional negative charges, respectively. The mass 
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spectrometric analyses for PTMs revealed a potential novel phosphorylation site (serine-231) 
and a cryptic, yet unknown modification, which was detected on three consecutive stomatin 
peptides. The significance of these modifications remains to be determined. Finally, another 
strategy was taking advantage of the increasing number of reported mutations in the C. 
elegans stomatin homologues MEC-2 and UNC-1. I identified conserved residues, whose 
mutations cause a phenotype in the worm, and constructed the respective point mutations in 
the human stomatin protein. The analyses of the mutants are only at the beginning but indicate 
that this strategy will lead to new insights in the mechanisms which direct the subcellular 
targeting and transport of this protein.  
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1 ZUSAMMENFASSUNG 
 
Die humane Stomatin-Proteinfamilie besteht aus 5 Mitgliedern, dem Prototypen Stomatin, 
Stomatin-like protein 1 (SLP-1), SLP-2, SLP-3 und das Nieren-spezifische Podocin-Protein, 
deren genaue Funktion noch weitgehend unbekannt ist. Das geringe Wissen über diese 
Proteinfamilie kann durch die hydrophobe Natur und die enge Assoziierung dieser Proteine 
mit Membranen erklärt werden, da diese Faktoren noch immer eine große Herausforderung 
für Biochemiker und Zellbiologen darstellen. Genetische Daten aus dem Modellorganismus 
C. elegans, knock-out Experimente in Mäusen und genetische Daten von Patienten mit 
Steriod-Resistant Nephrotic Syndrome lassen auf eine wichtige, aber wahrscheinlich 
redundante Funktion für diese Proteine schließen.  
Der Schwerpunkt dieser Arbeit liegt auf dem humanen SLP-1 Protein, dem am wenigsten 
charakterisierten Familienmitglied. Da kein Antikörper gegen das humane SLP-1 Protein 
erhältlich war, habe ich das SLP-1-Protein mit unterschiedlichen Tags verknüpft (GFP, myc-
Epitop und HA-Epitop) und exogen exprimiert und die Fusionsproteine mit biochemischen 
und zellbiologischen Methoden charakterisiert.  
In Analogie zu Stomatin wurde das getaggte SLP-1-Protein auf perinucleären Vesikeln 
detektiert, zeigte aber im Gegensatz zu Stomatin keine Plasmamembran-Lokalisation in der 
Immunfluoreszenz- und Immunoelektronen-Mikroskopie. Subzelluläre Fraktionierung und 
biochemische Analyse bestätigten die endosomale Lokalisation. Durch Vergleich der 
Lokalisation von SLP-1 mit unterschiedlichen Organellenmarkern in Immunfluoreszenz-
Versuchen konnte gezeigt werden, dass es sich bei den perinucleären, SLP-1-positiven 
Vesikeln um Late Endosomes (LEs) handelt. Die Co-Lokalisation mit unterschiedlichen 
Markern für dieses Kompartiment war variabel und wies auf eine breite Verteilung von SLP-1 
über die diversen LE-Subkompartments hin. Die Konstruktion von verschiedenen 
Verkürzungs- und Punkt-Mutanten des SLP-1-Proteins führte zur Identifizierung eines 
Tyrosin-basierenden N-terminalen Sortiersignals in den ersten 10 Aminosäuren des Proteins. 
In chimären Konstrukten, in denen der N-terminus des Stomatin-Proteins durch den N-
Terminus von SLP-1 ersetzt wurde, war dieses Motiv hinreichend, um das Fusionsprotein zu 
LEs/Lysosomen zu dirigieren und die Plasma-Membran-Lokalisation von stomatin zu 
unterbinden. C-Terminale Deletionsmutanten von SLP-1 zeigen auch Auswirkungen auf die 
korrekte subzelluläre Lokalisierung, wie am Beispiel eines Konstruktes klar wurde, welches 
zu cytoplasmatischen Aggregaten und tubulären Strukturen fehlgeleitet wird. Diese C-
terminale Verkürzung wurde in Elektronenmikroskopie-Experimenten untersucht, und es 
konnte gezeigt werden, dass die zytoplasmatischen Aggregate kleine Lipid Bodies 
(alternativer Name Lipid Droplets) darstellen. Wahrscheinlich führte die Über-Expression der 
SLP-1-Verkürzungsmutante zur Ausbildung dieser charakteristischen Strukturen.  
Unsere Hypothese, dass die menschlichen SLP-1- und stomatin-Proteine einen Komplex 
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bilden könnten wie ihre C. elegans Gegenstücke UNC-24 und UNC-1, wurde in dieser Arbeit 
verifiziert. Komplexbildung zwischen endogenem Stomatin und exogen exprimiertem, 
getaggtem SLP-1 konnte in Immunpräzipitations-Experimenten gezeigt werden. Beide 
Proteine ko-lokalisierten in Immunfluoreszenz-Experimenten auf Late Endosomes, und 
interessanterweise veränderte sich die Lokalisation von endogenem Stomatin bei 
Überexpression von SLP-1, wobei eine klare Verschiebung von der Plasmamembran zu Late 
Endosomes festzustellen war. Diese Daten verweisen darauf, dass hetero-oligomere 
Komplexe zwischen Stomatin und SLP-1 gebildet werden, und dass sich die Eigenschaften 
dieser hetero-oligomeren Komplexe von den bekannten homo-oligomeren Stomatin-
Komplexen stark unterscheiden könnten. Biochemische und zellbiologische Ergebnisse 
unterstützen eine oligomere Struktur von SLP-1. Wie Stomatin ist auch SLP-1 in sogenannten 
Detergent-Resistant Membranes (DRMs) oder Lipid Rafts angereichert, obwohl es nicht an 
der Plasmamembran zu finden ist. Einer der Hauptunterschiede zwischen SLP-1 und Stomatin 
wurde in Bezug auf die Assoziierung mit Lipid bodies/droplets festgestellt. Wild-Typ SLP-1 
wurde nie auf der Oberfläche dieser Lipid-Speicherorganellen detektiert, wohingegen sowohl 
Stomatin als auch eine C-terminale Verkürzung von SLP-1 auf Lipid bodies detektiert wurden 
und die charakteristische, ringförmige Färbung zeigten.  
Basierend auf der einzigartigen Domänenstruktur von SLP-1, welches eine Kombination von 
einer Stomatin–Domäne und einer Sterol Carrier Protein-2 (SCP-2)-Domäne beinhaltet, und 
auf der Anreicherung in lipid rafts, kamen wir zu der Annahme, dass eine Funktion des 
Proteins im Cholesterin/Lipid-Transport möglich ist. Ich verwendete den Farbstoff Filipin, um 
die subzelluläre Verteilung von Cholesterin in Zellen, die SLP-1 überexprimieren, zu 
untersuchen. Dabei fand ich keine augenfälligen Unterschiede zu Kontroll-Zellen. Aber als 
ich den Cholesterin-Transport von den Late Endosomes zur Plasma-Membran mit einem 
synthetischen Aminosteroid inhibierte, fand ich große Unterschiede zwischen Kontrollzellen 
und SLP-1-exprimierenden Zellen. Überexpression von SLP-1 führte zur Bildung von stark 
vergrößerten, Cholesterin-gefüllten perinukleären Strukturen. Dieses Ergebnis zeigt, dass die 
Cholesterin-Verteilung im Late-endosomalen Kompartment durch die Expression von SLP-1 
verändert werden kann. Eine Verkürzungsmutante, bei der die SCP-2-Domäne entfernt 
wurde, zeigte diesen Effekt nicht, wodurch gezeigt wird, dass diese Domäne für die 
Modifizierung der Cholesterin-Verteilung notwendig ist.  
Live-Cell-Imaging gab schließlich Aufschlüsse über die Dynamik des SLP-1-Proteins auf den 
perinukleären Vesikeln und zeigte, dass das SLP-1-Protein meist sehr inhomogen auf der 
Oberfläche von größeren Vesikeln verteilt ist und dass es einen zweiten Pool von kleineren, 
sehr schnell diffundierenden Vesikeln gibt. Diese kleinen Vesikel können entweder 
kurzfristig mit größeren Strukturen interagieren, oder sie fusionieren und schnüren sich dann 
wieder als diskrete Einheiten von den größeren Vesikeln ab. Worum es sich bei diesen 
kleinen, schnellen Strukturen genau handelt, muss erst geklärt werden.  
In einem zweiten Teil meiner Arbeit versuchte ich unser Wissen über das stomatin-Protein 
selbst zu erweitern. Ich konnte einen Fluorescence Recovery After Photobleaching (FRAP)-
Assay etablieren und zeigen, dass die Deletion des äußersten C-Terminus von Stomatin die 
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Diffusionseigenschaften des Proteins in der Plasmamembran beeinflusst. Sowohl die mobile 
Fraktion als auch die Diffusionsgeschwindigkeit erhöhen sich, sobald der C-Terminus, der 
auch für die Oligomerisierung und die Lipid-Raft-Assoziierung notwendig ist, deletiert ist.  
Um potentielle Interaktionspartner und funktionelle Mechanismen, bei denen Stomatin eine 
Rolle spielen könnte, auszumachen, führte ich 2D-PAGE-Analysen von Thrombozyten-
DRM-Fraktionen durch und ließ die Proteine und post-translationelle Modifikationen (PTMs) 
von Stomatin durch Massenspektrometrie identifizieren (Mass Spectrometry Unit, VBC). In 
unaktivierten Thrombozyten wurden 3 Spots für Stomatin gefunden, einer nahe am 
theoretischen iso-elektrischen Punkt, und zwei zur sauren Seite verschobene Spots, die eine 
bzw. zwei zusätzliche negative Ladungen darstellen könnten. Die massenspektroskopische 
Analyse auf PTMs ergab eine potentielle neue Phosphorylierungsstelle für Stomatin (Serin-
231) und eine kryptische, bis jetzt unbekannte Modifikation, die auf drei 
aufeinanderfolgenden Stomatin-Peptiden gefunden wurde. Die Natur und Bedeutung dieser 
Modifikation muss erst genauer untersucht werden.  
Schließlich habe ich in einem letzten Ansatz versucht, das zunehmende Wissen über 
Mutationen in den Stomatin-verwandten Proteinen MEC-2 und UNC-1 in C. elegans für die 
Untersuchung des humanen Proteins auszunutzen. Ich habe zuerst konservierte Aminosäuren 
in der Sequenz identifiziert, bei denen Mutationen einen Phänotyp im Wurm verursachen. 
Dann habe ich die entsprechenden Punktmutationen im humanen Stomatin-Protein 
konstruiert. Die Analyse dieser Punktmutationen steht erst am Anfang, aber erste Ergebnisse 
lassen vermuten, dass diese Strategie zu neuen Einsichten in die Transport- und Targeting-
Mechanismen des Proteins führen werden.  
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2 INTRODUCTION 
2.1 The stomatin protein family  
The human stomatin protein family currently comprises 5 members: stomatin (Hiebl-
Dirschmied et al., 1991b; Stewart et al., 1992), stomatin-like protein (SLP)-1 (alternative 
names hUNC-24, STOML-1, STORP) (Gilles et al., 2000; Seidel and Prohaska, 1998), SLP-2 
(Wang and Morrow, 2000), SLP-3 (Goldstein et al., 2003; Kobayakawa et al., 2002) 
(alternative name SRO) and podocin (Boute et al., 2000). These 5 proteins all share a 
stomatin-homology region and are part of the much larger SPFH (stomatin-prohibitin-
flotillin-HflK/C) superfamily (Tavernarakis et al., 1999). Of this superfamily, prohibitins and 
flotillins are also present in humans. The core SPFH domain is of very ancient origin, as it is 
already found in several archaebacteria and bacteria. Members of the SPFH family are found 
throughout the prokaryotic and eukaryotic kingdom, in E. coli, yeasts, fungi, plants and all 
animals from C. elegans to mammals. The numerous members of the SPFH protein family are 
thought to descend from a common ancestor, which must have evolved before the separation 
of archaebacteria and eubacteria. In the course of evolution of higher eukaryotes, the family 
has branched and the clearly distinct stomatin, flotillin and prohibitin families have 
developed. Another hypothesis, which was published recently (Rivera-Milla et al., 2006), 
suggests convergent evolution of different family members from different precursors instead 
of divergent evolution. As the main branches of the family are all of very ancient origin, it is 
very difficult to make a decision based on phylogenetic data of current organisms. 
Nevertheless, the ancient origin supports a basic function for SPFH family members. I will 
mainly focus on the stomatin family members here, a short summary of the status of research 
on prohibitins, flotillins and HflK/C proteins is given in chapter 2.3.  
 
Figure 1 shows a neighbour joining tree of the human members of the stomatin protein 
family. SLP-2 has diverged most early and probably represents the most ancient member of 
the family. It is missing the characteristic, unusually long hydrophobic stretch of amino acids 
found before the SPFH domain in all 4 other members. SLP-1 represents a combination of the 
SPFH domain with a C-terminal SCP-2 domain. Orthologues of SLP-1 and SLP-2 are already 
detected in C. elegans. In the course of evolution of higher organisms, the prohibitin and SLP-
3 proteins have evolved. They both share high sequence homology with stomatin over its 
whole length. Podocin is already found in fish and contains an elongated N-terminus which 
probably is responsible for its special function in the nephrotic system. SLP-3 is only 3 amino 
acids longer than human stomatin, and shares 68% identity and 84% similarity with stomatin. 
It is probably the result of a gene duplication event in mammals, and its expression is 
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restricted to olfactory neurons in mice. The current knowledge on the five stomatin family 
members is summarized in the following section.  
 
Figure 1: Neighbour joining tree of the human stomatin family 
 
Figure 1: Neighbour joining tree of the human stomatin family proteins. The tree is based on an alignment 
computed with the ClustalW programme (http://www.ebi.ac.uk/clustalw/). The Entrez accession numbers for the 
protein sequences are given in brackets.  
 
2.1.1 Stomatin 
Human stomatin was described as a major integral membrane protein of human erythrocytes 
(band 7.2b)(Hiebl-Dirschmied et al., 1991a). It was found to be missing in mouth-shaped = 
stomatocytic erythrocytes of patients suffering from a rare, hereditary anemic condition 
named “overhydrated hereditary stomatocytosis” (OHSt)(Wang et al., 1991). These 
stomatocytes show an increased membrane permeability for monovalent cations (Na+, K+) 
and therefore increased osmotic fragility, giving rise to a decreased lifetime of the 
erythrocytes. The band 7.2b protein was renamed to stomatin, as its lack was considered to 
cause the disease(Stewart et al., 1992). Analysis of the stomatin gene in patients revealed that 
no mutations are present in the gene or in the promoter region, raising the first doubts on the 
causative role of stomatin OHSt(Fricke et al., 2003). Later, it was shown that erythrocyte 
precursors of OHSt patients contain normal amounts of stomatin and that the protein is lost 
from the precursors during a terminal maturation step(Fricke et al., 2005). Additionally, 
stomatin knock-out mice were viable without any obvious phenotype and, especially, with 
normal erythrocytes(Zhu et al., 1999). Therefore, a defect in stomatin is not the cause for 
OHSt, but the increased cation permeability could be linked to the absence of stomatin from 
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the erythrocyte membrane. Stomatin contains an unusually long, hydrophobic sequence close 
to its N-terminus, which is an atypical membrane domain, as it probably is integrated into the 
membrane in the form of a hydrophobic hairpin, with both N- and C-terminus in the 
cytoplasm. This was deduced from findings that Serine-9 can be phosphorylated in intact 
erythrocytes in response to cAMP(Salzer et al., 1993), and from protease protection studies in 
intact erythrocytes. This peculiar organisation of the integral membrane domain is shared with 
the caveolin protein family. The stomatin promoter shows the typical features of a house-
keeping gene, like the absence of a TATA-box and binding sites for general transcription 
factors (SP1, AP1, AP2, CP1/2, NFκB, CREB). Two imperfect sequences for erythroid 
factors (EKLF and GATA-1) were also found(Unfried et al., 1995). The mRNA is detected in 
almost all tissues and cell types, consistent with a basic function of the stomatin 
protein(Unfried et al., 1995). Stomatin was shown to be palmitoylated on two cysteine 
residues, on cysteine-29 and, to a lesser extent, on cysteine 86(Snyers et al., 1999b). The 
protein forms high-order-oligomers in UAC cells(Snyers et al., 1998), erythrocytes(Salzer and 
Prohaska, 2001) and platelets(Mairhofer, 2001), with an oligomer size of approximately 300 
kDa. One of the most important features of stomatin is its association with detergent-resistant, 
cholesterol- and sphingolipid-rich membrane domains, also termed lipid rafts(Mairhofer et al., 
2002; Salzer and Prohaska, 2001; Snyers et al., 1999a). The protein was shown to be localized 
to the plasma membrane and to late endosomes in UAC cells (ratio 1:1 PM:LEs in UAC cells) 
and several other cell types. Plasma membrane stomatin colocalizes with filamentous actin 
even when the cells are treated with actin-filament-disrupting drugs like cytochalasin 
D(Snyers et al., 1997). Upon polarization of MDCK cells(Snyers et al., 1999a) or HepG2 
cells (M. Mairhofer, unpublished observations), stomatin translocates to the apical surface. 
Lipid rafts are thought to play an essential role in apical protein sorting, therefore it is not 
surprising that stomatin is sorted to the apical PM. Recently, Ellen Umlauf from our group 
could show that stomatin is also associated with cytoplasmic lipid droplets (alternative 
designation lipid bodies)(Umlauf et al., 2004). This finding supports the proposed hairpin 
structure for the hydrophobic domain, because proteins with membrane-spanning 
transmembrane domains are excluded from the lipid monolayer limiting the droplets(Brown, 
2001). In another publication, a region in the C-terminus of stomatin was identified, which is 
essential for lipid raft association and oligomerization of the protein. Point mutations in single 
amino acids were shown to differentially affect either oligomerization or lipid raft 
association(Umlauf et al., 2006), with the conclusion that oligomerization is not required for 
lipid raft association. The recent discovery that stomatin interacts with acid-sensing ion 
channels (ASICs) and modifies the gating properties of some ASICs(Price et al., 2004) is very 
interesting, because it fits very well to data from C. elegans, where stomatin orthologues were 
shown to interact with members of the degenerin channel family(Sedensky et al., 2004; Zhang 
et al., 2004a), and it could also explain the defect in cation permeability observed in OHSt 
patients. The mechanism for regulation of channel activity by stomatin is not clear yet. A 
model deduced from prokaryotes, where stomatin-related proteins form an operon with 
membrane-linked proteases(Green et al., 2004), suggests that the C-terminus of stomatin 
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directly interacts with the channel pore, inhibiting transport activity. Proteolytic cleavage of 
the stomatin C-terminus causes detachment of stomatin from the pore, thereby increasing ion 
transport. This so-called ball-and-chain model(Stewart, 1997) is highly speculative and not 
really backed up by experimental data. A direct interaction between ion channels and stomatin 
is supported by co-immunoprecipitation experiments in different systems(Price et al., 2004; 
Zhang et al., 2004a). Nevertheless, one must be aware that co-IPs of membrane proteins are 
prone to false positives due to incomplete solubilization of cellular membranes. 
Immunoprecipitations of lipid raft proteins are even more critical due to the inherent 
detergent-resistence of the raft domains. Therefore, it could also be true that stomatin and ion 
channels are both localized to lipid rafts, and that the regulation of ion channel activity 
happens by influencing the local properties of the membrane(Huber et al., 2006). The spider 
venom VSTX1, for example, was shown to have a dramatic influence on ion channel activity, 
but it does not affect channel activity by direct binding, but rather by changing the properties 
of the surrounding plasma membrane(Lee and MacKinnon, 2004). Two stomatin orthologues 
from C. elegans were shown to influence sensitivity to volatile anesthetics, which probably 
also affect membrane properties instead of direct binding to ion channels(Morgan et al., 1990; 
Rajaram et al., 1998). As outlined above, the function of the stomatin protein probably lies in 
the regulation of ion channels, but many details are still missing. Based on its enrichment in 
lipid rafts and its close linkage to the cytoskeleton, stomatin might play an important role as a 
membrane organizer, influencing the local properties of the inner leaflet of the plasma 
membrane. Unpublished data from E. Umlauf, which show that a photoreactive, radiolabeled 
cholesterol is bound by the core SPFH domain of stomatin, also support this role. Another 
string of evidence indicates that stomatin interacts with the glucose transporter GLUT-1 and 
negatively affects glucose transport (Zhang et al., 2001; Zhang et al., 1999). GLUT-1 is at 
least partially lipid raft-associated in erythrocytes and in nucleated cells. Conditions which 
induce an increased demand for glucose cause an increase of the non-raft associated fraction 
of GLUT-1, suggesting a mechanism where the activity of GLUT-1 is determined by 
association/dissociation of membrane microdomains(Rubin and Ismail-Beigi, 2003; Rubin 
and Ismail-Beigi, 2004). It remains to be determined if stomatin directly influences GLUT-1 
activity or if it rather acts by influencing its distribution between rafts and non-raft domains. It 
is also interesting that, although human erythrocytes strongly express GLUT-1, this protein is 
not expressed in mouse erythrocytes. If stomatin function in human erythrocytes was coupled 
to the GLUT-1 protein, this would explain why the erythrocytes of the stomatin knock-out 
mouse did not show the expected stomatocytic phenotype.  
 
2.1.2 Stomatin-like protein-1(SLP-1) 
SLP-1 was identified as the human homologue of C. elegans UNC-24 protein, which gives 
rise to an uncoordinated phenotype when the gene is mutated. The unc-24 gene could be 
mapped and sequenced, revealing the protein sequence of UNC-24. The protein contains a 
unique combination of an SPFH-domain followed by a SCP-2 domain (Barnes et al., 1996). 
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This combination is also found in the human SLP-1 protein. On multiple tissue northern blots, 
a strong expression of SLP-1 was observed in the brain, along with a considerable expression 
in skeletal muscle and heart, with only low levels of expression in other tissues (Seidel and 
Prohaska, 1998; Wang and Morrow, 2000). SLP-1 was therefore considered to be the brain-
specific stomatin, because stomatin was long considered to be absent from the brain. This 
view had to be corrected, because several groups have shown that stomatin is present in nerve 
cells of humans and rodents(Fricke et al., 2000; Mannsfeldt et al., 1999). Stomatin and SLP-1 
are now considered to be co-expressed in the brain, and in the light of findings from C. 
elegans, they could function in a hetero-oligomeric complex there. A second group also 
cloned the SLP-1 gene (they named it STORP) and mapped it to chromosome 15q22(Gilles et 
al., 2000). They deduced a slightly different protein sequence to Seidel et al, which was 
confirmed to be correct after the completion of the human genome. Like Seidel et al., they 
performed multiple tissue northern blotting and found SLP-1 to be ubiquitously expressed, 
although their data were clearly of lower quality than the data of Seidel et. al..  
 
Figure 2: Multiple sequence alignment of mammalian SLP-1 proteins and UNC-24 
 
Figure 2: Multiple sequence alignment of four mammalian SLP-1 proteins and C. elegansUNC-24. The 
alignment shows that the mammalian SLP-1 protein sequences are extremely well conserved, whereas there are 
big differences to UNC-24.  
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The number of isolated EST clones isolated from brain and microarray data support a 
preferential expression of SLP-1 in the nervous system, but low-level expression of SLP-1 in 
other tissues could be of interest in the light of a proposed regulatory function of SLP-1 on 
stomatin. Gilles et al. also analysed different tumor cell lines and again detected the SLP-1 
mRNA in all analysed cell lines. If SLP-1 were expressed in these established tumor cell 
lines, the endogenous protein could be studied in one of these cell culture systems. In their 
characterization of the human SLP-2 protein, Wang et al. also analysed the tissue distribution 
of SLP-1 by northern blotting and also found strong expression in the brain and substantial 
expression in heart and skeletal muscle(Wang and Morrow, 2000). Verification of SLP-1 
protein levels in different tissues and cell lines will eventually clarify the discrepancies 
between these studies.       
 
2.1.3 SLP-2 
SLP-2 was cloned and characterized in detail some years ago(Wang and Morrow, 2000). The 
protein does not contain a continuous hydrophobic domain close to its N-terminus, as do all 
other members of the stomatin protein family. The amino acid sequence shows the least 
homology to human stomatin, indicating the biggest evolutionary difference. The mRNA was 
shown to have a broad tissue distribution and the protein was detected in a wide range of cell 
lines, similar to stomatin. It was also detected in mature red blood cells, giving rise to a 
double band in western blots. Interestingly, the higher moleclular weight (MW) band was 
found to be largely detergent insoluble, whereas the lower MW band was largely soluble. This 
behaviour suggests that a post-translational modification, perhaps palmitoylation, is required 
for SLP-2 to partition into DRMs or lipid rafts. In support of a broad tissue distribution and 
lipid raft association of SLP-2, the protein was identified in several proteomic studies of lipid 
rafts (Sprenger et al., 2004). Recent reports revealed that SLP-2 expression is upregulated in 
esophageal squamous cell carcinoma (ESCC) and in other cancer types(Zhang et al., 2006). 
An ESCC cell line transfected with antisense SLP-2 showed decreased cell growth, 
proliferation, tumorigenecity, and cell adhesion(Zhang et al., 2006). This finding raises the 
possibility that SLP-2 upregulation is associated with the transformation of normal cells into 
tumor cells. During the writing of this thesis, Hajek et al. reported that SLP-2 is localized to 
mitochondria and forms a complex with mitofusin-2(Hajek et al., 2006). The authors deduced 
that SLP-2 is associated with the inner mitochondrial membrane and faces the intermembrane 
space. This mitochondrial localization is very interesting in respect to reports that SLP-2 
expression is up-regulated in several carcinomas. Several important questions concerning 
SLP-2 are still unresolved, the subcellular localization of the protein, for example, seems to 
be different in different cell types, and possible interactions with other stomatin family 
members have not been examined. Recently, two conference abstracts were published, which 
both report that the mouse knock-out of SLP-2 is embryonically lethal, which indicates an 
important function for SLP-2.  
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2.1.4 SLP-3  
SLP-3 was discovered shortly after the completion of the human genome sequence. It is the 
“youngest” stomatin family protein and has probably evolved by a gene duplication of the 
stomatin gene in mammals. It shares 68% identity and 84% similarity with stomatin in the 
homologous region, and the genomic organization is very similar. The biggest differences are 
found in exon 1, so this exon could have evolved independently and become fused to exons 2-
6 of a common progenitor. The mouse gene and protein were analysed in more detail and the 
transcript as well as the protein were found to be restricted to the olfactory epithelium, 
whereas vomeronasal neurons were negative for mSLP-3 staining(Kobayakawa et al., 2002). 
The promoter of the mouse and human gene contains a consensus site for the olfactory-
specific transcription factor Olf-1. The protein was shown to be membrane-associated and 
enriched in a cilia membrane fraction of the olfactory epithelium. Mouse SLP-3 was detected 
in lipid rafts and was found to co-immunoprecipitate with caveolin-1 and adenylyl cyclase 
type III (ACIII), and cAMP-production was enhanced after incubation of cilia with an anti-
SLP-3 antibody(Kobayakawa et al., 2002). These results indicate that SLP-3 could be 
involved in generating olfactory signals in a complex with caveolin and ACIII.  
Recently, a paper describing the knockout of SLP-3 in mice was published. In their work, 
Wetzel et al. showed that the SLP-3 knockout mice have distinct defects in 
mechanosensation. The animals are viable and fertile, and they also respond to touch, but they 
show no response to certain mechanical stimuli, and certain types of mechanosensory neurons 
in the skin of the mice are defective (Wetzel et al., 2007).  
 
 
2.1.5 Podocin  
Podocin was discovered in an effort to identify a causative gene for autosomal recessive 
steroid resistant nephritic syndrome(Boute et al., 2000). The gene, named NPHS2, was 
mapped to 1q25-31. Positional cloning revealed that the NPHS2 gene encodes a novel 
stomatin family protein, which was almost exclusively expressed in the podocytes of fetal and 
mature kidney glomeruli. The protein was named podocin, and numerous mutations in the 
gene, which cause defects in glomerular filtration, have been described. Interestingly, most 
disease-causing mutations were found in the central region homologous to stomatin(Caridi et 
al., 2005).  
Not surprisingly, podocin was found to be enriched in lipid rafts(Schwarz et al., 2001). The 
protein was shown to interact with nephrin (the protein product of the NPHS1 gene) and with 
CD2AP(Schwarz et al., 2001). Nephrin was identified as the protein product of the gene 
mutated in the finnish type of hereditary nephrotic syndrome, the most severe disorder(Kestila 
et al., 1998). Knockout-mice lacking CD2AP develop a nephrotic syndrome resembling 
NPHS mutations(Shih et al., 1999). All three proteins were shown to form a high-MW 
complex in lipid rafts, and lipid rafts were implicated in nephrin phosphorylation(Huber et al., 
Introduction 
PhD thesis   Mario Mairhofer 
 21 
 
2003). The clinical manifestations of mutations in the NPHS2 gene have drawn attention to 
the podocin protein. A great number of publications describing new cases and mutations have 
been published recently. To date, about 20 different NPHS2 mutations have been described in 
familial or sporadic cases of steroid-resistant nephrotic syndrome (Caridi et al., 2005). Some 
of the findings presented above, especially the complex between nephrin, podocin and 
CD2AP, have been challenged recently (Fan et al., 2006). Nevertheless, the essential role of 
podocin for the integrity of the glomerular slit diaphragm is undisputed, and future research 
will help improve treatment and diagnosis of hereditary nephrotic syndromes. In support of an 
interaction between podocin and nephrin, Nishibori et al. described podocin mutants, which 
interfere with wild-type nephrin trafficking(Nishibori et al., 2004). A recent paper also 
provided insights into the mode of plasma membrane targeting of podocin (Roselli et al., 
2004). The protein was shown to be targeted to the PM through the classical exocytic 
pathway, and several mutated podocin variants were shown to be mislocalized (either to the 
ER or to late endosomes). Other mutations did not abolish PM targeting. Mutations causing 
mistargeting to the ER showed a more early onset of the nephrotic syndrome compared to 
mutations targeted to the PM. Another report stated that a podocin mutant retained in the ER 
(R138Q) could be refolded  and correctly targeted to the PM through the addition of chemical 
chaperones(Ohashi et al., 2003). These compounds might lead to the development of novel 
therapeutic strategies for patients with podocin mutations. In a very interesting article dealing 
with the cholesterol binding properties of podocin and MEC-2, Huber et al. demonstrated that 
podocin binds cholesterol in its SPFH domain and that cholesterol binding is essential for 
regulation of a TRP family ion channel in kidney cells (Huber et al., 2006). For our group, 
which is interested in the function of stomatin, mutations in amino acids conserved between 
stomatin and podocin might provide insights into the function of the core stomatin region.  
 
2.2 Stomatins in C. elegans: Mecs and Uncs and several 
more! 
Several stomatin family members have been identified in genetic screens of the model 
organism C. elegans. The genetic data underline the importance of stomatin family members 
in C. elegans and had a big impact on the proposed function of human stomatin.  
Shortly after the genomic sequence of C. elegans was finished, it was recognized that the 
worm genome contains 10 different stomatin family members. Compared to the human 
genome, which contains only 5 stomatin family members, this is striking, because for the 
most protein families, the number of members has increased during the course of evolution 
from a simple worm to homo sapiens. Three stomatin family proteins, MEC-2, UNC-1 and 
UNC-24, have been characterized in detail. All three were identified in genetic screens and 
mutations in the genes were found to cause distinct phenotypes. Evidence was collected that 
these proteins have important functions in the nervous system of the worm, influencing 
normal locomotion, mechanosensation and sensitivity to volatile anesthetics. These data have 
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led to the proposal that human stomatin might have a similar function and that the common 
mechanism could be the interaction of stomatin family members with ion channels. A detailed 
overview of the data for each protein is presented in the following section.  
 
2.2.1 The MEC-2 protein and mechanosensation in C. elegans  
Mechanotransduction, the conversion of mechanical stimuli into an electrical signal, is an 
essential feature of all higher organisms. Hearing, touch sense and sense of acceleration are 
only a subset of features which rely on specialized mechanosensory cells, which generate 
electrical currents and transduce these signals to the CNS(Gillespie and Walker, 2001). Touch 
receptors in mammals are very difficult to study, because they are deeply embedded in the 
skin and only constitute a small fraction of total skin cells. The nematode C. elegans, which is 
composed of a constant number of cells and can be subjected to genetic screening methods 
after induced mutagenesis, was chosen by Martin Chalfie to study mechanotransduction 
(Chalfie and Au, 1989; Way and Chalfie, 1988). The worm contains only 6 touch receptor 
neurons (see figure 2A), which are characterized by typical 15-protofilament microtubules 
instead of 12-protofilament structures found in other cells. Chalfie and colleagues developed 
an assay to detect a changed response towards gentle or harsh touch and identified hundreds 
of so-called mechanosensory mutants(Chalfie and Au, 1989; Chalfie and Sulston, 1981). 
Thirteen genes are needed for touch cell function (mec-2, mec-4 through mec-10, mec-12, 
mec-14, mec-15 and mec-18)(Gillespie and Walker, 2001). These genes are most likely 
directly involved in mechanosensation, because they do not cause general nerve cell 
degeneration. Several of these components fit well to the proposed model of an ion channel, 
which is linked to the extracellular matrix and to the microtubule cytoskeleton (figure 2C). 
The C. elegans MEC-2 protein, which shows high sequence similarity with stomatin in its 
central region (see alignment Figure 4), plays a central role in this model because it is 
proposed to link the ion channel composed of MEC-4 and MEC-10 to the microtubule 
cytoskeleton. Generation of force through touch displaces the extracellular matrix and thereby 
generates a mechanical force on the ion channel, which opens if the force is bigger than a 
threshold value. Expression of MEC-2 was shown to be restricted to the 6 touch receptor 
neurons(Huang et al., 1995). The MEC-2 protein contains an elongated N- and C-terminus 
compared to stomatin, the C-terminus containing a SH3 domain(Huang et al., 1995). Both 
extra portions of MEC-2 are not found in any proteins of mammals. In experiments where a 
permanently active channel (MEC-4D/MEC-10D) was expressed in Xenopus oocytes 
together with MEC-2, the activity of the mutant channels was increased by a factor of 
40(Goodman et al., 2002). Deletion of either the elongated C-terminus or the N-terminus or 
both termini abolished this increase, indicating that both termini are involved in the regulation 
of channel activity(Goodman et al., 2002).  
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Figure 3: C. elegans mechanotransduction 
 
Figure 3: C. elegans touch-receptor structure and transduction model. Reprinted from (Gillespie and Walker, 
2001). (A) View of C. elegans showing positions of mechanoreceptors. AVM, anterior ventral microtubule cell; 
ALML/R, anterior lateral microtubule cell left/right; PVM, posterior ventral microtubule cell; PLML/R, 
posterior lateral microtubule cell left/right. (B) Electron micrograph of a touch receptor neuron process. 
Mechanotransduction may ensue with a net deflection of the microtubule array relative to the mantle, a 
deflection detected by the transduction channel. Arrow, 15-protofilament microtubules; arrowhead, mantle. (C) 
Proposed molecular model for touch receptor. Hypothetical locations of mec proteins are indicated.  
 
Nevertheless, these truncation mutants retained the ability to evoke small, but detectable, 
amiloride-sensitive currents. The central stomatin-homologous region of MEC-2 showed a 
strong dominant-negative effect when coexpressed with full-length MEC-2, indicating an 
oligomeric structure of MEC-2(Goodman et al., 2002). Interestingly, also stomatin could 
induce small, amiloride-sensitive currents when coexpressed with the mutant channel and also 
acted dominant-negative on full-length MEC-2(Goodman et al., 2002). This result suggests 
the formation of hetero-oligomers between MEC-2 and human stomatin. The interaction 
between MEC-2 and both the MEC-4 and MEC-10 channel subunits could be confirmed by 
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coimmunoprecipitation experiments in Xenopus extracts(Goodman et al., 2002).  
In genetic screens for touch-insensitive mutants, 54 alleles of mec-2 were identified. More 
than half of these are missense mutations mapped to conserved positions in the central 
stomatin-like domain(Zhang et al., 2004a) (Figure 4). The data summarized above support a 
function for stomatin in the regulation of ion channels. Based on the findings that stomatin is 
palmitoylated and enriched in lipid rafts, Goodman et. al. summarize their results in this 
way,“We propose that the highly conserved, stomatin-like domain of MEC-2 provides an 
essential structural scaffold for interaction with DEG/ENaC proteins, with the lipids 
surrounding the channel or both.“(Goodman et al., 2002) Recently, another stomatin family 
protein from C. elegans, UNC-24 was shown to be also expressed in touch receptor 
neurons(Zhang et al., 2004a). Unc-24 mutants are touch sensitive, but they strongly enhanced 
the touch-insensitive phenotypes of some mec animals(Zhang et al., 2004a). Also, UNC-24 
protein could not replace MEC-2 in Xenopus patch-clamp experiments, but it was co-
immunoprecipitated with MEC-2 as well as MEC-4(Zhang et al., 2004a). Further work will 
be necessary to clarify the influence of stomatin proteins on ion channels, but as Price et 
al.(Price et al., 2004) and Huber et al.(Huber et al., 2006) have described recently, this 
mechanism is also of high interest in humans.  
For our work, the described MEC-2 mutants (P134S = u274 allele; C140/174A = 
palmitoylation-deficient) deficient in cholesterol-binding could provide important insights 
also in the function of the human stomatin(Huber et al., 2006). As a consequence of these 
findings, a function of PHB-domain proteins in maintainance/formation of cholesterol-rich 
micro-environments and thereby regulating the function of ion channels is now accepted by 
most of the researchers in the field.  
 
2.2.2 Uncoordinated worms: UNC-1 and UNC-24  
Both the unc-1 and unc-24 mutants were identified in early genetic screens for genes essential 
for normal locomotion of the worm (Brenner, 1974). Wild-type worms show a sinusoid 
locomotion. After chemical or radiation-induced mutagenesis, worms with defects in 
locomotion could easily be separated from normal worms. Unc-1 and unc-24 alleles both 
showed defects in locomotion(Brenner, 1974). The genes could be cloned more than two 
decades later and revealed that both genes code for proteins which are homologous to human 
stomatin (Barnes et al., 1996; Rajaram et al., 1998).  
 
UNC-1:  
UNC-1 has approximately the same length as human stomatin and shows 52% identity to the 
human protein. Dominant and recessive alleles of unc-1 could be isolated in genetic 
screens(Park and Horvitz, 1986). These alleles showed complex genetic interactions, which 
led to the suggestion that the protein product of unc-1 should exist in an oligomeric form(Park 
and Horvitz, 1986).  
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Figure 4: Alignment of MEC-2 and human stomatin 
Figure 4: Multiple sequence alignment of MEC-2 and human stomatin. Point mutations in conserved amino 
acids are marked by red boxes, whereas point mutations in non-conserved amino acids are marked by green 
boxes. The yellow boxes represent point mutations, where the mutated amino acid in the corresponding mec-
allele is the same as in the stomatin sequence.  
 
After the cloning of the unc-1 gene, the molecular defects in several different unc-1 alleles 
were identified(Rajaram et al., 1998). Some of these defects are missense mutations of amino 
acids conserved between UNC-1 and stomatin, which are very interesting for the investigation 
of the human protein function (see alignment Figure 47). The unc-1 gene was already found 
to be involved in regulating the sensitivity of C. elegans to volatile anesthetics(Morgan et al., 
1990). Volatile anesthetics (VAs) are indispensable tools for medicine since they had been 
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introduced more than 150 years ago, yet their mode of action is very incompletely understood. 
C. elegans was chosen as a model system to identify target sites for the action of volatile 
anesthetics, because its nervous system is very simple compared to mammals. Recessive loss-
of-function-mutations in unc-1 made the animals hypersensitive to diethylether, whereas the 
sensitivity to other VAs like halothane, enflurane and isoflurane remained unchanged(Morgan 
et al., 1990). Importantly, such mutations in unc-1 also suppressed the hypersensitivity of 
unc-79-animals to halothane and instead made the animals hypersensitive to 
diethylether(Morgan et al., 1990). Dominant unc-1 mutations increased sensitivity to all 
volatile anesthetics, but did not suppress unc79 hypersensitivity to halothane(Rajaram et al., 
1998). Different alleles of unc-1 often had different effects on the sensitivity to volatile 
anesthetics. Reporter constructs with GFP under the control of the unc-1 promoter as well as 
expression of UNC-1-GFP fusions and immunostaining of the UNC-1 protein showed that 
unc-1 is broadly expressed in the nervous system of the worm(Rajaram et al., 1999). The unc-
8 gene, which encodes a member of the degenerin family of sodium channels, shows a similar 
pattern of expression and mutant unc-8 alleles affect locomotion and anesthetic sensitivity 
similar to unc-1. Several unc-8 mutants could suppress the phenotypes of unc-1 alleles, but 
the opposite behaviour, suppression of unc-8 phenotypes by certain unc-1 alleles, was also 
observed. A complex of UNC-1, UNC-8 and UNC-79 was suggested, which should be a 
direct target for volatile anesthetics(Rajaram et al., 1999). Recently, UNC-1 was shown to be 
essential for lipid raft targeting of UNC-8 and could be coimmunoprecipitated with an anti-
UNC-8 antibody(Sedensky et al., 2004). These results strongly support the proposed complex 
of UNC-1 and UNC-8.  
 
UNC-24:  
The first unc-24 alleles had also been described by S. Brenner in 1974. Unc-24 mutants 
especially have difficulties moving forward, whereas their backward motion is more 
pronounced (but also not wild-type)(Brenner, 1974). Unc-24 therefore was classified as a 
candidate B-circuit-specific gene (the B circuit of motor neurons is thought to govern forward 
locomotion). Worms carrying both unc-4 and unc-24 mutations cannot move at all and were 
used to screen for revertants of the unc-4 phenotypes (Miller et al., 1993). The function of the 
unc-24 gene was recognized to be closely related to the unc-1 gene. Null-alleles of both genes 
cause a similar locomotory defect, and mutations in both genes can suppress the 
hypersensitivity of animals with mutations in unc-79 to halothane (Sedensky et al., 2001). 
Additionally, an extragenic suppressor acting on both genes was described (Riddle and 
Brenner, 1978). The unc-24 gene was found to code for a protein sequence, which contained 
an SPFH domain and a SCP-2 domain in its C-terminus(Barnes et al., 1996). The long 
hydrophobic domain was also shared with stomatin, and a similar structure with both N- and 
C-termini cytoplasmic and a hydrophobic hairpin anchoring the protein to the PM was 
suggested. Based on this unique domain structure, a function of UNC-24 in lipid transfer 
between closely apposed membranes was proposed. Later, Sedensky et al. described a genetic 
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interaction between unc-24 and unc-1 and showed that the localization of UNC-1 is changed 
in unc-24 null animals(Sedensky et al., 2001). The protein is targeted to the PM of neurons in 
wild-type animals, whereas it accumulates in the perinuclear region of these neurons in unc-
24 null animals, and the amounts of UNC-1 were strongly reduced. Further, unc-24 was found 
to be fully epistatic to unc-1 in respect to locomotion defects as well as to anesthetic 
sensitivity(Sedensky et al., 2001). The authors concluded that UNC-24 probably affects the 
expression or the stability of the UNC-1 protein, and propose that hetero-oligomers 
constisting of UNC-1 and UNC-24 might explain this behaviour. Later, they showed that, 
whereas unc-1 interferes with lipid raft targeting of UNC-8, UNC-24 does not interfere with 
lipid raft targeting of UNC-1 as initially expected(Sedensky et al., 2004).  
 
A novel extragenic genetic suppressor of unc-1 and unc-24: ssu-1 (suppressor of 
stomatin uncoordination) 
Recently, a gene was identified which suppresses the phenotype of unc-1 and unc-24 
mutations(Carroll et al., 2006). The gene was cloned and was found to be a cytosolic ethanol 
sulfotransferase. Ssu-1 is the only such sulfotransferase in C. elegans. Reporter constructs 
revealed that its expression in the nervous system is not as broad as unc-1 expression, but that 
it is restricted to two ASJ neurons(Carroll et al., 2006). The mutation in ssu-1, which is 
responsible for suppression of the phenotype of unc-1, was identified as a deletion removing a 
big part of the C-terminus of the protein(Carroll et al., 2006). Based on its expression in ASJ 
neurons, which function in endocrine signalling, it was proposed that ssu-1 modifies 
signalling molecules, most probably sterols(Carroll et al., 2006). These signalling molecules 
must have some effect on the UNC-1 and UNC-24 proteins or on the ion channels putatively 
regulated by these proteins. If unc-1 negatively regulates the unc-8 degenerin channel, an unc-
1 null mutation should cause increased channel activity, which leads to an unc phenotype. 
Ssu-1 activity is somehow necessary for the manifestation of this phenotype, because ssu-1(0) 
and unc-1(0) animals show normal locomotion. Mec-2 mutations were not suppressed by ssu-
1, therefore ssu-1 is not a general suppressor of all stomatin family members(Carroll et al., 
2006). The mechanism which is responsible for the suppression of the unc mutations is still 
unclear. Carroll et al. suggest that SSU-1 could be responsible for the sulfation of steroids, 
which are functioning as a second messenger and must be transported to the neurons where 
they could regulate UNC-1 and associated ion channels. Interestingly, neurosteroids have 
been shown to modulate the activity of GABA (A) receptors in the human brain (Majewska, 
1992). In addition, the cholesterol content of the plasma membrane was found to influence the 
modulation of GABA (A) activity (Sooksawate and Simmonds, 2001). A mechanism where 
UNC-1 and sulfo-sterol signals generated by SSU-1 cooperatively regulate ion channel 
activity in C. elegans neurons can be envisaged. A central question for the future is whether 
similar mechanisms operate in human cells.  
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2.2.3 Even more stomatins in C. elegans  
In addition to the three genes discussed above, sequencing of its genome revealed that C. 
elegans contains 6 more genes with protein products similar to stomatin. These genes are not 
well characterized, and some of them might be pseudogenes. STO-1, STO-2 and STO-5 have 
an extended N-terminus compared to human stomatin. Interestingly, they all have a 
characteristic long, hydrophobic domain close to their N-terminus. The amino acid sequence 
in this hydrophobic domain is not well conserved, but conservation is generally very high in 
the core stomatin domain after the hydrophobic region. Examination of a multiple sequence 
alignment of all stomatin family proteins in C. elegans except UNC-24 illustrates the high 
conservation, which leads us to the conclusion that the tertiary structure of this central region 
is probably well conserved. UNC-1, MEC-2 and STO-1 to STO-6 are closely related to 
human stomatin and not to SLP-1/UNC-24 or SLP-2. A SLP-2 orthologue is also present 
(named stomatin-like-1=STL-1 to increase confusion). STL-1 shows 60% identity and 80% 
similarity to human SLP-2. No functional data are available for this gene/protein. It is an 
interesting question why C. elegans contains 8 closely related stomatins, whereas mammals 
(to our knowledge) only contain 3 closely related stomatin family members (stomatin, SLP-3 
and podocin). At the moment, answers to this question are purely speculative. One possibility 
is that some functions of the stomatin proteins in C. elegans might have been transferred to 
the flotillin protein family, which is not represented in the C. elegans genome. The sto-1 and 
sto-2 genes were recently identified as candidate genes for a specific expression in ciliated 
neurons of C. elegans by two independent methods (serial analysis of gene expression 
(SAGE) and a bioinformatics screen for binding sites of a cilia-specific transcription 
factor)(Blacque et al., 2005). This is the first evidence that these genes could have a 
specialized function. Reporter constructs under the control of the sto-6 promoter were 
recently found to be broadly expressed in the nervous system of C. elegans (Zhang et al., 
2004b). The same study also revealed that UNC-24 is probably widely expressed in the 
nervous system of the worm. No experimental data are available for sto-3. All 6 sto genes are 
found on the X chromosome, and are probably the result of gene duplications. Most of the 
predicted genes are supported by cDNA-sequences, and they are also present in different 
worms like C. briggsae and C. remanei. Therefore, it is possible that every different stomatin 
fulfils a specialized function, but as we can not be sure if the sto-1 to sto-6 genes are 
functional and expressed, future work could also show that the number of expressed stomatin 
family members is even lower than in mammals.  
In addition to these “core” stomatin family members, the C. elegans genome also contains 2 
prohibitin genes.  
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2.3 The distantly related prohibitin, flotillin and HflK/C 
protein families 
2.3.1 The prohibitin protein family: A mitochondrial story at the PM? 
Two genes encoding prohibitin family proteins are present in mammals: PHB1 and PHB2. 
The two proteins share a highly conserved mid-region, whereas the N- and C-termini are less 
conserved(Coates et al., 1997). Prohibitin homologues have been described in mammals, C. 
elegans, plants and yeast. These family members are highly conserved, suggesting an 
important function for the proteins. Additionally, homologues to both proteins were also 
found in the Cyanobacterium Synechocytis(Coates et al., 1997), highlighting the ancient 
origin. Prohibitin-1 has been described as an intracellular protein, which blocks DNA 
synthesis. It has been cloned in an effort to identify anti-proliferative genes, and micro-
injection of the in-vitro synthesized mRNA into fibroblasts and HeLa cells resulted in 
strongly reduced DNA synthesis(Nuell et al., 1991). Several years later, a refined analysis 
showed that the growth-suppressive activity of the prohibitin mRNA is localized to the 3’ 
UTR and that microinjection of the protein-coding sequence alone had no effect(Jupe et al., 
1996). Prohibitin could be localized to mitochondria(Coates et al., 1997; Ikonen et al., 1995) 
and the S. cerevisiae homologues of prohibitin-1 and -2 were found to regulate replicative 
lifespan of the yeast(Coates et al., 1997). Deletions of either the PHB1 or PHB2 or both genes 
resulted in decreased survival of the cells after a number of cell divisions compared to control 
cells(Coates et al., 1997). The effects of the deletions were additive, suggesting that PHB1 
and PHB2 may be involved in the same processes(Coates et al., 1997). Defective 
mitochondrial segregation was observed in PHB mutants and was suggested as an explanation 
for the shortened replicative life span(Piper et al., 2002). 
Interestingly, prohibitin-1 and prohibitin-2 were also described to non-covalently associate 
with the IgM antigen receptor on B lymphocytes(Terashima et al., 1994) (prohibitin-2 was 
consequently named as BAP37, this designation is still common) and were found to be 
enriched in B cell lipid rafts(Mielenz et al., 2005). These studies suggest that the prohibitins 
can associate with the plasma membrane in lymphocytes. Similar to other SPFH family 
members, the prohibitins were shown to form high-order hetero-oligomers, but in the inner 
mitochondrial membrane(Nijtmans et al., 2000). Nijtmans et al. suggested a function as 
membrane-bound chaperones for the yeast Phb1/2 complex based on observations that it 
stabilizes mitochondrial translation products and is up-regulated when the balanced 
expression of COX-subunits is disrupted(Nijtmans et al., 2000). Tatsuta et al. also analysed 
the yeast prohibitins and confirmed the hetero-oligomeric complex in the inner mitochondrial 
membrane. They identified an unconventional, non-cleavable N-terminal presequence, which 
is essential for mitochondrial targeting of the yeast Phb1 protein and determined that the 
TIM23-translocase mediates membrane insertion(Tatsuta et al., 2005). Additionally, they 
analysed purified prohibitin complexes by single particle electron microscopy and found that 
these complexes are ring-shaped(Tatsuta et al., 2005), which indicates a possible scaffolding 
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function for the yeast prohibitins in the mitochondrial membrane. Importantly, the Phb1/2 
complex was found to directly interact with the mitochondrial AAA-protease which mediates 
degradation of misfolded mitochondrial membrane proteins(Steglich et al., 1999), also 
supporting a role for the prohibitins in the modulation of membrane protein proteolysis.  
Prohibitin-1 was identified in a yeast two-hybrid screen as an interaction partner for the 
retinoblastoma (Rb) protein, which inhibits E2F transcriptional activation(Wang et al., 
1999a). Further studies indicated that prohibitin-1 can directly interact with E2F and the 
kinase Raf-1(Wang et al., 1999b). To increase confusion, prohibitin-1 and Rb were shown to 
co-localize in the nucleus, and prohibitin-1 was shown to recruit other proteins (e.g. HDAC1) 
for transcriptional repression(Wang et al., 2002). Another study showed that prohibitin can 
also interact with the p53 tumor suppressor protein in vitro and in vivo and appears to induce 
p53 –mediated transcription(Fusaro et al., 2003). This study also showed a substantial nuclear 
localization for prohibitin-1 in breast cancer cells, which is reduced upon induction of 
apoptosis. The 3’ UTR RNA of prohibitin1 has recently received much attention in cancer 
research, because it was shown to suppress tumor formation in nude mice when introduced 
into the MCF7 breast cancer cell line(Manjeshwar et al., 2003) and because a polymorphism 
in this region was described, which increased breast cancer susceptibility(Jupe et al., 2001). 
The results on the increased breast cancer susceptibility, though, could not be confirmed in 
another study(Campbell et al., 2003). Additionally, the 3’UTR was shown to decrease breast 
tumor cell motility (Manjeshwar et al., 2004). Independently, prohibitin-2 was identified as an 
interaction partner for the estrogen receptor(Montano et al., 1999). Recently, it was reported 
that prohibitin-1 is recognized by a monoclonal antibody raised against the SV40 Large T 
antigen. The antigenic epitope is necessary for immortalization of cells by the SV40 Large T, 
and the authors speculate that the Virus could thereby overcome cell cycle repression by 
prohibitin(Darmon and Jat, 2000).  
The data presented here for the prohibitin proteins seem conflicting. There are several 
unsolved questions concerning the subcellular localization and function. The subcellular 
localization seems to be different in different cell types (plasma membrane in B 
lymphocytes(Terashima et al., 1994); mitochondria in HeLa cells(Coates et al., 1997), BHK 
cells(Ikonen et al., 1995) and in yeast(Nijtmans et al., 2000; Tatsuta et al., 2005); nucleus in 
MCF7 and T47D breast cancer cells(Fusaro et al., 2003)). One open question is how 
prohibitin-1, which is widely regarded as a type-I transmembrane protein of the inner 
mitochondrial membrane, can alternatively be targeted to the nucleus or the plasma membrane 
under different conditions. It should be noted that the N-terminal, putative membrane-
spanning hydrophobic domain of prohibitin-1 is not found in the yeast homologue. Of course, 
the interaction of prohibitin-1 with key regulators of the cell cycle like Rb and p53 and its 
regulation by c-myc(Menssen and Hermeking, 2002) is very interesting and also fits well to 
its anti-proliferative function. Also, mitochondrial integrity is critical for cell proliferation and 
survival, which could also explain the importance of prohibitin for cell proliferation. Finally, 
the anti-proliferative effect of the prohibitin 3’UTR is still enigmatic. Based on our current 
knowledge, one can conclude that the prohibitins seem to be very versatile proteins with 
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important functions. Further research will eventually shed light on the underlying mechanisms 
which are responsible for the puzzling variety of prohibitin functions. For readers who are 
interested in more details, I would like to mention two reviews on the prohibitin proteins, one 
by Nijtmans et al(Nijtmans et al., 2002), which critically discusses the relevance of non-
mitochondrial functions for the prohibitins, and a second one by Mishra et al.(Mishra et al., 
2006), which cleary promotes the importance of extra-mitochondrial functions for these 
proteins and adds even a new facette by mentioning the observation that prohibitins are also 
detected in human serum (probably they are released into the circulation via lipid droplets), 
and that prohibitin-1 strongly binds complement component C3.  
 
2.3.2 Flotillins/Reggies  
Flotillins/Reggies have been identified independently by 3 different groups. First, a cDNA 
encoding a N-terminally truncated version of flotillin-2 was identified and sequenced in an 
approach to identify the antigen of the antibody ECS-1, which recognized a protein on the 
surface of skin cells(Schroeder et al., 1994b). The gene product (which essentially was a large 
fragment of flotillin-2) was named ESA (epidermal surface antigen), and it was considered to 
play a role in epidermal structure and maintainance, but later, it was recognized that the ECS-
1 antibody did not recognize this protein(Hazarika et al., 1999). Several years later, Schulte et 
al. identified two related proteins, which were strongly upregulated in regenerating nerve cells 
of zebrafish, and named them reggie-1 (= flotillin-2) and reggie-2(flotillin-1)(Schulte et al., 
1997). In the same year, Bickel et al identified two novel proteins in the floating lipid raft 
fractions from mouse lung tissue and named them flotillin-1 and flotillin-2(Bickel et al., 
1997). The name flotillins nowadays is most commonly used, so I will stick to this 
designation. Flotillin proteins are widely used as marker proteins for lipid rafts, because they 
are particularly strongly enriched in these low-density, cholesterol-enriched fractions, but the 
exact function of the proteins is still not known. Nevertheless, the flotillins can now be 
considered the best–studied members of the SPFH superfamily. Well-conserved homologues 
are found in drosophila, and related proteins are found in some bacteria, plants and fungi. 
Flotillins have been shown to participate in important cellular processes in human and 
zebrafish. Recently, the 3D structure of a soluble fragment of mouse flotillin-2 has been 
determined (see Figure 5).  
A small outline of the flotillin structure and proposed functions is given below. 
Flotillins do not contain a very long, hydrophobic domain at their N-termini like stomatin. 
They are quite hydrophobic at their N-terminus, but these hydrophobic stretches are thought 
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Figure 5: 3D structure of a fragment of flotillin-2 
 
Figure 5: Schematic 3D structure of a soluble fragment of flotillin-2/reggie-1. PDB accession number 1WIN. 
The structure was visualized with the Cn3D programme. Alpha-helical regions are shown in green, beta sheets 
are shown in yellow.  
 
not to span the bilayer, but to associate with it. Anchoring to the cytoplasmic leaflet is 
mediated by myristoylation and palmitoylation (flotillin-2)(Neumann-Giesen et al., 2004) or 
only by palmitoylation (flotillin-1)(Morrow et al., 2002). At their C- termini, both flotillins 
contain a flotillin domain which is characterized by numerous EA (glutamic acid-alanine) 
repeats. This domain is necessary for homo-oligomerization(Neumann-Giesen et al., 2004), 
which is probably mediated by formation of coiled coils in the EA-rich region.  
Proposed functions of flotillins/reggies:  
The zebrafish reggie proteins were found to be co-immunoprecipitated with zebrafish Thy-1, 
and this association is also conserved in different mammalian cell types like PC12 cells and 
lymphocytes(Deininger et al., 2003; Lang et al., 1998). Flotillins/reggies can also be co-
immunoprecipitated with other GPI-anchored proteins like F3/contactin(Stuermer et al., 2001) 
and the Prion Protein (PrPc)(Stuermer et al., 2004), which suggests a role for the proteins in 
signal transduction through GPI-anchored proteins. The flotillins also seem to be closely 
associated with the Src-family kinases lck and fyn, as revealed by co-immunoprecipitation 
and co-localisation (LM and ELMI). Two further transmembrane proteins, the ABCA1 
transporter and the thrombin receptor PAR-1, have been co-immunoprecipitated with flotillin-
2. The proposed function as a regulator of cytoskeletal dynamics is supported by the induction 
of filopodia by over-expression of flotillin-2 in several cell types(Hazarika et al., 1999) and 
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by the interaction of the sorbin homology (SoHo) domain of adaptor proteins of the vinexin 
family and flotillin-1(Kimura et al., 2001). The vinexin family of adaptor proteins includes 
vinexin alpha and beta, CAP/ponsin and ArgBP2(Kioka et al., 2002). These proteins are 
characterized by a N-terminal SoHo domain and a C-terminal SH3 domain. The SoHo domain 
is proposed to mediate membrane association via the interaction with flotillin-1, whereas the 
SH3 domain can interact with a variety of proteins (c-Cbl, vinculin, afadin, Grb4 and Sos). 
Flotillin-1-dependent recruitment of a CAP/c-Cbl complex was shown to be essential for 
insulin-stimulated translocation of the GLUT4 glucose transporter from cytoplasmic vesicles 
to the plasma membrane in adipocytes(Baumann et al., 2000). Flotillins also seem to play an 
essential role in T-cell activation. They are thought to control the assembly of signalling 
complexes and cytoskeletal rearrangements necessary for prolonged TCR-signalling via 
interaction with lck, fyn and the adaptor protein LAT. Furthermore, flotillin-1 and -2 show a 
polarized localization in resting lymphocytes, forming a so-called “preformed cap”. Recently, 
it was demonstrated that flotillin-2 is practically immobile in this cap structure, whereas it is 
highly mobile in the rest of the plasma membrane(Rajendran et al., 2003). Stimulation of the 
cells by cross-linking of cell surface components leads to the accumulation of the TCR 
signalling machinery in this pre-formed cap, which underscores the importance of flotillins in 
T cell activation. Flotillins could also be involved in the pathogenesis of neurodegenerative 
disorders like Alzheimer and BSE/CJD/scrapie. Both flotillins are highly expressed in the 
brain, and lipid rafts are thought to play a role in the formation of amyloid beta(Aß) protein, 
the major constituent of senile plaques. Primitive senile plaques showed strong flotillin-2 
labeling, and in AD patients, staining for flotillin-2 in the cortex was increased. Progression 
of AD seems to be accompanied by an accumulation of flotillins at sites of Aß 
production(Kokubo et al., 2000). Likewise, the accumulation of the disease form of the Prion 
protein (PrP) probably takes place in lipid rafts, and the flotillins seem to be closely 
associated with the GPI-anchored PrP. Of course, the direct involvement of the flotillins in the 
pathogenesis of these disorders is not proved yet and further investigations will be necessary 
to reveal their exact role in these processes.  
For me, the most interesting publication on the flotillin proteins in the last years was 
published by Glebov et al. in 2006. This paper describes a novel, non-clathrin and non-
caveolin-dependent endocytic pathway, which is defined by the presence of flotillin-1 in the 
endocytic structures(Glebov et al., 2006). The authors could show that the non-clathrin and 
non-caveolar uptake of Cholera-toxin B is strongly reduced upon depletion of flotillin-1 by 
siRNA, which suggests a role for flotillin-1 in the endocytic pathway. Nevertheless, the article 
also shows that the endocytic pathway is rather complex and that the same cargo can utilize 
different uptake pathways. Down-regulation of one pathway may then be compensated by up-
regulating another one and thereby, overall uptake might not be different. The authors admit 
that they can not rule out the possibility that flotillin might be a cargo instead of a component 
of the transport machinery, but most likely, flotillin-1 participates in the formation and 
transport of non-clathrin- and non-caveolin-coated endocytic structures. A mechanism for the 
formation of “permanently coated” caveolin transport vesicles in the endocytic system has 
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recently been proposed by Bauer et al.(Bauer and Pelkmans, 2006), and similar flotillin-1 
transport intermediates might also exist. For us, these reports offer the fascinating possibility 
that stomatin might also define a separate endocytic pathway, which could directly connect 
the plasma membrane and the late endocytic compartment.  
 
2.3.3 HflK/C proteins in bacteria  
HflK/C are two polypeptides, which are encoded by genes in the hflA (high frequency of 
lysogenization) locus of E. coli, which governs the lysis-lysogeny decision of bacteriophage λ 
by controlling the stability of the phage cII protein. The two proteins HflK and HflC have 
molecular weights of 46 and 37 kDa, respectively, and were found to be membrane proteins 
with putative transmembrane helixes close to the N-terminus(Noble et al., 1993). It was 
already recognized in 1993 that the two proteins share sequence homology with each other 
and with stomatin(Noble et al., 1993). Additionally, HflC was shown to contain a domain 
distantly related to the catalytic domain of bacterial and chloroplast ClpP proteases, which 
gave rise to the theory that the HflK/C complex itself might be able to proteolytically cleave 
cII. Indeed, cleavage of cII by a purified HflA protein complex had been described several 
years ago(Cheng et al., 1988). But Kiahara et al. could show later that the HflK/C proteins 
form a complex with the AAA-Protease FtsH (encoded by the hflB locus) and inhibit the 
degradation of mutant, uncomplexed SecY by FtsH(Kihara et al., 1996). In further 
experiments, it was shown that both HflK and HflC are typeII transmembrane proteins, with 
their short N-termini being cytoplasmatically oriented and with their larger C-termini 
protruding into the periplasmic space of E. coli, which strongly argues against proteolytic 
processing of cytoplasmic cII by the HflK/C complex(Kihara et al., 1997). Additionally, the 
authors could not reproduce the proteolytic cleavage of cII by a purified HflK/C complex and 
concluded that the described purified HflA complex probably also contained traces of either 
an unknown protease or of FtsH, thereby explaining the observed cII degradation in vitro. 
Consequently, it is now widely accepted that a complex of HflK/C and FtsH exists in the 
plasma membrane of E. coli, with the HflK/C complex modulating the degradation of 
polypeptides mediated by FtsH(Ito and Akiyama, 2005). The degradation of 
mutated/misfolded membrane proteins by the AAA-protease FtsH and the negative regulation 
of the proteolytic function by HflK/C is very similar to the prohibitins in mitochondria, which 
also interact with an AAA-protease and protect newly synthesized, unassembled polypeptides 
from degradation. This similarity has led Tavernarakis et al. and others to the suggestion that 
the other SPFH family members could also have a function in the regulation of membrane-
associated protein degradation(Tavernarakis et al., 1999). In my opinion, this speculation is 
not backed up by any experimental data. Recently, a number of interaction partners have been 
described for other member s of the SPFH family like flotillin-1, podocin and stomatin. No 
associations with AAA-proteases have been described, and a “membrane chaperone” activity 
for these family members is also purely speculative. More work is necessary to clarify the 
precise function of the SPFH domain. Additionally, the level of sequence conservation is 
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generally low between different branches of the SPFH family, which, together with the 
ancient origin of the different subfamilies, makes a deduction of the protein function from the 
comparison of sequence data very unreliable. During evolution, the core fold of the SPFH 
domain may have been conserved, but the functionally important regions for protein-protein 
interactions may have been subject to big changes, leading to widely different functions for 
the different family members. Still, the functional similarities between HflK/C and the 
prohibitins are very interesting and will help to gain more insights into the functional 
determinants of the SPFH domain.  
 
2.4 Lipid rafts: A controversial concept for membrane 
organisation  
A detailed description of the basic concept of lipid rafts was already given in my diploma 
thesis(Mairhofer, 2001). I would not like to fully reproduce this summary here, but instead 
would like to focus on the relevant contributions made since 2001. Nevertheless, I would like 
to start with a short introduction to the topic.  
2.4.1 The lipid raft hypothesis  
Pioneering studies on lipid sorting in epithelial cells were performed in the laboratory of Kai 
Simons at the EMBL in Heidelberg. First, Simons and Gerrit van Meer noticed that enveloped 
viruses, which either bud from the apical (foul paque virus, an avian influenza virus) or 
basolateral (vesicular stomatitis virus) membrane of polarized MDCK cells, have a different 
lipid composition in their envelopes(van Meer and Simons, 1982). Next, they made use of a 
fluorescently labeled phospholipid analogue (NBD-ceramide), which is metabolically 
converted either into NBD-glucosylceramide or NBD-sphingomyelin in the golgi apparatus. 
This lipid probe proved to be especially valuable, because both NBD-glucosylceramide  and 
NBD-sphingomyelin were found to be enriched at the apical surface(van Meer et al., 1987). 
From these experiments, they deduced a model where lipid sorting was proposed to happen in 
the golgi apparatus or in post-golgi carriers and where lateral segregation of the lipids in the 
plane of the membrane was the key step, with the subsequent formation of apical or 
basolateral carriers enriched in certain lipids(Simons and van Meer, 1988). Other groups 
reported at the same time that several GPI-anchored proteins also followed the apical 
transport pathway(Lisanti et al., 1988). In 1992, a crucial paper by Brown and Rose revealed 
that apically destined lipids and a GPI-anchored protein get detergent-insoluble after they 
leave the golgi apparatus and introduced the method of Triton-X-100 lysis and sucrose 
density gradient centrifugation for the isolation of glycolipid- and cholesterol-enriched 
membrane domains(Brown and Rose, 1992). In such a sucrose gradient, a detergent-insoluble 
membrane fraction enriched in certain lipids and proteins “floats” to the top of the gradient. 
The method for the preparation of detergent-resistant membranes (DRMs) was easy to 
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perform and led to the characterization of the major protein constituents of the DRM fractions 
in the following years. Another important paper drew a connection between model 
membranes and cultured cells and described that saturated acyl chains are crucial for 
detergent insolubility of GPI-anchored proteins and lipids(Schroeder et al., 1994a). All these 
results led to the formation of the lipid raft hypothesis, a term coined by Simons and Ikonen in 
1997(Simons and Ikonen, 1997). The lipid raft hypothesis states that certain proteins and 
lipids are specifically targeted to sphingolipid- and cholesterol-enriched membrane domains, 
which are in a more ordered state than the rest of the surrounding bilayer. This liquid-ordered 
(lo) domain is resistant to solubilization by cold detergent and was proposed to “float” in a sea 
of membrane in the liquid-disordered (ld) state. The co-existence of lo and ld membrane 
domains had already been described in model membranes, and detergent-resistance was 
shown to correlate well with targeting to ordered or disordered domains(Ahmed et al., 1997; 
Schroeder et al., 1994a).  
 
2.4.2 Lipid raft “proliferation and growth”  
The isolation of numerous signalling proteins in detergent-resistant membranes strongly 
raised the interest for these freshly introduced lipid raft domains(Simons and Toomre, 2000). 
In the next years, DRM isolation and disruption of lipid rafts by cholesterol depletion were 
the major tools for cell biologists and led to the proposal that important cellular processes 
depend on lipid raft microdomains(Brown and London, 1998; Simons and Toomre, 2000; van 
der Goot and Harder, 2001). Cholesterol depletion can be performed by treating cells with 
agents like methyl-beta-cyclodextrin (mβCD), which removes cholesterol from the plasma 
membrane, with agents which complex cholesterol in the lipid bilayer (filipin, digitonin) or by 
prolonged incubation with inhibitors of cholesterol biosynthesis(Simons and Toomre, 2000). 
Acute cholesterol depletion by treatment with mβCD developed into the most commonly used 
method. It was recognized that especially proteins which possess a saturated lipid anchor 
(palmitoylation, myristoylation or GPI-anchor) are enriched in DRM fractions, whereas 
proteins with unsaturated lipid anchors (for example a geranyl-geranyl-group) are excluded 
from lipid rafts. Additionally, some integral membrane proteins were detected in the lipid raft 
fractions. The lipid-anchored proteins include Src-family kinases (like lck, lyn, fyn and 
others), subunits of hetero-trimeric G proteins (Gαi, Gαs), H-ras and GPI-anchored proteins 
like PLAP, the folate receptor, CD59 and CD55. Integral membrane proteins detected in the 
lipid raft fractions were the untypical hydrophobic hairpin-loop proteins caveolin and 
stomatin, LAT, influenza hemagglutinin (HA) and neuraminidase and CD36. Caveolin and 
the flotillins developed into the most important marker proteins for lipid rafts, because these 
proteins show a very strong enrichment in the DRM fractions and high-quality antibodies are 
commercially available from Transduction Laboratories. These “early” lipid raft proteins all 
show strong enrichment in biochemically isolated DRMs. As non-raft markers, integral 
transmembrane proteins like the transferrin receptor (CD71, TfR) are most widely used. The 
most important examples for lipid raft function were, besides apical sorting in epithelial cells, 
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signalling through the T-cell receptor (Moran and Miceli, 1998; Viola et al., 1999) and the B-
cell receptor (Aman and Ravichandran, 2000; Petrie et al., 2000). Of course, although the 
basic concept soon turned popular, the idea of lipid rafts was highly controversial. Inside the 
“lipid raft community”, it was clear that one can not rely on detergent resistance as the sole 
criterion for lipid raft association and that more sophisticated methods, which should be able 
to prove the existence of lipid rafts in vivo and elucidate the important questions regarding 
lipid raft size and dynamics, are necessary. Advanced light microscopy methods like single 
particle tracking, FRET and FRAP were considered to be the methods of choice for the 
examination of lipid rafts in vivo. In the meanwhile, based on DRM isolation, also many of 
the low-abundance constituents of lipid rafts were identified, which often showed very weak 
enrichment in lipid raft fractions, leading to the state that we now have hundreds of 
potentially lipid-raft associated proteins. Of these proteins, many fulfil important functions in 
the cells, and these functions have often been inhibited by cholesterol depletion, leading to the 
situation that virtually every process in the cell is dependent on lipid raft microdomains 
according to published literature. In my opinion, the lipid raft hypothesis, which, most 
importantly, raised the attention for the function of lipid domains in cellular transport- and 
signalling-processes, had somehow been hi-jacked to explain many enigmatic processes 
without careful examination of the biochemical and cell biological evidence. In addition, 
although the hypothesis stresses the importance of lipids for sorting and phase separation in 
the lipid bilayer, the analysis of lipid constituents was neglected in favour of an analysis of 
the DRM protein constituents. Together with the flood of published papers on lipid rafts, 
some major drawbacks in attempts to analyse lipid rafts in vivo led to the current situation, 
where major doubts are cast on the significance of the lipid raft hypothesis in vivo(Edidin, 
2001; Lai, 2003; Munro, 2003).  
 
2.4.3 Shrinking rafts back to a “healthy” size  
As already mentioned above, lipid rafts have proven difficult to be detected in vivo. Based on 
solubilization with cold Triton X-100, a major proportion of the plasma membrane was found 
to be detergent resistant. This behaviour was most commonly not reflected by examination of 
live cells with advanced methods. In an early single particle tracking study, Pralle et al. 
concluded that lipid raft associated GPI-anchored proteins diffuse as stable, small entities of 
approximately 26 nm diameter(Pralle et al., 2000). This size is clearly beyond the limit of 
resolution of light microscopy. Diffusion of a fluorescent lipid probe was analysed in muscle 
cells by Schütz et al(Schutz et al., 2000). This study stated that a lipid probe with saturated 
acyl chains occupied much larger domains (0.7 µm in diameter), but these results may be cell-
type specific, because they could not be reproduced in other studies. Generally, most single-
particle tracking studies gave results which are only consistent with the model of pre-existing 
rafts if these rafts are 1) small/short-lived and/or 2) their constituents exchange rapidly with 
the bulk membrane (for a review, see Kusumi et al.(Kusumi et al., 2005)). Other techniques 
like FRET also failed to detect stable clusters of GPI-anchored proteins(Kenworthy et al., 
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2000). On the contrary, Zacharias et al., who used raft probes tagged with monomeric GFP-
variants targeted to the inner leaflet of the plasma membrane, could show that these probes 
are clustered in a cholesterol-dependent manner and also co-cluster with caveolin in a FRET 
assay (Zacharias et al., 2002). This assay made use of the different dependence of FRET 
efficiency on acceptor density when the fluorophores are clustered or randomly 
organized(Kenworthy, 2002; Zacharias et al., 2002). The large scatter in the results by 
Zacharias et al. makes a precise determination of cluster size impossible, but also suggests 
that cluster size could be quite heterogenous(Kenworthy, 2002). Interestingly, a non-raft 
probe also showed clustering, but in a cholesterol-independent manner(Zacharias et al., 2002). 
A specialized FRET-technique, homo-FRET, which monitors changes in signal anisotropy, 
was used together with theoretical modeling by Sharma et al. and revealed clustering of 20-
40% of GFP-tagged GPI-anchored proteins, but again, the clusters were proposed to be very 
small (< 5nm) and to contain only four GPI-anchored proteins(Sharma et al., 2004). This 
nanoscale clustering was sensitive to cholesterol depletion, which indicates that the observed 
clusters could be very small lipid rafts(Sharma et al., 2004). This deduced small size of lipid 
rafts already comes close to the lipid shell-model proposed by Anderson and 
Jacobson(Anderson and Jacobson, 2002), which states that membrane proteins (or membrane-
anchored proteins) can be encased in a shell of cholesterol and sphingolipids. These small 
lipid shells determine if a protein partitions into DRMs or not and can coalesce into large lipid 
rafts dependent on protein interactions. This model is still different from the concept of 
boundary lipids, because the proposed lipid shells should be much more stable than boundary 
lipids (boundary lipids are only detected by electron spin resonance measurements). A big 
caveat of this model is that it is hard to imagine how a single lipid anchor (consisting of two 
fatty acids) could organize the surrounding lipids in a way to induce a relatively stable lipid 
shell(London, 2005). For membrane proteins, this model is even more problematic, because in 
model membranes, transmembrane domains are excluded from liquid-ordered domains and 
are thought to disturb the formation of ordered domains(London, 2005). A FRAP study by 
Kenworthy et al. also failed to detect diffusion of raft proteins in stable structures(Kenworthy 
et al., 2004). Instead, the type of membrane anchor (transmembrane, GPI-anchor, 
palmitoylation) was found to be most important(Kenworthy et al., 2004). Cholesterol 
depletion and temperature variation affected both raft- and non-raft proteins in a similar 
manner. The authors concluded that rafts can not be stable, mobile structures (which diffuse 
as stable entities on the cell surface and should dominate the diffusion coefficient of raft-
associated proteins), but either are very dynamic structures or do not exist at all(Kenworthy et 
al., 2004). Another set-back for the field of lipid rafts was the observation that Triton X-100 
itself can induce domain formation in model membranes(Heerklotz, 2002; Heerklotz et al., 
2003). Although the results by Heerklotz and colleagues are not undisputed(Brown, 2006; 
London, 2005) and the technique of detergent solubilization had been critisized 
before(Edidin, 2001), these studies had a big impact on the field. Before, most researchers 
were aware that detergent solubilization can induce artefacts and that DRMs are surely 
different from native rafts in living cells. Nevertheless, based on observations in model 
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membranes, most people were confident that the DRMs might at least give a good hint for the 
composition of rafts in living cells. With the observation that the detergent itself can promote 
domain formation in a up-to-then homogenous mixture, doubt was cast on all these 
results(Heerklotz, 2002). Now, all researchers agree that detergent-resistant membranes 
should not be identified with lipid rafts in living cells(Brown, 2006; Hancock, 2006; 
Lichtenberg et al., 2005; Mayor and Rao, 2004). Detergent resistance is still considered to 
yield important information by some researchers(Brown, 2006), while others state that only 
sophisticated imaging techniques can provide information about the lipid raft association of 
certain molecules. In addition to the possibility that detergent might induce domain formation, 
the other key biochemical technique to determine if a process is dependent on cholesterol-
enriched rafts, cholesterol depletion, also was discredited recently. As Kwik and colleagues 
showed, depletion of cellular cholesterol by treatment of cells with mβCD had a profound 
effect on the cytoskeleton(Kwik et al., 2003). Additionally, cholesterol depletion was shown 
to induce domain segregation in living cells, an effect which is also inconsistent with the 
usage as a raft-disrupting agent(Hao et al., 2001). The third major drawback for the lipid raft 
hypothesis came from studies on the prototype of lipid raft-dependent signalling, the T-cell 
receptor: First, Glebov and Nichols, using FRET analysis, showed that GPI-anchored lipid 
raft probes have a random distribution during activation of Jurkat T-cells with antibody-
coated beads(Glebov and Nichols, 2004). Second, Douglass and Vale performed single-
molecule microscopy on Jurkat T cells activated on antibody-coated glass coverslips and 
found evidence for membrane microdomains. But these microdomains were shown to be 
dependent on protein-protein interactions rather than on lipid rafts(Douglass and Vale, 2005). 
On the contrary, using Jurkat T-cells and peripheral blood CD4+ T-cells stimulated by 
Antigen-Presenting Cells (APCs), Tavano et al. could show an enrichment of lipid raft 
markers at the immunological synapse, whereas non-raft markers were not enriched(Tavano 
et al., 2006). They also showed that the co-stimulatory molecule CD28 and FilaminA are 
essential for raft accumulation at the immunological synapse. This recent paper almost 
certainly reflects the in-vivo situation better than activation with antibody-coated beads or by 
plating. Gaus et al. used the Laurdan lipid probe, whose emission spectrum changes when it 
encounters an ordered lipid environment, to show that the plasma membrane at the site of T-
cell activation is in a more ordered state compared to the rest of the membrane, which also 
supports a function for lipid rafts in TCR signalling(Gaus et al., 2005). Nevertheless, the 
results by Douglass et al. confirm that protein-protein interactions are essential for the 
formation of microdomains at the T-cell synapse. These publications clearly show that the 
concept of raft-mediated signalling has to be carefully re-examined without pre-conceived 
ideas. Despite these drawbacks, the last few years have also seen some very positive 
developments in the field of lipid rafts. For example, Prior et al. have developed an electron 
microscopy technique to visualize lipid rafts with the help of spatial point pattern 
analysis(Prior et al., 2003a; Prior et al., 2003b). They found that lipid raft probes and ras 
proteins are clustered on the plasma membrane, and that raft clustering is sensitive to 
cholesterol depletion. Another highlight was the definitive identification of a clathrin- and 
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caveolin-independent endocytic pathway, which clearly is cholesterol-dependent(Glebov et 
al., 2006; Kirkham et al., 2005). Additionally, in a pioneering systems biology approach, 
Pelkmans et al. have investigated the function of hundreds of kinases, many of them poorly 
characterized, in either clathrin- or caveolae/raft-mediated endocytosis(Pelkmans et al., 2005). 
This screen identified almost all kinases which were already known to regulate endocytotic 
events and a plethora of new kinases, which had not been implicated in endocytosis yet. The 
most important finding was that there are quite many kinases which influence both pathways 
simultaneously or differentially. Of course, only an in-depth characterization of newly 
identified kinases can reveal their precise mode of action. Nevertheless, this study gives a hint 
on the complex regulation of endocytosis, and one can expect that other cellular processes are 
also subject to complex regulation. Yet another highlight of the last years was the refined 
analysis of ordered and disordered domains in model membranes.  
Figure 6: Induction of lipid domains in GUVs by addition of cholera toxin B 
 
 
One example is the study by Baumgart et al., which shows, using two fluorescent lipid probes 
either prefering ordered and disordered domains and directly observing these probes in giant 
unilammellar vesicles (GUVs), that membrane domains may differ in their intrinsic 
curvature(Baumgart et al., 2003). These experiments visualizing distinct membrane domains 
produced very impressive pictures. 
Similarly, Roux et al. showed that the lipid composition of tubes pulled from GUVs is 
significantly different from the vesicles(Roux et al., 2005). Precisely, disordered domain 
preferring lipids were enriched in the tubes. Additionally, phase separation induced in the 
 
Figure 6: Lipid domains induced by 
addition of cholera toxin B subunit 
(CTB) to Giant Unilamellar 
Vesicles (GUVs) of a certain lipid 
composition. Reprinted from 
((Hammond et al., 2005). (A) 
Addition of CTB to previously 
homogenous vesicles triggers 
domain formation. (B) Domain size 
is determined by the lipid 
composition before CTB addition.  
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tubes by photoactivation led to fission events(Roux et al., 2005). Another important 
contribution came from Hammond et al., who could show that addition of cholera toxin B 
subunit to GUVs triggered the phase-separation of ordered and disordered 
domains(Hammond et al., 2005) (see Figure 6).  
Milhiet et al. used atomic force microscopy (AFM) to visualize phase separation and followed 
the fate of alkaline phosphatase (AP) added to supported phospholipid bilayers containing 
ordered domains. When AP was added to bilayers without cholesterol, the protein was 
preferentially inserted at the periphery of the gel phase. In bilayers containing cholesterol, AP 
was homogenously distributed throughout the gel phase(Milhiet et al., 2002). These results 
from model membranes might have important consequences for the analysis of membrane 
sorting events in living cells, too. For example, tubular transport intermediates are 
characteristic of recycling endosomes and might (at least in part) be driven by similar domain 
separation events. The internalization of lipid raft constituents might also be induced by the 
crosslinking of pre-existing rafts or by the local induction of phase separation. This pathway 
is hijacked by numerous pathogens and could therefore be of therapeutic interest(Gruenberg 
and van der Goot, 2006; Reig and van der Goot, 2006; van der Goot and Harder, 2001). 
Although the value of the results obtained on model membranes has recently been doubted 
because cellular membranes are, of course, much more complex than model systems and, 
most importantly, are not in equilibrium with the surroundings but are actively maintained (in 
an energy-dependent fashion; e.g. “flippases”, transporters, vesicular transport and 
endocytosis) in a non-equilibrated state(Mayor and Rao, 2004), in my opinion, similar 
mechanisms for the formation, fusion and fission of membrane domains might also operate in 
living cells. It is particularly intriguing that cells might use transient, local inhomogenities and 
the energy derived from phase separations for the formation of, for example, non-clathrin-
dependent endocytic carriers. This could explain the importance of certain lipids (e. g. PIP2) 
and lipid-binding proteins/domains in endocytosis. Additionally, the cellular membrane might 
have a composition (which is actively maintained) close to a critical point of the system. In 
such a system, minor changes in the lipid composition could have large effects on the phase 
behaviour and could again be used to drive certain cellular processes(Hancock, 2006; London, 
2005). In a recent review by John Hancock, he also outlined several interesting theoretical 
results from computational approaches(Hancock, 2006). Such a recent study showed that 
inter-protein-collisions were maximal when rafts were small (6-14 nm), mobile and when the 
diffusion rate of proteins was two-fold slower than outside rafts(Nicolau et al., 2006). 
Additionally, another computational approach revealed that, if small lo domains might 
eventually coalesce to form larger domains, endocytosis might be the process that limits raft-
domain size(Turner et al., 2005). In conclusion, the last few years have seen a revision of the 
“classical” lipid raft model(Simons and Ikonen, 1997). Lipid rafts are now seen as extremely 
small, dynamic inhomogenities of the plasma membrane (see Figure 7).  
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Figure 7: Different models for lipid raft structure 
 
Figure 7: Current models for membrane organization. Reprinted from (Mayor and Rao, 2004) 
The most commonly cited hypothesis for membrane rafts (Simons and Ikonen, 1997) depicts rafts that are 
relatively large structures (~50 nm), enriched with cholesterol and sphingolipid (SL), with which proteins are 
likely to associate. Anderson & Jacobson (Anderson and Jacobson, 2002) visualize rafts as lipid shells that are 
small, dynamic molecular-scale assemblies in which raft proteins preferentially associate with certain types of 
lipids. The recruitment of these “shells” into functional structures could be a dynamic and regulated process. (C) 
Another point of view is that a large fraction of the cell membrane is raft-like and exists as a “mosaic of 
domains”; cells regulate the amount of the different domains via a cholesterol-based mechanism (Maxfield, 
2002). (D) Actively generated spatial and temporal organization of raft components. A different picture, which is 
consistent with data from GPI-anchored protein studies in living cells (Sharma et al., 2004), suggests that 
preexisting lipid assemblies are small and dynamic, and coexist with monomers. They are actively induced to 
form large-scale stable “rafts”. Black circles, GPI-anchored proteins; red and pink circles, nonraft associated 
lipids; yellow circles, raft-associated lipids; green, cholesterol. Scale bar ~5 nm.  
 
Additionally, it became clear that protein constituents of lipid rafts might have more 
important functions than previously anticipated. Lipid raft proteins are not passively 
compartmentalized, but are essential for the stabilization of small, dynamic rafts, for 
cholesterol-dependent signalling and transport processes and perhaps also for the maintenance 
of the small lipid rafts. This view is now accepted by most researchers in the field(Hancock, 
2006; Mayor and Rao, 2004; Rajendran and Simons, 2005).  
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The lipid raft hypothesis has, without doubt, stimulated research on membrane structure and 
function. Even when no stable lipid rafts exist in cells in a resting state, membrane 
inhomogenities have been shown to be crucial for many events after stimulation. Novel 
methodologies will certainly enable us to draw a more precise picture of lateral membrane 
organisation in living cells and its consequences for membrane protein function.  
An essential point is that, only because lipid rafts have proven hard to “pin down” in vivo, 
this must not mean that they do not exist or are not important for cellular functions. The 
situation is surely more complex than anticipated several years ago, and it can be that lipid 
rafts only comprise a few molecules and only exist on a nano-second timescale(Kusumi et al., 
2005). These dynamic processes might be ideal for tight regulation, although they are, of 
course, more difficult to understand than a simple phase separation, with rafts floating on a 
sea of non-rafts and signalling proteins either associated with or excluded from the rafts. For 
our work, which deals with the functional characterization of stomatin and stomatin-like 
proteins, the novel focus on protein function in the lateral membrane organization is surely 
positive. As already proposed several years ago, several properties of stomatin make it a 
candidate scaffolding protein on the cytoplasmic leaflet(Snyers et al., 1999a). 
2.5 Stomatin and SLP-1 structure  
2.5.1 Stomatin structure 
Because of its hydrophobic character, bacterial expression of stomatin and stomatin fragments 
was found to be problematic (E. Umlauf, unpublished results). Therefore, all attempts to 
express and purify sufficient amounts of stomatin fragments for structural analyses like X-ray 
diffraction or NMR were not successful. The only high-quality NMR structure available is 
one of a fragment of the distantly related mouse flotillin-2 protein (PDB accession 1win). 
This fragment contains the SPFH domain signature and one could assume that a similar 
structure represents the core fold in stomatin. Figure 4 shows a schematic representation of 
the structure. A comparison of the amino acid sequence of flotillin-2 and stomatin reveals that 
a big part of the central fold consisting of 4 beta-sheets and two alpha helices could also be 
present in stomatin, whereas the loops connecting these elements are less conserved. For a 
second distantly related molecule, human prohibitin-1, a computed structural model is 
available, which also shows a compact central domain of 6 beta-sheets which is followed by 
several alpha-helices. Based on secondary structure predictions with the programme JPRED, 
we assume that the tertiary structure of stomatin could be similar to the prohibitin model. 
After the long hydrophobic region, several beta-sheets and alpha-helices probably form a 
compact, tightly membrane-associated fold (amino acids 63 to 195), which is followed by 
alpha-helical structural elements, which dominate the rest of the stomatin C-terminus. No data 
is available for the perhaps most interesting part of stomatin, the long, hydrophobic integral 
membrane domain. Based on the localization of stomatin to lipid droplets, one can assume 
that the putative hairpin loop is only embedded into the cytoplasmic leaflet of the lipid 
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bilayer. Secondary structure prediction programs indicate an alpha-helical structure for this 
hydrophobic region, but the significance of this prediction is not clear, because alpha-helices 
of about 12 amino acids are long enough to span the bilayer. At present, the stomatin 
hydrophobic domain is thought not to span the bilayer at all. Perhaps we will be able to get 
more insights into the structure by circular dichroism measurements of hydrophobic peptides 
in collaboration with the department of structural biology in the future.  
 
2.5.2 SLP-1 
No structure is available for the SPFH domain of SLP-1 as well, but the central region can 
also be assumed to have a similar fold as flotillin-2 and prohibitin-1. For the SCP-2 domain, 
several high-quality structures are available. Cytoplasmic SCP proteins are of small size and 
well soluble, so they were successfully expressed in bacteria, crystallized and subjected to X-
ray diffraction analysis by several groups. Although only about 25% of the amino acids are 
conserved between SCP-2 and the SCP-2 domain in SLP-1, a comparison of the determined 
structures and a structure prediction for the SLP-1 SCP-2 domain reveals an almost identical 
sequence of structural elements. Recently, a group has solved the structure of an insect SCP 
protein in complex with a fatty acid and could determine the amino acids which line out the 
hydrophobic binding site. These positions are all occupied by hydrophobic amino acids in the 
SLP-1 sequence, which also supports the thesis that the SCP-2 domain of SLP-1 could be 
functional and bind and/or transfer lipids. Bacterial expression of the C-terminal SCP-2 
domain of SLP-1 is a future project and could enable us to determine if the domain is 
functional in established in-vitro lipid transfer assays. If we were lucky, we could also purify 
enough material for 3D structure analysis.  
 
2.6 The SCP-2 protein  
The SCP-2 protein was initially isolated and purified from rat liver cytosol as a soluble factor, 
which enhances the conversion of sterol precursors to cholesterol in rat microsomal 
fractions(Noland et al., 1980).  
The same protein had been purified independently by another group(Bloj et al., 1978) and 
designated non-specific lipid transfer protein (nsLTP), because it was shown to stimulate the 
transfer of a broad range of lipids including sterols between donor and acceptor membranes in 
vitro(Bloj and Zilversmit, 1977; Crain and Zilversmit, 1980; Nichols and Pagano, 1983). The 
protein was found to contain a low-affinity lipid binding site, which can accomodate a variety 
of different lipids(Gadella and Wirtz, 1991). Transfer of cholesterol was found to be enhanced 
dramatically by acidic lipids (Butko et al., 1990). There was a big debate on the mode of 
action of SCP-2, if it is actually a carrier-protein (Butko et al., 1990) or if it interacts with 
membranes to enhance the desorption rate of lipids into the aqueous phase (Gadella and 
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Wirtz, 1991). Nowadays, the carrier function is widely accepted, and cytosolic SCP-2 is 
considered to play an important role in non-vesicular sterol transport as well as cellular uptake 
of cholesterol and lipids(Gallegos et al., 2001; Wirtz, 2006). 
 
2.7 Aims of this study  
Stomatin is widely expressed in different human cells and tissues. The function of this 
ubiquitous membrane protein is still unclear. The aims of my studies were to get more 
insights into the function of the stomatin family protein SLP-1 and stomatin. Several different 
approaches were used to perform this task:  
1) I undertook a first cell biological and biochemical characterization of SLP-1, which is 
prone to play a role in lipid transport due to its unique combination of a SPFH domain and a 
SCP-2 domain and which is a potential interaction partner for stomatin based on data from C. 
elegans.  
2) The dynamic behaviour of stomatin and SLP-1 was analysed by live cell imaging studies of 
GFP-fusion proteins. During the course of the work, we established a FRAP assay to analyze 
the plasma membrane dynamics of stomatin and stomatin mutants.  
3) Point mutations of human stomatin were constructed in analogy to several mutations 
described in the C. elegans MEC-2 and UNC-1 proteins to get non-functional stomatin 
variants. Based on our mass spectroscopy results (see 4), we also targeted amino acids which 
potentially carry post-translational modifications.  
4) Lipid raft fractions of platelets and neutrophils were analysed by 2D-PAGE, silver staining 
and mass spectroscopy to identify post-translational modifications of stomatin and possible 
binding partners in the lipid raft fractions.  
 
In my opinion, this work adds some interesting pieces to the puzzle of stomatin family protein 
function (which is still far from completion).  
Methods 
PhD thesis   Mario Mairhofer 
 46 
 
3 METHODS 
3.1 Biochemical Methods  
3.1.1 SDS-PAGE  
Equipment:  Hoefer Vertical Slab Gel Unit SE400 
power supply: BioRad PowerPack 1000 or 3000 
precision syringe 
 
solutions for SDS-PAGE (all in milliQ-H2O):  
 
5x sample buffer:  0.1 M Tris.HCl, pH 6,8 
   5% SDS 
   17% glycerol 
   5% mercaptoethanol 
   1/100 volume of a 0.5 % bromophenolblue solution  
 
running buffer:  0.19 M glycine 
   25 mM Tris 
   0.1% (w/v) SDS 
 
solution A:   30% acrylamide 
   0.8% bis-acrylamide 
buffer B:   1 M Tris.HCl, pH 8,8 
buffer C:   1 M Tris.HCl, pH 6,8 
 
10% (w/v) SDS 
TEMED (Tetramethylethylendiamine) 
10% (w/v) APS (Ammonium-peroxodisulfate) 
 
polyacrylamide gels were prepared as follows:  
 stacking gel:   2,4 mL solution A 
    2 mL of buffer C 
    11,2 mL milliQ-H2O 
    160 µl 10% SDS 
    24 µl TEMED 
    80 µl 10% APS 
Methods 
PhD thesis   Mario Mairhofer 
 47 
 
 
 separating gel:  11 ml of solution A 
    11.2 ml of buffer B 
    7 ml milliQ H2O 
    300 µl 10% SDS 
    20 µl TEMED 
    150 µl 10% APS 
 
• the components were thoroughly mixed in glass beakers, the respective amount of 
10% APS was added immediately before pouring the gel; I routinely used 11% 
acrylamid gels for my work, other concentrations can be achieved by changing the 
volumes of solution A and H2O, e .g. 10 ml solution A and 8 ml H2O yield a 10% 
acrylamide gel 
• glass plates and spacers were thoroughly rinsed with tap water, cleaned with ethanol, 
air-dried, assembled in the clamps and mounted in the pouring stand, the lower edge 
was sealed with vacuum grease to prevent leakage 
• the separating gel was poured to a height of 11 cm, then 1 ml of water was carefully 
added to be able to monitor complete polymerization 
• after the separating gel was completely polymerized (15-30 minutes), the water was 
poured off and the stacking gel was added on top of the separating gel, with an 
appropriate comb for the number and volume of samples to be analyzed (combs with 
10, 15 or 20 slots available) 
• when polymerization of the stacking gel was complete (30 minutes), the comb was 
removed and the gel was inserted into the Hoefer Vertical Slab Gel Unit, the two 
buffer chambers were filled with running buffer and the samples and markers were 
filled into the slots with a precision syringe (Hoefer)  
• gels were either run over night at 50 V or for approximately 4 hours at 200 V and were 
stopped shortly before the running front reached the lower edge of the gel 
 
3.1.2 2D-PAGE of lipid raft fractions  
The method for isoelectric focusing of lipid raft fractions was based on a protocol recently 
published by Sprenger et al. (Sprenger et al., 2004), with some modifications to adopt the 
method for our equipment.  
Equipment:  IPGphor IEF apparatus (Amersham/Pharmacia)  
ceramic strip holders 13 cm 
  Immobiline DryStrips pH 3-10, 13 cm (Amersham) 
  Servalyt carrier ampholytes pH 3-10 for IEF, stock solution 40% w/v (Serva) 
  Hoefer Vertical Slab Gel Unit SE400 
 
Solutions:  all compounds were of ultra-pure quality to avoid contaminations and were 
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prepared with milliQ-water! 
 
Rehydration Stock Solution (RSS):   7 M Urea 
        2 M Thiourea 
        4% Triton X-100 
        2% carrier ampholytes pH 3-10 
        20 mM Tris-base 
        55 mM DTT 
        0.003 % w/v bromophenol blue 
   
a concentrated solution of thiourea was prepared first and was incubated for 1 
hour with ampholyte ion exchange resin to remove contaminating salts, this 
solution was then diluted to a concentration of 2 M in the solution containing 
the other compounds;  
 
SDS-Equilibration buffer (SDS-EB):  50 mM Tris.HCl, pH 8.8 
       6 M Urea 
       30% v/v glycerol 
       2% w/v SDS 
       0.002 %bromophenol blue 
 
  Agarose sealing solution (ASS):   25 mM Tris.HCl, pH 8.8 
        200 mM Glycine 
        0.1 % w/v SDS 
        0.002 % bromophenol blue 
 
• Platelet lipid rafts were isolated as described in 3.1.11. Lipid raft fractions (fractions 
1-4) were collected from the gradients and diluted with 10 mL of pre-cooled TBS, pH 
7,4 in Beckman SW40 centrifuge tubes 
• the tubes were centrifuged for 1h at 100.000xg (20.000 rpm) in a SW40 rotor in a 
Beckman Ultracentrifuge 
• the supernatant was discarded and the lipid raft pellet was resuspended in 
approximately 10-15µl of a 1% SDS solution in milliQ-H2O for 15 minutes at RT 
• a protein determination was carried out with a 1 µl-aliquot of this suspension, 
especially if different lipid raft fractions were compared 
• total protein concentration for individual 2D-PAGE runs varied from approximately 
10 to 30 µg of total protein, equal amounts of different samples were loaded and run 
simultaneously 
• 3-10 µl of the lipid raft suspension was mixed with 280 µl of Rehydration Stock 
Solution (RSS) and rotated at RT for 1 hour 
• this mixture (280 µl) was transferred into a 13 cm strip holder cassette, and a 
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dehydrated Immobiline DryStrip was carefully mounted on top of the sample (gel side 
down, plus-end at the pointed end of the strip holder, avoid air bubbles under the gel 
strip!!!) 
• then, approximately 1 ml of DryStrip cover fluid is layed on top of the IEF strip to 
prevent leakage of the sample 
• the cassette is covered with a plastic lid, transferred to the IPGphor apparatus and 
placed on the gold electrodes 
• sample loading by in-gel-rehydration was performed for 12 hours  
• the temperature was set to 20°C and the current per strip was limited to 50 µA 
• after rehydration was complete, a focusing program was started:  
 
   Step 1:  200 V for 30 minutes (step-n-hold) 
   Step 2:  500 V for 45 minutes (step-n-hold) 
   Step 3:  750 V for 1 hour (step-n-hold) 
Step 4:  gradual increase from 750 V to 3500 V for 2,5 hours 
(gradient) 
   Step 5:  3500 V for 9 hours (step-n-hold) 
   Step 6:  100 V until the run is stopped (step-n-hold) 
 
• after the completion of Step 5, the run is stopped, and the IEF strip is carefully 
removed from the strip holder cassette 
• the strip is then incubated in 5 ml of SDS-Equilibration buffer supplemented with 10 
mg/ml DTT for 15 minutes, followed by an incubation in SDS-Equilibration buffer 
with 25 mg/ml Iodoacetamide 
• while the strips are equilibrated, a vertical separating gel is prepared as described in 
chapter 3.1.1, with the difference that it is not poured to a height of 11 cm, but to 
approximately 15 cm 
• the separating gel is overlaid with 1 ml of Isopropanol to get a very smooth gel 
boundary 
• after polymerization is complete, the isopropanol is removed and the equilibrated gel 
strip is mounted on top of the separating gel between the glass plates with the plus end 
(pH 3) at the left and the minus end (pH 10)at the right side of the second dimension 
gel (only touch the plastic support of the gel strip, avoid air bubbles between the gel 
strip and the separating gel!!!) 
• if needed, a filter paper with molecular weight marker or/and a 1D-PAGE sample can 
be included on each side of the strip 
• the strip is then overlaid with 1-2 ml of Agarose sealing solution (ASS), which has to 
be melted before use (when cooling down, a gel is formed, which fixes the position of 
the IEF strip and the markers/1D-samples) 
• the second dimension SDS-PAGE is run normally (run time has to be increased to 5-6 
hours at 200 V if it is run along the full length for silver staining, for western blotting, 
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also short run times (1,5-2 hours at 200 V) can be used) 
• silver staining and/or western blotting is performed as described below 
 
3.1.3 Silver staining of proteins on polyacrylamide gels (standard protocol) 
All incubations were performed on a shaker at room temperature! 
• gels were fixed for 1h in fixing solution (50 % methanol, 12 % acetic acid, 0.5 ml/l 
formaldehyde (37% solution)) 
• washed 3 times for 20 min in 50 % ethanol 
• pretreated for 1 min with 0.2 g/l Na2S2O3.5 H2O 
• washed 3 times for 20 sec. with dest. H2O 
• incubated for 20-30 minutes in the dark with staining solution (2g/l AgNO3, 0.75 ml/l 
formaldehyde (37%)) 
• washed 2 times, 20 sec. with dH2O 
• developed for 1-5 minutes in developing solution (60 g/l Na2CO3, 4 mg/l Na2S2O3.5 
H2O,0.5 ml/l formaldehyde (37%)) 
• development was stopped with stop solution (50 % methanol, 12 % acetic acid) 
• gels were stored at 4°C in 20 % methanol, 1 % glycerine until they were scanned and 
dried between cellulose sheets for long-term-storage; 
 
3.1.4 Silver staining for mass spectroscopy 
• for the purpose of identifying proteins by MALDI-TOF peptide mapping, a special 
protocol was used and all solutions were prepared with high-quality milliQ-water to 
minimize contaminations;  
• the solutions for this protocol are: 
fixing solution: 50 % methanol, 5 % acetic acid 
washing solution 50 % methanol 
sensitizing solution 0.2 g/l Na2S2O3.5 H2O 
silver solution 1 g/l AgNO3 
developing solution 20 g/l Na2CO3, 0.4 ml/l formaldehyde 
stop solution 5 % acetic acid 
• the staining procedure is as follows: 
- fix the gel (20 min, fixing solution) 
- wash the gel (10 min, washing solution) 
- wash the gel (2 h or over night, milliQ-H20 
- sensitize the gel (1 min, sensitizing solution) 
- wash the gel (2x 1 min, milliQ-H20) 
- incubate the gel (20 min, silver solution, at 4°C!!!, in the dark!!!) 
- wash the gel (2x 1 min, milliQ-H20) 
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- develop the gel (0.5-5 min, developing solution) 
- stop the color development (3x 1 min, stop solution) 
 
• gels can be stored for several weeks in 1% acetic acid at 4°C 
• protein bands of interest are excised with a clean scalpel, digested by trypsin, and 
identified by mass spectrometry (Bruker Reflex III MALDI-TOF-MS, peptide 
mapping);  
• the identity of the respective proteins should be (if an antibody is available) confirmed 
by Western blotting; 
 
3.1.5 Western blotting 
Equipment/Materials:  Hoefer TE 50X wet blotting unit;  
AGFA Curix 60 developing machine;  
   SuperSignal West Pico Chemiluminescence Detection reagent (Pierce) 
   CL Xposure films (Pierce) 
   blotting buffer: 0.19 M glycine, 25 mM Tris, 10% methanol 
 
• after SDS-PAGE, the gel is incubated in blotting buffer for ~1min, then the gel 
sandwich is assembled (black side of map, sponge, whatman paper, gel, nitrocellulose 
membrane, whatman paper, sponge, grey side of map; all compounds soaked in 
blotting buffer), inserted into the blotting chamber (anode - nitrocellulose membrane - 
gel - cathode), and blotted over night at setting 100 mA, 10 V; 
• after blotting, the membrane is either stained with Ponceau S (staining of protein 
markers, control for blotting efficiency) or immediately blocked 
• blocking of non-specific binding sites on the membrane is performed with blocking 
buffer (150 mM NaCl; 20 mM Tris.HCl, pH 8.0; 1% non-fat dry milk, 1% PVP) for 1 
hour 
• then incubations with primary antibodies are performed for 1 h; antibodies are diluted 
in washing buffer (150 mM NaCl; 20 mM Tris.HCl, pH 8,0; 0.1 % Tween 20) 
• the blots are washed 3x 5 min with washing buffer 
• incubation with secondary antibodies (horseradish peroxidase (HRP) conjugates from 
Pierce) diluted 1:5000 for 1 h; 
• washing step 3x 5 min, washing buffer 
• blots are mounted on transparent plastic foil in an autoradiography map and incubated 
with the Pierce West Super Signal Chemiluminescence Detection reagent 
(approximately 1 ml for a full-size blot) according to the manufacturer’s instructions 
• protein bands are visualized by exposure of X-ray films (exposure times from ~ 15 
seconds to 1 h or overnight, depending on the antibody and the amount of protein) 
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3.1.6 Isolation of platelets and neutrophil granulocytes from whole blood  
• whole blood (45 mL) is obtained from healthy donors by venipuncture and collected 
into heparinized tubes; 
• red cells and leukocytes are pelleted (15 minutes, 200xg=900 rpm, Heraeus Varifuge 
3.0R, room temperature = RT), the platelet rich plasma is removed from the tubes and 
9 parts are mixed with 1 part ACD-solution (25 g/L Na3-citrate, 13.7 g/L citric acid, 
20 g/L glucose) as anticoagulant 
• platelets are pelleted from this solution (12 minutes, 2000xg≡3200 rpm, Heraeus 
Varifuge 3.0R, RT) and resuspended in 2 ml wash buffer (90 mM NaCl, 5 mM KCl, 
36 mM Na3citrate, 10 mM EDTA, pH 6,5) 
• this platelet suspension is transferred to Eppendorf tubes, the platelets are pelleted by 
centrifugation (10 minutes, 2000xg=2000 rpm, Eppendorf bench-top centrifuge, RT) 
the supernatant is discarded and the platelet pellets are resuspended in 2 ml wash 
buffer; remaining erythrocytes are removed by 2-3 quick spins (quick spin: the button 
is pressed for approx. 3-5 seconds, shortly released, pressed again for 3-5 seconds, 
released and finally pressed a third time for 3-5 seconds, this procedure is used to 
prevent too big g-forces), 
• the supernatants after the quick spins are transfered to new Eppendorf tubes, the quick 
spins are repeated 2-3 times, then the platelets are again pelleted (10 
minutes,2000xg=2000 rpm, Eppendorf bench-top centrifuge, RT)  
• the final platelet pellet is resuspended in the appropriate buffer for following 
experiments 
 
• for the isolation of neutrophils, the leukocyte-rich buffy coat is removed from the top 
of the erythrocyte layer after the collection of the PRP and transferred into a 15 ml 
Falcon tube 
• the buffy coat (approximately 5 ml) is then mixed with 1/9 volume of ACD-solution, 
and 2 ml of a 6% dextran solution (average MW ~ 168000 kDa) are added 
• the suspension is mixed well by inverting several times, and then is left at RT for 1 
hour, during this period, most erythrocytes, which are crosslinked by the dextran, 
sediment to the bottom of the tube 
• next, the yellow plasma layer is carefully removed from the erythrocyte pellet, 
transferred into a fresh 15 ml Falcon tube and precooled to 4°C on ice 
• then, the leukocytes are pelleted by centrifugation (Heraeus Varifuge 3.0R, 700 rpm, 
12 min, 4°C), the supernatant is discarded and the pellet is resuspended in 100 µl 
DPBSE (Dulbecco’s Phosphate Buffered Saline+5mM EDTA, pH 7,4) 
• 3 ml dH2O are added (to lyse residual erythrocytes) 
• after 30 seconds, 1 ml of 0.6 M KCl is added to again yield an isotonic suspension 
• the leukocytes are pelleted (Heraeus Varifuge 3.0R, 900 rpm, 4 min, 4°C), the 
supernatant is discarded and the pellet again resuspended in 100 µl of DPBSE 
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• the lysis and pelleting step are repeated  
• the leukocytes are resuspended in 8 ml of DPBSE 
• this suspension is carefully layered on top of a cushion of 4 ml Ficoll-Paque in a 15 ml 
Falcon tube 
• the tube is centrifuged (Heraeus Varifuge 3.0R, 2000 rpm, 30 minutes, 4°C) 
• after centrifugation, a band is visible at the DPBSE/Ficoll phase border; this band 
consists of lymphocytes and some residual platelets 
• the granulocytes are recovered from the pellet at the bottom of the tube, this pellet is 
resuspended in 1 ml DPBSE, and a cell count with a CASY cell counter is performed 
to analyse the number of isolated cells and the homogenity of the preparation (the cell 
counter also yields the mean diameter and mean volume of the cells) 
• the cells are pelleted (Eppendorf desk-top centrifuge, 2000 rpm, 5 min, 4°C) and 
finally resuspended in the appropriate volume of HBSS (Hank’s balanced salts 
solution) for further experiments 
 
3.1.7 Preparation of HeLa PNS  
solutions:   Dulbecco´s PBS  
 
   PBS+PI:   +5µg/ml aprotinin 
      +5 µg/ml leupeptin 
      +0.5 µg/ml pepstatin A 
      + 0.4 mM AEBSF 
    
 Homogenization Buffer (HB):  250 mM sucrose 
      3 mM imidazole, pH 7.4 
 
   HB+PI:   +5µg/ml aprotinin 
      +5 µg/ml leupeptin 
      +0.5 µg/ml pepstatin A 
      + 0.4 mM AEBSF 
 
   HB+PI/EC:   +1 mM EDTA 
      +15 µg/ml cycloheximide 
+10 µg/ml aprotinin 
      +10 µg/ml leupeptin 
      +1 µg/ml pepstatin A 
      + 0.8 mM AEBSF 
 
• HeLa cells were cultured on 150 mm culture dishes  
• at confluency, cells were removed from the incubator and washed twice with 5 ml ice-
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cold PBS per culture dish 
• the cells were scraped off the dish on ice with a rubber policeman in 5 ml PBS+PI  
• the cells were pelleted by centrifugation at 1000 rpm in a refrigerated Heraeus 
Varifuge 3.0R 
• the supernatant was discarded and the cell pellet was resuspended in 5 ml of HB+PI  
• the suspended cells were pelleted at 2500 rpm and resuspended in 2 ml HB+PI/EC  
• the cells were homogenized on ice with a syringe by seven passages through a 23-
gauge needle, efficiency of homogenization was checked with a drop of the lysate 
mounted on a coverslip and viewed on a microscope  
• the homogenate was centrifuged at 3000 rpm to pellet nuclei and unbroken cells, the 
supernatant was recovered carefully and used for further experiments 
 
3.1.8 Subcellular fractionation of detergent lysates on linear density gradients  
• cells were grown to confluency on 150mm cell culture dishes and a PNS was prepared 
as described in 3.1.7.  
• the PNS was diluted with cold TBS, pH 7.4 to a final volume of 4 mL, transferred to a 
SW50 centrifuge tube and centrifuged at 100.000xg (25000 rpm, 1 hour, 4°C) to pellet 
cellular membranes 
• the membrane pellet was resuspended in 500 µl of ice-cold TNET lysis buffer (10 mM 
Tris.HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% TritonX-100 + protease 
inhibitors) and incubated for 20-30 minutes on ice (vortexing was performed every 5-
10 minutes to ensure proper mixing) 
• then, the lysates were centrifuged (10 minutes, 15.000xg=14.000 rpm, Eppendorf 
centrifuge, 4°C), the supernatants were removed and layed on top of preformed, 
precooled (4°C) sucrose gradients 
• the linear sucrose gradients were formed with a gradient mixer connected to a 
peristaltic pump (Gilson Minipuls 3, speed set to 12-16) and a long syringe needle at 
room temperature;  
• 6 ml 5% sucrose solution in TBEST (10 mM Tris.HCl, pH 7,4; 150 mM NaCl; 5 mM 
EDTA; 1% TX100) were pipetted into the first chamber, the second (mixing) chamber 
was filled with 6 ml 25% sucrose in TBEST, a magnetic stirrer was placed in the 
second chamber, and a linear sucrose gradient was formed in SW40 polycarbonate 
centrifuge tubes (the needle is always kept close above the liquid meniscus to prevent 
excessive mixing) and precooled to 4°C (alternatively, one can also pipet the lower 
density solution into the mixing chamber and the higher density solution into the 
second chamber; then, the needle is always kept at the bottom of the tube, and the 
mixture gets more and more dense and displaces the lighter solution upward; ) 
• 400 μl of the different supernatants were loaded on top of the 5-25% sucrose gradients 
and centrifuged over night in a Beckman SW40 swing-out rotor (200.000xg=36.000 
rpm, 4°C, 20 h) 
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• 19 fractions of 650 μl were taken from the top of the gradient, pelleted material was 
resuspended in the 19th fraction 
• the fractions were mixed with 165 μl of 5xR, boiled for 3 min, and aliquots of 100 μl 
of each fraction were then analyzed by SDS-PAGE, silver staining or western blotting; 
the rest of the fractions was stored at –20°C 
 
3.1.9 Subcellular fractionation of HeLa cell lysates on sucrose step gradients  
solutions:    HB 
 
HB+PI/EC 
     
    25 % w/w sucrose solution   0.806 M sucrose 
         3 mM imidazole, pH 7.4 
         1 mM EDTA 
 
35 % w/w sucrose solution   1.177 M sucrose 
         3 mM imidazole, pH 7.4 
         1 mM EDTA 
 
    62 % w/w sucrose solution  2.351 M sucrose 
         3 mM imidazole, pH 7.4 
         1 mM EDTA 
 
• a PNS is prepared as described above; all subsequent steps are performed at 4°C;  
• 2 ml of PNS is adjusted to a sucrose concentration of 40.6 % (w/w) by addition of 2.4 
ml of 62% sucrose solution; the suspension is thoroughly mixed and the sucrose 
concentration is be checked with a refractometer (everything between 40 and 41 % is 
acceptable) 
• 4 ml of the diluted PNS is transferred to the bottom of a SW40 centrifuge tube and 
sequentially overlaid with 4.5 ml of 35 % sucrose solution and 3.5 ml of HB 
• the tubes aremounted in a SW40 rotor and centrifuged for 1 hour with 35.000 rpm at 
4°C 
• the interphases between the HB and 35 % sucrose phase and between the 35 % and 
40.6 % sucrose phase are collected (equal volumes, should be as small as possible, 
approximately 500 µl!), the rest of the gradient is fractionated in 1 ml steps, the pellet 
is resuspended in 1 ml of HB, these fractions are included in cholesterol and protein 
determinations; the HB/35% interphase represents a crude endosomal fraction and 
should be enriched in early endosomal (e.g. rab5) and late endosomal/lysosomal 
markers (e.g. LAMP-1), whereas the 35%/40.6% interface should contain plasma 
membrane, ER and Golgi markers;  
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• equal protein amounts of a PNS aliquot, the crude endosomal fraction and the 
PM/ER/Golgi fraction are analysed by western blotting/silver staining;  
 
• alternatively, a two-step gradient centrifugation can be performed; therefore, the 
volume of the 35% sucrose solution is reduced to 3.5 ml, then, 2.5 ml of 25% sucrose 
solution are carefully overlaid, and the tube is subsequently filled by addition of 2 ml 
HB;  
• centrifugation is performed analogous to the one-step-gradient 
• the HB/25% interface should be enriched in late endosomal markers, whereas the 
25%/35% interface should be enriched in early endosomal proteins;  
• we were unable to obtain fractions enriched in late endosomal markers with this 
protocol, either because we did not use sufficient starting material or because the 
endosomes of HeLa cells behave differently in such gradients (the protocol was 
originally developed for BHK cells/MDCK cells) 
 
3.1.10 Subcellular fractionation of HeLa cell lysates on linear optiprep gradients  
Fractionation of HeLa cell lysates on Optiprep gradients was performed as described (Meyers 
and Prekeris, 2002), with some modifications.  
 
Solutions:   HB+E:  Homogenization Buffer (HB) + 1 mM EDTA 
 
   Optiprep stock solution:  60% iodixanol 
 
   Optiprep working solution (OWS):  50 % w/v iodixanol  
        250 mM sucrose 
        3 mM imidazol 
        1 mM EDTA 
 
   5 % Optiprep solution:  mix 1 vol. OWS with 9 vol. HB+E 
   20 % Optiprep solution:  mix 2 vol. OWS with 3 vol. HB+E 
 
• one 150 mm-dish containing confluent cells was used for preparing lysates  
• a PNS was prepared as described above  
• one ml of this supernatant was loaded on top of a precooled 11 ml linear density 
gradient from 5% to 20% Optiprep repared in a SW40 centrifuge tube (the gradient 
was prepared with a gradient mixer connected to a peristaltic pump (Gilson Minipuls 
3) and a long syringe needle in a SW40 centrifuge tube; the 5% Optiprep solution was 
pipetted in the front chamber of the gradient mixer, therefore, the density increases 
during the process; the syringe needle is kept at the bottom of the tube, the density 
gradually increases and the gradient is formed; this method was found to be superior 
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to the inverse protocol, where one has to move the needle up in the tube, in respect to 
gradient reproducibility)  
• the gradients were centrifuged at 100 000xg for 14-16 hours 
• nineteen fractions of 580 µl were taken from the top and analyzed by SDS-PAGE and 
Western blotting.  
• aliquots were assayed for alkaline phosphatase content as described (Lowry, 1957).  
 
3.1.11 Isolation of lipid rafts/DRMs 
Isolation of lipid raft/DRM fractions was performed with different cells during my work. I 
established a protocol for the isolation of DRMs (as they should be called, but lipid rafts just 
sounds nicer) from platelets during my diploma thesis, which was continuously improved 
during the next years(Mairhofer et al., 2002). This protocol was then adapted for the isolation 
of DRMs from cultured cell lines. The basic centrifugation procedure is the same, only the 
starting material and the lysis buffers are different. For platelets, I used the cells isolated from 
~50 ml of fresh blood for 2-4 experiments, whereas I used the membrane pellet from 1-2 
150mm cell culture dishes for adherent cell lines.  
 
• Platelets (~1x109 cells/mL) were resuspended in 250 µL Tyrode´s buffer and lysed by 
addition of a same volume of ice-cold lysis buffer (2% Triton X-100 or CHAPS, 100 
mM Tris.HCl, pH 7.4, 10 mM EGTA, protease inhibitors)  
• lysis was performed on ice for 20 minutes  
• for cell culture cells, a detergent lysate was prepared by lysing a membrane pellet 
(prepared as in section 3.1.8) in 500 µl ice-cold lysis buffer (1% Triton X-100, 150 
mM NaCl, 10 mM Tris-Cl, pH 7.4, 5 mM EGTA, and protease inhibitors)  
• the lysate was then brought to 50% sucrose by addition of 800 µL 80% sucrose in 
TBS containing 1% detergent 
• 1,2 mL of the 50%-sucrose-layer was pipetted onto the bottom of a SW50-Beckman 
centrifuge tube 
• this layer was overlaid with 0.8 mL 40% sucrose in TBS, followed by 2 mL of 35% 
and 0.5 mL 5% sucrose in TBS 
• the gradient was centrifuged at 48.000 rpm (230.000 xg) for 17 to 18 hours in a 
Beckman Ultracentrifuge at 4°C  
• nine fractions of 0.5 mL were collected from the top of the gradient, the pellet was 
resuspended in 0.5 mL of TBS, pH 7.4; fractions were analysed by SDS-PAGE, silver 
staining and western blotting 
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3.1.12 Immunoprecipitation  
The protocol for immunoprecipitation was adapted from “Current Protocols in Cell Biology” 
(Bonifacino and Dell'Angelica, 1998).  
 
Solutions:    PBS 
     
TX-100 Lysis-Buffer:  1% w/v Triton X-100 
        50 mM Tris.HCl, pH 7.4 
        300 mM NaCl 
        5 mM EDTA 
        0.02 % w/v sodium azide  
(this mixture can be stored for several months at 4°C) 
        5µg/ml aprotinin 
        5 µg/ml leupeptin 
        0.5 µg/ml pepstatin A 
        0.4 mM AEBSF 
        10 mM iodoacetamide 
(add protease inhibitors and iodoacetamide directly before use) 
 
    RIPA-Lysis-Buffer:   1% w/vNP-40 
        1% sodium-deoxycholate 
        50 mM Tris.HCl, pH 7.4 
        150 mM NaCl 
        1 mM EDTA 
        5µg/ml aprotinin 
        5 µg/ml leupeptin 
        0.5 µg/ml pepstatin A 
        1 mM PMSF or 0.4 mM AEBSF 
    Phosphatase Inhibitors:  1 mM sodium vanadate 
        1 mM NaF 
(alternatively, Phosphatase Inhibitor cocktails I and II from 
Sigma can be used at a dilution of 1/100) 
 
    wash buffer TX:   0.1% w/v Triton X-100 
        50 mM Tris.HCl, pH 7.4 
        300 mM NaCl 
        5 mM EDTA 
        0.02% w/v sodium azide 
 
    wash buffer RIPA:   0.1% NP-40 
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        0.1% sodium deoxycholate 
50 mM Tris.HCl, pH 7.4 
        300 mM NaCl 
        5 mM EDTA 
        0.02% w/v sodium azide 
 
     
10% w/v BSA stock solution in milliQ-H2O 
 
50% v/v slurry of ProteinA-Agarose beads in phosphate buffer 
(20 mM phosphate, pH 8, 150 mM NaCl)  
 
• HeLa cells (stably expressing the tagged protein of interest) were cultivated on 
100mm cell culture dishes;  
• at confluency, the plates were removed from the incubator, washed twice with 3 ml 
ice-cold PBS and the cells were lysed by addition of 1 ml of ice-cold lysis buffer 
(either TX-100 or RIPA-lysis buffer);  
• the cells were scraped off with a rubber policeman and were transfered to an 1.5 ml 
Eppendorf tube, vortexed thoroughly and left on ice for 20-30 minutese 
• the lysates were cleared by centrifugation (15 min, 16.000xg, 4°C), the supernatant 
was transferred to a new tube  
• a preclearing step was performed by adding 30 µl of the ProteinA-Agarose to the 
lysate and rotating for 30 minutes, the beads were spun down after the pre-clearing 
step and the supernatant was then combined with the antibody-ProteinA-Agarose 
complexes;  
• ProteinA-Agarose-antibody complexes were prepared as follows:  
- 30 µl of the ProteinA-Agarose slurry were diluted with 500 µl PBS, and the 
respective amount of primary antibody was added: 
1-5 µl of polyclonal antiserum  
1µg of purified polyclonal/monoclonal antibody  
50 µl of hybridoma culture supernatant  
- the suspension was mixed thoroughly and tumbled end-over-end for 1-2 hours 
at 4°C;  
- then, the beads were recovered by centrifugation (15-30 seconds), the 
supernatant was discarded and the beads were washed twice with the 
respective lysis buffer;  
- finally, the beads were spun down again, the lysis buffer was aspirated and the 
antibody-Protein-A-Agarose complexes were ready for immunoprecipitation;  
 
• per immunoprecipitation, 10 µl of 10% BSA and 500 µl of pre-cleared lysate were 
added to the antibody-ProteinA-Agarose complexes, the suspensions were carefully 
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mixed and tumbled end-over-end for 1-2 hours at 4°C; 
• after this incubation, the beads were spun down, and the supernatant was removed and 
transferred to a fresh tube (an aliquot of this IP-supernatant can also be analysed by 
western blotting, alternatively, a second IP can be performed with a different 
antibody) 
• the beads were washed 4 times with 1 ml of the respective wash buffer and finally 
with 1 ml of PBS;  
• the beads were spun down and the PBS was aspirated as completely as possible;  
• the precipitated proteins were eluted from the beads by rotating with 50-100 µl of SDS 
sample buffer for 1 hour at RT, the beads were spun down again and the 
immunoprecipitate was recovered from the beads and transfered to a new tube; 
alternatively, the beads can be directly boiled in the respective volume of SDS sample 
buffer; sometimes, it can be useful to use SDS sample buffer without mercaptoethanol 
or DTT (non-reducing sample buffers) to avoid strong bands from the antibodys at 55 
and 25 kDa;  
• IPs were analysed by SDS-PAGE and western blotting or silver staining;  
• as controls, IPs were performed with either pre-immune serum (for rabbit antiserum) 
or with irrelevant hybridoma supernatants/purified antibodies 
 
3.2 Molecular biological techniques  
3.2.1 Bacterial strains, media and solutions for bacteria culture  
Bacteria:  
DH5α, chemically competent, subcloning efficiency (Invitrogen) 
DH10B  
BL21 
 
The DH5α strain was used as a host for all standard cloning procedures.  
The genotype of this strain is: F- 80dlacZ M15 (lacZYA-argF) U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 - thi-1 gyrA96 relA1.   
 
The purchased cDNA clones (STOML-1, STOML-2, STOML-3) were provided in the 
DH10B E. coli strain.  
This strain was optimised for the construction of cDNA libraries and has the following 
genotype: F- mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 recA1 endA1 ara 139 
(ara, leu)7697 galU galK - rpsL (StrR) nupG.  
 
The BL21 strain was planned to be used for bacterial expression and subsequent purification 
of the SCP-2 domain of SLP-1 cloned into the pET28a vector. Due to lack of time, only one 
transformation of BL21 cells with the pET28a constructs was performed, and proper 
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expression of the protein domain was not verified yet.  
The genotype of the BL21 strain is: F- ompT hsdSB (rB-mB-) gal dcm rne131.  
 
Media and solutions:  
LB medium:   1% w/v NaCl 
   1% w/v BactoPeptone (Difco) 
   0.5% w/v yeast extract 
   pH adjusted to 7.5 and autoclaved 
 
LB agar:   15 g agar are solubilized in 1 l of LB medium,  
   the solution is autoclaved and stored at 4°C;  
 
Antibiotics:   
Antibiotic stock solution final concentration 
Ampicillin (AMP) 50 mg/ml in H2O 50 µg/ml 
Kanamycin (KAN) 10 mg/ml in H2O 30 µg/ml 
Chloramphenicol (CAM) 34 mg/ml in EtOH 25 µg/ml 
   
LB agar plates:  
LB agar is melted in the microwave oven (low power setting, 150 W, takes about 30 minutes), 
then the solution is cooled down to 65°C in a heated water bath, the respective amount of 
antibiotic is added from a stock solution and the plates are poured in 10cm culture dishes, 
cooled down to RT and stored at 4°C until use;  
 
3.2.2 Polymerase chain reaction (PCR)  
Equipment:    
RoboCycler Gradient 40 (Stratagene) 
 
Composition of a single reaction:  
  
 1.5 µl forward Primer (50 ng/µl) 
 1.5 µl reverse Primer (50 ng/µl) 
 1 µl DNA-template (100-250 ng) 
 2 µl 10 mM dNTPs (dATP, dCTP, dGTP, dTTP, 10 mM each) 
 5 µl 10x Pfu buffer (Stratagene) 
 0.5 µl Pfu Polymerase (Stratagene) 
 H2O-PCR ad 50 µl 
 
• the different PCR-reactions were prepared in 0.5 ml PCR tubes at 4°C, the 
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proofreading-competent Pfu-Polymerase was added last;  
• the following standard PCR protocol was used (unless indicated) and found 
appropriate for our cloning needs (inserts in the size range from 800-1500 base pairs):  
 
  Step 1:  94°C   1 minute  1 cycle 
 
  Step 2:  94°C   1 min 30 sec  ⎫ 
    55°C   1 min 30 sec  ⎬ 35 cycles 
    72°C  3 min             ⎭ 
  
  Step 3:  72°C  5 min   1 cycle 
 
• the PCR reactions were stored at 4°C until further use, an aliquot (1-2 µl) was diluted 
to 10 µl with a 1/5 mixture of 6x loading buffer and H2O and analysed on 1-1.5% 
agarose gels 
 
Figure 8: PCR mutagenesis 
Figure 8: Schematic overview of the method used 
for the introduction of defined point mutations into 
proteins. Reprinted from the on-line version at the 
NCBI bookshelf of “Human Molecular Genetics 
2”by Tom Strachan and Andrew P. Read, Garland 
Publishing Ltd. 
 
3.2.3 Site-directed mutagenesis (oligonucleotide-directed PCR mutagenesis)  
• to introduce point-mutations in the coding sequence of stomatin or SLP-1, forward 
and reverse oligonucleotides carrying the desired mutant codons were designed 
• on both sides of the introduced mismatch, approximately 18 matching bases were 
included  
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• a schematic representation of the mutagenesis procedure is given in Figure 8.  
• first, 2 separate PCRs are performed, with a N-terminal forward primer and the 
mutagenic reverse primer, and the complementary reaction, with the mutagenic 
forward primer and a C-terminal reverse primer; 
• the PCR products were then separated on low-melting agarose gels (NuSieve GTG 
agarose from BioWhittaker, 2-3%), the bands of correct size were excised, the agarose 
was melted at 50-60°C, and the fragments were used as “Megaprimers” for the 
subsequent second PCR step; the N- and C-terminal primers were included in the 
reaction mix to get strong amplification of the mutagenic full-length construct;  
• the mutagenic insert was then purified, digested and ligated into the vector of choice 
• the mutations were verified by sequencing of the inserts after cloning 
 
3.2.4 DNA sequencing  
• DNA sequencing was performed by capillary electrophoresis of fluorescently end-
labelled, prematurely terminated PCR products with an ABI PRISM 310 automated 
sequencer.  
 
Sequencing PCR:  (V=20µl)  1 µl sequencing primer (4-10 pmol/µl) 
2 µl BigDye terminator Mix (ABI, contains Taq 
Polymerase, dNTPs and ddNTPs labelled with different 
fluorophores in an optimal ratio) 
3 µl 5X sequencing buffer (100 mM Tris.HCl, pH 9, 10 
mM MgCl2 
     0.2-0.5 µg Plasmid-DNA 
     H2O ad 20 µl 
 
PCR protocol:  Step 1:  96°C   5 minutes  1 cycle 
 
   Step 2:  96°C   1 min 30 sec  ⎫ 
     50°C   1 min 30 sec  ⎬ 30 cycles 
     60°C  4-5 min          ⎭ 
 
• excess fluorescent ddNTPs must be removed prior to capillary electrophoresis by 
Sephadex G-50 minicolumn purification 
• Sephadex G-50 (Amersham-Pharmacia, DNA grade) was swollen o/n in milliQ-water 
(1 g Sephadex G-50 in 15 ml of H2O)  
• 650 µl of this G-50 slurry were pipetted into a UltrafreeMC column (Millipore) in an 
Eppendorf tube, and the tube was centrifuged for 3 minutes at 2500 rpm 
• the flow-through was discarded and the column was placed in a fresh tube  
• the product of the sequencing PCR (~20 µl) was loaded on top of the G-50 column 
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• the tube was again spun for 3 minutes at 2500 rpm 
• the flow-through should have approximately the same volume as the added PCR 
reaction (~20 µl) and can be directly used for sequencing 
 
3.2.5 Purification of DNA from PCR reactions  
Phenol-chloroform extraction of PCR fragments:  
• the PCR reaction was diluted with 100µl H2O-PCR to 150 µl 
• an equal volume of equilibrated phenol/chloroform/isoamylalcohol (25:24:1, Fluka) 
was added and the mixture was vortexed;  
• after centrifugation (14.000 rpm, 2 minutes), the aqueous (upper) phase was 
transferred to a new tube, and the organic phase was mixed with 150 µl of TE, 
vortexed and centrifuged again  
• the aqueous phases were combined and re-extracted with an equal volume of 
chloroform/isoamylacohol (24:1), vortexed and centrifuged again 
• the aqueous phase was carefully removed from the organic phase, mixed with 1/9 
volume of 3 M sodium acetate (vortex!) and 2.5 volumes of 96% EtOH (vortex!) and 
kept at -20°C o/n to precipitate the DNA 
• the precipitate was pelleted by centrifugation (14.000 rpm, 30 minutes, 4°C), the 
supernatant was discarded and the pellet was washed once with 150 µl 70% EtOH 
(vortex!), and centrifuged (14.000 rpm, 3 minutes) 
• the supernatant was discarded and the DNA pellet was air-dried and resuspended in 20 
µl of H2O-PCR 
 
Purification of PCR fragments with the Wizard SV Gel and PCR Clean-Up system 
(Promega):  
• the PCR reaction was combined with an equal volume of Membrane Binding Solution 
(acidic solution (pH 5) containing a high concentration (4.5 M) of guanidine 
isothiocyanate), mixed thoroughly, transferred into the DNA binding columns and 
incubated for 1 minute 
• the column was centrifuged (14.000 rpm, 1 minute), the flow-through was discarded 
and the column was washed with 700 µl Membrane Wash Solution (an acidic buffer 
containing 80% EtOH, add wash solution, incubate for ~1min, centrifuge (14.000 rpm, 
1 min.)) 
• the washing step was repeated with 500 µl Membrane Wash Solution, centrifugation 
time 5 minutes! 
• finally, the collection tube was emptied again, and the empty column was centrifuged 
for 1-2 minutes with the centrifuge lid open (to allow evaporation of any residual 
EtOH) 
• the DNA binding column was then transferred to a clean 1.5 ml tube and the DNA is 
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eluted with 20 µl H2O-PCR or TE 
 
3.2.6 Restriction digestion of PCR fragments and vector DNA  
• restriction enzymes used were from New England Biolabs, and the recommended RE 
buffers were used for single- and double digests; in case of a total incompatibility of 
the two buffers for a digest, sequential digestion was performed;  
 
control digests:  (V=10µl)  1 µl 10x NEBuffer (NEB 1, 2, 3,4, EcoRI, BamHI) 
     0.2 µl restriction enzyme (s) 
     2 µl Mini-Prep-DNA/vector DNA 
     H2O ad 10 µl 
 
preparative digests:  
 
for vectors:   (V=50µl)  5 µl 10x NEBuffer (NEB 1, 2, 3,4, EcoRI, BamHI) 
     1 µl restriction enzyme (s) 
     ~ 3 µg vector DNA 
     H2O ad 50 µl 
 
for inserts:   (V=25µl)  2.5 µl 10x NEBuffer (NEB 1, 2, 3,4, EcoRI, BamHI) 
     0.5 µl restriction enzyme (s) 
     20 µl purified insert-DNA 
     H2O ad 25 µl 
 
• control and preparative digests were analysed by agarose gel electrophoresis 
• preparative digests were purified from the alarose gels as described in 3.2.11 
 
3.2.7 Dephosphorylation of (vector) DNA  
• for cloning of inserts into vectors via a single restriction site (non-directional cloning), 
the vector DNA was dephosphorylated after the restriction digest 
 
(restriction digest, V=50µl) +5 µl 10x Alkaline Phosphatase buffer (Promega) 
    +0.5 µl Alkaline Phosphatase (1 U/µl, Promega) 
 
• the reaction mix was incubated for 30 minutes at 37°C 
• then, another 0.5 µl of Alkaline Phosphatase was added, followed by further 
incubation for 30 minutes at 37°C 
• the reaction was processed for Agarose gel electrophoresis and the vector DNA was 
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isolated as described 
 
3.2.8 Phosphorylation of insert DNA/oligonucleotides  
• for cloning methods where the inserts are directly used without a restriction digest 
(e.g. blunt-end cloning after PCR, insertion of oligonucleotide linkers etc.), the 
inserts/oligonucleotides/Primers have to be phosphorylated prior to use 
• phosphorylation was done with the T4 polynucleotide kinase from Promega, the 
reaction mix was as follows:  
 
  300-350 ng insert DNA / 10 µg of oligonucleotide/Primer 
  5 µl 10 mM ATP 
  5 µl 10x One-Phor-All buffer (Promega) 
  2 µl T4 Kinase (Promega) 
  H2O-PCR to 50 µl 
 
• the reaction mix was incubated for 1 hour at 37°C, then, the reaction was stopped by 
adding 2 µl of 0.5 M EDTA 
• purification of the DNA was either done by Phenol extraction/ethanol precipitation or 
with the Promega Wizard SV Gel and PCR Clean-Up system;  
 
3.2.9 Creation of blunt end DNA with Klenow Polymerase fragment  
• for some cloning purposes, it was necessary to convert DNA containing “sticky” ends 
(5´ or 3´ overhangs) to blunt end DNA 
• the optimal buffer for the Klenow Polymerse is NEB Buffer 2, but according to the 
manufacturer, the enzyme should be active in all restriction enzyme buffers 
• after the restriction digest of the vector/insert DNA, 33 µM of dNTPs were added to 
the restriction enzyme digest from a 1 mM stock solution 
• approximately 1U Klenow polymerase (5U/µl) was added per µg of DNA 
• incubation was performed for 15 minutes at 25°C 
• Klenow polymerase fills in 5´overhangs (polymerase activity) and removes 
3´overhangs (3´-5´exonuclease activity) 
• after the 15 minute incubation, the Klenow polymerase is inactivated by adding 10 
mM EDTA and heating to 75°C for 20 minutes 
• the vector/insert DNA is the purified as described  
 
3.2.10 Agarose Gel Electrophoresis  
Equipment:  MINNIE submarine agarose gel unit HE33 (Hoefer) 
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Mighty Bright power supply, Model UVTM 25 (Hoefer) 
Microwave 
UV screen 
GenXpress Doc-Print Video system and Mitsubishi P91 thermal printer 
 
Solutions:  running buffer (0.5x TBE) 50 mM Tris 
      45 mM boric acid 
      1 mM EDTA 
 
  6x loading buffer   0.25% bromophenol blue 
      0.25% Xylene Cyanol FF 
      15 % Ficoll (Type 400, Amersham) 
 
  ethidium bromide stock  10 mg/ml in milliQ-H2O 
 
• Agarose (GibcoBRL) was weighed in an Erlenmeyer (to yield a 0.7-1.5 % w/v 
solution in 60 ml 0.5x TBE), TBE was added, the suspension was mixed thoroughly 
and the agarose was solubilized by boiling in the microwave 
• the agarose solution was cooled down to approximately 50°C , 6 µl of the ethidium 
bromide stock was added and the solution was thoroughly mixed 
• the agarose solution was poured into the horizontal gel holder with the appropriate 
comb and let stiffen (~20 min) 
• the comb was carefully removed, the gel was transferred to the agarose gel unit, 
overlaid with running buffer, and the samples (mixed with 1/5 vol. of 6xloading 
buffer) were loaded together with a DNA size standard (1kb DNA ladder from 
GibcoBRL or Fermentas) 
• electrophoresis was performed at 90 V for 30-45 minutes 
• DNA was visualized under UV light, and pictures of the gel were taken 
 
3.2.11 Purification of DNA from Agarose gels 
Purification of DNA from gel slices with the QIAEX II Gel Extraction Kit (Qiagen) 
Solutions:  10 mM Tris.HCl, pH 8.5 
 
• insert and vector bands were excised from agarose gels on the UV screen, and 
purification of DNA from the gel slices was done exactly according to the 
manufacturer´s instructions;  
• vector DNA was eluted from the QIAEX beads with 50 µl of Tris.HCl, whereas insert 
DNA was eluted with 20 µl of Tris.HCl 
(this method was most frequently used for purification, and yielded good results) 
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Purification of DNA bands from DEAE-membrane:  
Materials:  NA45 DEAE membrane (0.45 µm), Schleicher&Schuell 
 
Solutions:  low-salt washing buffer 50 mM Tris.HCl, pH 8 
      150 mM NaCl 
      10 mM EDTA, pH 8 
 
  high-salt washing buffer 50 mM Tris.HCl, pH 8 
      2 M NaCl 
      10 mM EDTA, pH 8 
 
  10 M ammonium acetate 
 
• after separation of DNA fragments by agarose gel electrophoresis, the band of interest 
was identified 
• the gel was cut exactly below the band, and a piece of DEAE membrane was inserted 
in the cleft  
• the gel was put back into the apparatus, and electrophoresis was performed for another 
5 minutes (then, the gel was checked under the UV screen; the band of interest should 
have disappeared, and the EtBr staining should be detectable on the DEAE membrane; 
if transfer was still incomplete, electrophoresis was continued for 2-3 minutes) 
• the piece of DEAE membrane was transfered to a tube and was washed 6 times with 1 
ml low-salt washing buffer 
• the DNA was eluted from the membrane by incubation with 150 µl high-salt buffer at 
65°C for 30 minutes 
• the elution step was repeated, the eluates were combined 
• DNA was precipitated by adding 1/5 volume (60µl) 10 M ammonium acetate (vortex!) 
and 2 volumes (600 µl) 96% EtOH (vortex!), the mixture was incubated for at least 30 
minutes at -20°C 
• the DNA was pelleted (14.000 rpm, 30 minutes, 4°C), the supernatant was discarded 
• the pellet was washed with 150 µl of 70% EtOH (vortex, centrifuge 14.000 rpm, 3 
minutes, remove supernatant) 
• the pellet was air-dried, resuspended in 7-10 µl of H2O-PCR and DNA was stored at -
20°C 
(with this method, stronger concentration of digested insert-DNA can be achieved)  
 
Isolation of DNA from gel slices with the Wizard SV Gel and PCR purification kit:  
• gel bands were excised as described above 
• the bands were weighed and mixed with 10 µl of Membrane Binding Solution per 10 
Methods 
PhD thesis   Mario Mairhofer 
 69 
 
µg gel slice 
• the mixture was vortexed and incubated at 50-60°C until the gel slice was completely 
dissolved 
• the solution was transferred to the DNA binding column, incubated for 1 minute and 
the rest of the procedure was identical to the purification of PCR reactions (Verweis) 
(this is the fastest method, which was only used if time was short, this kit is best used 
for purification from PCR reactions; vector bands from gels can be problematic 
because of their weight!) 
 
3.2.12 Ligation of DNA fragments into vector DNA  
Materials:  T4 DNA ligase 1U/µl (Invitrogen) 
Ligation reaction:    
• for a ligation with “sticky ends“, approximately a 3-fold molar excess of insert over 
vector DNA should be used; the amounts of vector and insert DNA were estimated on 
an Agarose gel prior to ligation;  
 
a typical ligation reaction was as follows:  
    insert DNA 5-7.5µl 
    vector DNA 0.5-1µl 
    2 µl 5x ligase buffer 
    0.5 µl T4 DNA Ligase (diluted to 0.1 U/µl in 1x Ligase buffer)  
    H2O-PCR to 10 µl 
 
• a control ligation reaction (insert DNA replaced with H2O) was always included 
• the reactions were mixed gently and incubated for 1-2 hours at room temperature (for 
sticky ends; for blunt-end cloning, incubation o/n at 16°C is necessary, and 1 µl of 
undiluted T4 ligase should be used) 
• the ligation reaction was diluted 1:5 in H2O-PCR, and 5 µl of this dilution were used 
for transformation of chemically competent E. coli; the remainder of the ligation 
reaction was stored at 4°C 
•  
3.2.13 Transformation of chemically competent E. coli with the heat-shock method  
Materials:  chemically competent E. coli, strain DH5α, subcloning efficiency (Invitrogen) 
water bath at 37°C 
• chemically competent E. coli were thawed upon arrival, aliquoted and stored at -80°C 
until use 
• aliquots were thawed on ice directly before use 
• the competent cells were mixed with 5µl of the respective ligation reaction and 
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incubated for 30 minutes on ice  
• transformation was performed by a brief heat-shock (transfer the cells to the 37°C-
water bath for 30 seconds) 
• cells were incubated for further two minutes on ice, then mixed carefully with 1 ml of 
LB-medium, transferred to a 14ml round-bottom polypropylene tube (Falcon) and 
incubated in a shaker for 1 hour (recovery) 
• then, 1/10 and 9/10 of the cells were plated on the respective selective LB plates 
and incubated over night in an incubator at 37°C 
• grown colonies were counted, numbers were compared with the control plates;  
• single colonies were picked, single colony streaks were produced on fresh plates and 
the colonies were analyzed for the presence of the correct plasmid DNA (Mini-Prep or 
single-colony PCR) 
3.2.14 Plasmid Mini-Prep (boiling Prep)  
Equipment:  Lab-Therm Shaker (Adolf Kühner AG) 
  Eppendorf desk-top centrifuge 
  sterile toothpicks/yellow pipette tips 
 
Solutions: STET lysis buffer:   8% w/v sucrose 
      0.5% Triton X-100 
      50 mM EDTA pH 8 
      50 mM Tris.HCl pH 8 
      sterile filter, store at -20°C;  
 
  Lysozyme stock solution:  50 mg/ml in 250 mM Tris.HCl, pH 8 
 
RNAse A stock solution:  10 mg/ml in milliQ-H2O 
 
  70% EtOH 
 
  TE buffer:    10 mM Tris.HCl, pH 8 
      1 mM EDTA, pH 8 
• 6 colonies per agar-plate were picked in case of directional cloning (2 different 
restriction enzymes), whereas 12 colonies were picked when the insert was not cloned 
directionally;  
• the colonies were picked with sterile toothpicks or sterile yellow pipette tips 
• the colonies were streaked out on fresh agar plates before inoculating the medium 
(these plates are grown o/n and can then be used to inoculate cultures for Midi-Preps) 
• 4 ml of LB medium supplemented with the respective antibiotic were inoculated with 
the toothpicks/tips and grown over night at 37°C in a shaker 
• 2 ml of these o/n cultures were transferred to 2 ml Eppendorf tubes and the bacteria 
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were pelleted by centrifugation (Eppendorf desk-top centrifuge, 5000 rpm, 5 minutes) 
• the supernatant was sucked off and the pellet was resuspended in 500 µl ice-cold 
STET buffer by rigorous vortexing 
• 4 µl of Lysozyme stock solution were added and the lysate was incubated for 10 
minutes on ice 
• the lysates were then heated to 95°C for 3 minutes 
• debris was pelleted by centrifugation (13.000 rpm, 15 minutes) 
• the pellet was removed with a toothpick, and 4 µl of RNAseA stock solution were 
added 
• the lysate was incubated for 30 minutes at RT 
• then, 500 µl isopropanol were added to precipitate plasmid DNA, the solution was 
vortexed and centrifuged (13.000 rpm, 15 minutes) 
• the supernatant was discarded and the pellet was washed once with 150 µl 70% EtOH, 
pelleted again (13.000 rpm, 15 minutes) and finally resuspended in 80 µl of TE buffer 
 
3.2.15 Single-colony-PCR  
• single colonies grown after transformation and plating o/n were picked with a sterile 
yellow tip, a single-colony streak was produced on a new LB-antibiotic plate 
• the tip was then transferred to a sterile tube with 50 µl H2O-PCR, the tube was 
vortexed vigorously and the tip was discarded 
• the tubes were heated to 95°C for 5 minutes and centrifuged (14.000 rpm, 1 minute) 
• 10 µl of the supernatant were used as template for a PCR reaction, the primers were 
chosen to reveal the orientation of the insert (e.g. the forward primer was slightly 
upstream of the MCS, and the reverse primer was somewhere in the coding sequence; 
correct insertion leads to a fragment of known length) 
 
PCR reaction:   10 µl template DNA 
   1 µl 10 mM dNTPs 
   5 µl 10x Taq buffer 
   2 µl 25 mM MgCl2 solution (final: 1 mM) 
   1 µl forward primer (50 ng/µl) 
   1 µl reverse primer (50 ng/µl) 
   0.5 µl Taq-Polymerase (Promega) 
   to 50 µl with H2O-PCR 
 
• PCRs were done as described, and 1-2 µl aliquots of the PCRs were analysed by 
Agarose gel electrophoresis 
• colonies with correct inserts were chosen and used for Midi-Preps 
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3.2.16 Plasmid Midi-Prep  
Qiagen Plasmid Midi Kit:  
Equipment:  Lab-Therm Shaker (Adolf Kühner AG) 
  RC5C preparative centrifuge (Sorvall Instruments) 
  sterile toothpicks/yellow pipette tips 
  QIAGEN Plasmid Midi Kit 
 
• a fresh o/n single colony streak from a LB agar plate was used for inoculation, bacteria 
were picked with a sterile inoculation loop  
• approximately 100 ml of LB-medium (+antibiotic) were inoculated and cultivated o/n 
at 37°C in a shaker 
• 100 µl of each culture were transferred into an Eppendorf tube, mixed with 400 µl of 
sterile glycerol and stored at -80°C (Glycerol-stocks)  
• the rest of the cultures was transferred to Sorvall GSA beakers and the bacteria were 
pelleted by centrifugation (GSA rotor, 3000 rpm, 10 minutes, 4°C)  
• the supernatant was discarded and the pellet was used to isolate the plasmid DNA 
according to the QIAGEN Plasmid Preparation handbook (basically, the bacteria are 
lysed in an alkaline SDS lysis buffer, the lysate is filtered and the plasmid DNA is 
bound to an anion exchanger, washed bound to the column and eluted at high salt 
concentrations) 
• after elution of the plasmid DNA from the anion exchanger with 5 ml of elution buffer 
into a corex tube, 3.5 ml of isopropanol were added to precipitate DNA, the solution 
was vortexed thoroughly and then centrifuged for 30 minutes (Sorvall centrifuge, HB-
4 swing-out rotor, 12.000 rpm, 4°C)  
• the supernatant was discarded, and the pellet was washed with 2 ml of 70% ethanol 
(add washing solution, vortex, discard washing solution) 
• the pellet was then air-dried, finally resuspended in 150 µl of sterile H2O and stored at 
-20°C 
• the plasmid´s concentration and purity was analysed as follows:  
- the optical density (OD) of a 1:100 dilution of the plasmid DNA is determined 
at 260 and 280 nm 
- concentration: 1 OD corresponds to  50µg/ml double-stranded DNA 
      40µg/ml single-stranded DNA or RNA 
      30µg/ml single-stranded oligonucleotides 
- purity: the ratio between OD280 and OD260 should be 2/3 to 3/4 
 
Plasmid Midi-Prep with the PureYield Plasmid Midiprep system (Promega):  
Equipment:  Lab-Therm Shaker (Adolf Kühner AG) 
  RC5C preparative centrifuge (Sorvall Instruments) 
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  Heraeus Varifuge 3.0R 
  Vac-Man Jr. Laboratory Vacuum Manifold 
  sterile toothpicks/yellow pipette tips 
 
• approximately 100 ml over-night culture and a glycerol stock was prepared as 
described above 
• the rest of the cultures was transferred to Sorvall GSA beakers and the bacteria were 
pelleted by centrifugation (GSA rotor, 3000 rpm, 10 minutes, 4°C)  
• the pellet was used to isolate plasmid DNA according to the technical manual of the 
PureYield plasmid MidiPrep system from Promega (similar system, filtration column 
and DNA binding column can be used by centrifugation of the lysate or by use of a 
vacuum manifold; sterile H2O is used for elution of the DNA) 
• due to the presence of EtOH in the final eluate when using the original protocol, a 
precipitation step was included 
• the DNA was eluted from the Promega column with the elution buffer from the 
Qiagen Kit, DNA precipitation, washing and resuspension in sterile H2O was done as 
described (this procedure yielded plasmid DNA of higher purity) 
 
3.2.17 Isolation of the SLP-1 coding sequence from the IMAGE clone  
Image clone Nr. 5185908 was purchased from the RZPD (German Resource Center for 
Genome Research), RZPD Clone ID: IRATp970H0745D;  
The full coding sequence of SLP-1 (gene name STOML-1) was inserted into the multiple 
cloning site of the pCMV-Sport6 vector (Invitrogen) via the 5´EcoRV and the 3´NotI 
restriction sites.  
Some DH10B bacteria were picked with an inoculating loop, streaked on a LB-AMP agar 
plate and incubated over night at 37°C. Then, single colonies were picked, streaked out on a 
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fresh LB-AMP plate and used to inoculate 100 ml LB-AMP for over-night cultures for Midi-
Preps.  
Midi-Preps were performed as described, the isolated vector DNA was resuspended in 150 µl 
of sterile H2O and stored at -20°C. The vector DNA was digested with EcoRV and NotI and 
digested and undigested vector were analyzed by Agarose gel electrophoresis. The insert of 
the Midi-Prep vector DNA was sequenced with the SP6 promotor primer and was found to be 
identical to the SLP-1 cDNA sequence from the database. With the expression vector pCMV-
Sport6, it should be possible to express untagged SLP-1 protein, but as we did not have an 
antibody recognizing the untagged SLP-1 protein, we had to construct tagged SLP-1 
constructs. Therefore, we used the vector DNA as template for PCR reactions with the 
primers specified below, purified the PCR-products, performed restriction digests of the insert 
and vector DNA and ligated the coding region of SLP-1 into the described vectors, yielding 
in-frame fusions to either the short myc-tag, the GFP-tag or a 3xHA-tag.  
 
Image clone Nr. 3346384 (SLP-2/STOML2) (RZPD Clone ID: IRALp962M085Q) and Image 
clone Nr. 5204252 (SLP-3/STOML3) (RZPD Clone ID: IRATp970D0742D) were also 
purchased. The coding sequence for SLP-3 was also present as EcoRV/NotI insert in pCMV-
Sport6, whereas the coding sequence for SLP-2 was inserted into the MCS of the pOTB7 
vector (CAM resistance) via a 5´EcoRI and 3´XhoI restriction site. The vector DNA was 
isolated as described above and the inserts were sequenced with the SP6 promotor primer. No 
further experiments were performed with these cDNAs, but they are ready for the preparation 
of tagged constructs and could be used in the future.  
 
3.2.18 Cloning of tagged SLP-1 constructs  
SLP-1-GFP:  
Primers:   
forward: SLP-1 GFP NT EcoRI CGGAATTCGCCATGCTCGGCAGGTCT 
reverse: SLP-1 GFP CT SacII TCCCCGCGGCTGCGCCCTTCAAGGCCCTGAGGAC 
 
• the insert spanning the entire coding region of SLP-1 was prepared by PCR as 
described, digested with EcoRI and SacII and ligated into the pEGFP-N3 vector (BD 
Biosciences Clontech) digested with the same restriction enzymes 
• this procedure leads to an in-frame fusion of the GFP coding sequence to the C-
terminus of SLP-1, a linker sequence (GAAAAGSIAT) connects the final amino acid 
of SLP-1 and the start methionine of GFP 
GFP-SLP-1:  
Primers:   
forward: C/G/YFP-SLP1 ATCTCGAGCTCTCGGCAGGTCTGGG 
reverse: SLP-1 myc CT SpeI GGACTAGTCTTCAAGGCCCTGAGGAC 
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• the XhoI and XbaI restriction sites were used for cloning of GFP-SLP-1; the reverse 
primer for the SLP-1-myc construct was re-used, the insert was digested with XhoI 
and SpeI; SpeI and XbaI digestion creates compatible ends;  
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SLP-1-myc:  
• to get a myc-tagged SLP-1 construct, the vectors used in our group had to be 
modified, because the SLP-1 coding region contains a KpnI restriction site, the use of 
the pEFKmyc vector constructed by Luc Snyers in our laboratory was not possible.  
• therefore, a novel vector containing the myc tag and a stop codon in frame with a SpeI 
restriction site was constructed from the pEFBOSpuro vector (pEFBOSpuro is a 6.1 
kb mammalian expression vector with the following features: the gene of interest is 
constitutively expressed through an EF1α promotor, for selection in bacteria, the 
vector contains an ampicillin resistance gene and for selection in mammalian cell lines 
a puromycin resistance gene as well as an ori for replication in E. coli) 
 
• forward and reverse oligonucleotides were designed, which code for the myc-tag 
(EQKLISEEDL) followed by a stop-codon; at the 5´end of the resulting double-
stranded oligonucleotide, an overhang equal to digestion with SpeI was included, 
whereas the 3´overhang was designed to be blunt-ended 
Oligonucleotides:   
Myc fwd SpeI/EcoRV CTAGTGAGCAGAAATTAATCAGCGAAGAGGACCTCTAGGAT 
Myc rwd SpeI/EcoRV ATCCTAGAGGTCCTCTTCGCTGATTAATTTCTGCTCA 
• the oligonucleotides were solubilized in water at a concentration of 2 µg/µl, the 
concentration was checked by measuring the OD260/280 of a 1/400 dilution 
• 10 µg of each oligonucleotide were used for a phosphorylation reaction:  
   
  10 µg Myc fwd (3.3 µl)/Myc rwd (5.1 µl) 
  5 µl 10 mM ATP 
  5 µl 10x One-Phor-All buffer (Promega) 
  2 µl T4 Kinase (Promega) 
  H2O-PCR to 50 µl 
• the phosphorylation reaction was incubated for 1 hour at 37°C 
• for the annealing of the oligos, the phosphorylation reactions Myc fwd and Myc rwd 
were mixed and transferred in a styrofoam floater to a beaker with boiling water, 
which was let cool down to RT (destruction of T4 kinase and annealing of the oligos) 
• the double-stranded oligo was then purified with Sephadex G-50 nick columns 
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(Amersham/Pharmacia) as follows: the column was equilibrated with TE-buffer, then 
the annealing reaction (100 µl) was loaded on the column, the column was washed 
with 400 µl of TE and the ds-oligo was eluted with another 400 µl of TE 
• 100 µl of this eluate were diluted with 400 µl of H2O and the OD260/280 was 
measured (the concentration of the phosphorylated ds-oligo was ~72 ng/µl) 
• a 1:60 dilution of the phosphorylated ds-oligo was made (~1.2 ng/µl) and used for the 
subsequent ligation reaction:  
 
  (V=5µl) 2.5 µl phosphorylated ds-Myc-oligo 
    1.5 µl pEFBOSpuro, digested with SpeI and EcoRV 
    0.5 µl 10x Ligase buffer (Promega) 
    0.5 µl T4 Ligase 
 
• the ligation was performed as described (3.2.12), and chemically competent E. coli 
(DH5α) were transformed as described (3.2.13) 
• full-length SLP-1 inserts for cloning into this new myc-tag vector were prepared with 
the following primers:  
Primers:   
forward: SLP-1 myc NT SpeI GGACTAGTGCCATGCTCGGCAGGTCT 
reverse: SLP-1 myc CT SpeI GGACTAGTCTTCAAGGCCCTGAGGAC 
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SLP-1-3HA:  
• the vector pC3HA (based on pcDNA3.1hygro, with a triple HA-tag (YPYDVPDYAG) 
inserted) was a kind gift of Dr. Christoph Thiele (Max-Planck-Institute for Molecular 
Cell Biology and Genetics, Dresden); see vector map above!  
• for cloning into pC3HA, I used the XbaI site (see vector map); because XbaI and SpeI 
restriction digestion produces compatible ends for ligation, I could use the primers for 
the myc-tagged constructs for PCR or prepare the inserts by digestion of the existing 
myc-tagged constructs with SpeI 
 
Primers:   
forward: SLP-1 myc NT SpeI GGACTAGTGCCATGCTCGGCAGGTCT 
reverse: SLP-1 myc CT SpeI GGACTAGTCTTCAAGGCCCTGAGGAC 
 
3.2.19 SLP-1 truncation mutants 
• N- and C-terminal truncations were prepared by performing PCR-reactions with 
primers which bound internally in the coding region and contained appropriate 
initiator/terminator codons and restriction sites for cloning into the vectors to yield 
GFP- or myc-tagged truncation mutants 
SLP-1(1-288)-GFP:  
Primers:   
forward: SLP-1 GFP NT EcoRI CGGAATTCGCCATGCTCGGCAGGTCT 
reverse: SLP-1 dnsLTP GFP TCCCCGCGGCTGCGCCAGGCTGCTTCGGACTGG 
SLP-1(1-224)-GFP:  
Primers:   
forward: SLP-1 GFP NT EcoRI CGGAATTCGCCATGCTCGGCAGGTCT 
reverse: SLP-1 T225 GFP TCCCCGCGGCTGCGCCCGGCTGGAGCACGGCCT 
SLP-1(1-96)-GFP:  
Primers:   
forward: SLP-1 GFP NT EcoRI CGGAATTCGCCATGCTCGGCAGGTCT 
reverse: SLP-1 T96 GFP TCCCCGCGGCTGCGCCGATCCGGCCCAGGCGG 
SLP-1(1-288)-myc:  
Primers:   
forward: SLP-1 myc NT SpeI GGACTAGTGCCATGCTCGGCAGGTCT 
reverse: SLP-1 dnsLTP myc GGACTAGTAGGCTGCTTCGGACTGG 
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SLP-1(1-224)-myc:  
Primers:   
forward: SLP-1 myc NT SpeI GGACTAGTGCCATGCTCGGCAGGTCT 
reverse: SLP-1 T225 myc GGACTAGTCGGCTGGAGCACGGCCTC 
SLP-1(43-397)-myc:  
Primers:   
forward: SLP-1 dNT myc GGACTAGTCCACCATGGCCGATGTACCCCAGAGC 
reverse: SLP-1 myc CT SpeI GGACTAGTCTTCAAGGCCCTGAGGAC 
SLP-1(43-288)-myc:  
Primers:   
forward: SLP-1 dNT myc GGACTAGTCCACCATGGCCGATGTACCCCAGAGC 
reverse: SLP-1 dnsLTP myc GGACTAGTAGGCTGCTTCGGACTGG 
SLP-1(43-224)-myc:  
Primers:   
forward: SLP-1 dNT myc GGACTAGTCCACCATGGCCGATGTACCCCAGAGC 
reverse: SLP-1 T225 myc GGACTAGTCGGCTGGAGCACGGCCTC 
SLP-1(11-397)-myc:  
Primers:   
forward: SLP-1 dGYRAL GGACTAGTCCACCATGCTGGGTGATTTTGACCGC 
reverse: SLP-1 myc CT SpeI GGACTAGTCTTCAAGGCCCTGAGGAC 
SLP-1(1-384)-myc:  
Primers:   
forward: SLP-1 myc NT SpeI GGACTAGTGCCATGCTCGGCAGGTCT 
reverse: SLP-1 T385 rwd GGACTAGTCAGGTCGCCCTTCACC 
SLP-1(1-288)-3HA: 
Primers:   
forward: SLP-1 myc NT SpeI GGACTAGTGCCATGCTCGGCAGGTCT 
reverse: SLP-1 dnsLTP myc GGACTAGTAGGCTGCTTCGGACTGG 
SLP-1(1-224)-3HA:  
Primers:   
forward: SLP-1 myc NT SpeI GGACTAGTGCCATGCTCGGCAGGTCT 
reverse: SLP-1 T225 myc GGACTAGTCGGCTGGAGCACGGCCTC 
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SLP-1(1-49)-GFP:  
Primers:   
forward: SLP-1 GFP NT EcoRI CGGAATTCGCCATGCTCGGCAGGTCT 
reverse: SLP-1 1-50 rwd SacII TCCCCGCGGCTGCGCCGCTCTGGGGTACATCGG 
• the same primers were used with the mutagenised Y7A and L10S constructs as 
templates, giving rise to SLP-1(Y7A,1-50)-GFP and SLP-1(L10S,1-50)-GFP 
constructs!  
GFP-SLP-1(278-397):  
Primers:   
forward: GFP-LTP fwd BglII GGAAGATCTGCCCCTCAAGTTGGTGC 
reverse: HIS/GFP LTP rwd BamHI CGGGATCCCTACTTCAAGGCCCTGAGG 
GFP-SLP-1(278-384): 
Primers:   
forward: GFP-LTP fwd BglII GGAAGATCTGCCCCTCAAGTTGGTGC 
reverse: HIS/GFP LTPT385 rwd BamHI CGGGATCCCTACAGGTCGCCCTTCACC 
6xHIS-SLP-1(278-397):  
Primers:   
forward: HIS LTP fwd NdeI GGAATTCCATATGGCCCCTCAAGTTGGTGC 
reverse: HIS/GFP LTP rwd BamHI CGGGATCCCTACTTCAAGGCCCTGAGG 
6xHIS-SLP-1(278-384):  
Primers:   
forward: HIS LTP fwd NdeI GGAATTCCATATGGCCCCTCAAGTTGGTGC 
reverse: HIS/GFP LTPT385 rwd BamHI CGGGATCCCTACAGGTCGCCCTTCACC 
• for cloning of the HIS-tagged constructs, which were constructed for future bacterial 
expression and purification of the SCP-2/nsLTP-domain of SLP-1, the pET28a+ 
vector was used 
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3.2.20 SLP-1 point mutations  
SLP-1(Y7A)-3HA:  
• a long oligo covering the 5´end of the coding region and bearing the desired point-
mutation along with a SpeI restriction site was used for mutagenesis; the 5´KpnI 
restriction site in the coding region is destroyed by the mutation and can be used for 
analysis of clones;  
forward: SLP1 Y7A GGACTAGTCCACCATGCTCGGCAGGCTTGGGGCCCGGGCGCTGCC 
reverse: SLP-1 myc CT SpeI GGACTAGTCTTCAAGGCCCTGAGGAC 
SLP-1(Y7A)-GFP:  
• the mutated SLP-1(Y7A)-3HA construct was used as template for a PCR with primers 
for cloning into pEGFP-N3! 
forward: SLP-1 GFP NT EcoRI CGGAATTCGCCATGCTCGGCAGGTCT 
reverse: SLP-1 GFP CT SacII TCCCCGCGGCTGCGCCCTTCAAGGCCCTGAGGAC 
SLP-1(L10S)-myc:  
• the region between the KpnI and BamHI restriction site within the coding region of 
SLP-1 was amplified with a mutagenic 5´primer and a non-mutagenic 3´primer, and 
this mutagenised fragment was then inserted into the SLP-1-myc construct via these 
restriction sites;  
 
forward: SLP1 L10S fwd GGTCTGGGTACCGGGCGTCCCCCCTGGGTGATTTTGACC 
reverse: SLP-1 L10S rwd GCGGATCCGGCCCAGG 
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3.2.21 Stomatin point-mutations 
STOM (S231A)-myc/GFP:  
forward: MM S231A GAAATGAATGCAGCCAGGGCTCTGAAAG 
reverse: MM S231A as CTTTCAGAGCCCTGGCTGCATTCATTTC 
STOM (S231E)-myc/GFP: 
forward: MM S231E GGAGAAATGAATGCAGAGAGGGCTCTGAAAGAAGCC 
reverse: MM S231E as GGCTTCTTTCAGAGCCCTCTCTGCATTCATTTCTCC 
• the following forward and reverse primers from Ellen Umlauf were used in the PCR 
mutagenesis reaction to enable cloning into the pEFKmyc-vector (also kindly 
provided by Ellen (Snyers et al., 1998; Umlauf et al., 2004)) via the unique KpnI site 
forward: STCt Kpn1 CGGGGTACCATGGCCGAGAAGCGGCACACA 
reverse: STCt Kpn2 CGGGGGTACCGCCTAGATGGCTGTGTTTTGC 
• for cloning the point mutations and wt stomatin into the pEGFP-N3 vector, the 
constructs were excised with KpnI and ligated into the unique KpnI site in the MCS of 
pEGFP-N3 
STOM (E210K)-GFP:  
forward: StomE210Kfwd GAGAGCTATGGCTGCAAAAGCAGAAGCGTCCCG 
reverse: StomE210Krwd CGGGACGCTTCTGCTTTTGCAGCCATAGCTCTC 
STOM (E212K)-GFP:  
forward: StomE212Kfwd CTATGGCTGCAGAAGCAAAAGCGTCCCGCGAGGC 
reverse: StomE212Krwd GCCTCGCGGGACGCTTTTGCTTCTGCAGCCATAG 
STOM (E210,212K)-GFP:  
forward: StomE210,212Kfwd GAGAGCTATGGCTGCAAAAGCAAAAGCGTCCCGCGAGGC 
reverse: StomE210,212Krwd  GCCTCGCGGGACGCTTTTGCTTTTGCAGCCATAGCTCTC 
STOM (S214A)-GFP:  
forward: StomS214Afwd CTGCAGAAGCAGAAGCGGCCCGCGAGGCCCGCGCCAAG 
reverse: StomS214Arwd CTTGGCGCGGGCCTCGCGGGCCGCTTCTGCTTCTGCAG 
STOM (S214E)-GFP:  
forward: StomS214Efwd  GCTGCAGAAGCAGAAGCGGAGCGCGAGGCCCGCGCCAAG 
reverse: StomS214Erwd CTTGGCGCGGGCCTCGCGCTCCGCTTCTGCTTCTGCAGC 
• the 5´ and 3´primers used for PCR mutagenesis were (also from Ellen Umlauf(Umlauf 
et al., 2006)) as follows:  
forward: ST1Kozak.EcoRI  TACGGAATTCCGCCACCATGGCCGAGAAGCGGCACACAC 
reverse: ST287Ala.BamHI TGCGGGATCCGGCGGCAGCGGCTCCGCCTAGATGGCTGTGTTTTGCC 
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• mutated fragments were cloned into pEGFP-N3 via EcoRI and BamHI sites 
• for the construction of the C-terminal truncation mutant (S231A,T262), a different 
reverse primer was used in a normal PCR with STOM (S231A)-myc as template: 
ST262Ala.BamHI: 
TGCGGGATCCGGCGGCAGCGGCTCCTTTCTCAGCAGCAATGGTGGTC 
• double mutants S214,231A and S214,231E were constructed by using the STOM 
(S231A/E)-myc constructs as templates for a second PCR mutagenesis step 
 
3.2.22 Fusion of the N-terminus of SLP-1 to STOM (21-287)-GFP 
• the constructs SLP-1(1-50)-GFP (see 0) and STOM (21-287)-GFP (kindly provided by 
Ellen Umlauf) were used as starting material 
• the vector containing STOM (21-287)-GFP was digested with EcoRI and subsequently 
incubated with Klenow Polymerase (see 3.2.9)  
• Klenow enzyme was heat-inactivated by incubation at 75°C for one hour, and 
subsequently, the vector was digested with BglII 
• the insert containing amino acids 1-50 of SLP-1 (or of the point mutations Y7A or 
L10S) was prepared by digestion of SLP-1(1-50)-GFP by digestion with SacII, 
followed by Klenow incubation, heat-inactivation of Klenow enzyme and subsequent 
digestion with BglII 
• the ligation of this insert into the STOM (21-287)-GFP vector yields an in-frame 
fusion of the wild-type or point-mutated N-terminus of SLP-1 to the N-terminally 
truncated stomatin construct, with an 8 amino acid linker (GAANSATM) between the 
two sequences  
 
3.2.23 Construction of pECFP-N3 and pEYFP-N3 
• as only the vectors pECFP-C1 and pEYFP-C1 (a kind gift from J. Weghuber) were 
available and due to the fact that N-terminal tagging of stomatin (and also SLP-1, as 
we found out during our work) is problematic even with small tags, we decided to 
create the C-terminal CFP- and YFP-tag-vectors corresponding to pEGFP-N3, which 
we had used successfully for tagging of stomatin and SLP-1, by ourselves 
• the CFP/YFP coding sequence was amplified from the pECFP-C1/pEYFP-C1 vectors 
with the following primers:  
C/G/YFP fwd BamHI  CGCGGATCCATCGCACCATGGTGAGCAAGG 
C/G/YFP rwd NotI TTTTCCTTTTGCGGCCGCTTTACTTGTACAGCTCGTCCATGC 
• the PCR products were purified, digested with BamHI and NotI and ligated into the 
pEGFP-N3 vector digested with BamHI and NotI, thereby exchanging the GFP-coding 
region with CFP/YFP, preserving almost the entire MCS of the vector (only the XcmI 
site was lost) and creating a novel STOP-codon after the CFP/YFP (which was of 
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course not present in the C1 vectors) 
• both vectors were successfully used for the creation of STOM-CFP/YFP as well as 
SLP-1-CFP/YFP and showed good expression of the fluorescent fusion proteins 
 
3.3 Methods in cell culture 
3.3.1 Cell lines used during my work:  
• HeLa cells (human cervical cancer cells) were routinely used for stable expression of 
tagged proteins because of their fast growth and unproblematic maintainance.  
Medium: DMEM, 5% FCS, Penicillin/Streptomycin, L-Glutamine 
 
• COS7 cells (african green monkey kidney cells, immortalized with SV40 largeT) were 
used for transient transfections and live microscopy because of their large, flat shape.  
Medium: DMEM, 5% FCS, Penicillin/Streptomycin, L-Glutamine 
 
 
• MDCK cells (adult dog kidney cells) were used because they polarize when grown to 
confluency on Costar filters and form distinct apical and basolateral domains.  
Medium: DMEM, 5% FCS, Penicillin/Streptomycin, L-Glutamine 
 
 
• HepG2 cells (human hepatic carcinoma cells) were used because they polarize when 
they approach confluency and form apical domains without the need for filter wells.  
Medium: DMEM, 10% FCS, Penicillin/Streptomycin, L-Glutamine 
 
• HL-60 cells (acute myeloid leukemia cells) were used because they can be induced to 
differentiate along the neutrophil lineage with DMSO (our HL-60 cells did not 
differentiate properly!!!-fresh cells from ATCC should be purchased) 
Medium: RPMI medium, 10% FCS, Penicillin/Streptomycin 
 
3.3.2 Passaging of cells/subculture  
Adherent cells:  
• cells were grown to confluency, Medium was changed every 2-3 days or when yellow 
• cells were washed 1x with PBS 
• a small volume (just enough to wet the entire surface, excess liquid was removed!) of 
10x Trypsin/EDTA solution was added to the dish/flask, and the dish/flask was 
incubated for 3-5 minutes at 37°C; (alternatively, a larger volume of 1x trypsin/EDTA, 
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e.g. 500 µl per 25 cm2 flask can be used, especially for cells which detach easily) 
• cells were briefly inspected under the microscope for proper detachment; if cells were 
not rounded up and cell-cell contacts were not broken, further incubation at 37°C was 
necessary 
• trypsinisation was stopped by addition of Medium with FCS, cells were singled and 
washed off the surface by pipetting the suspension up and down several times 
• the desired subcultivation ratio was achieved by mixing the cell suspension with fresh 
medium and seeding them into a fresh dish/flask; (a washing step after trypsinisation 
was routinely performed every 2nd to 3rd passage) 
Suspension cells:  
• cell number was routinely analysed by CASY counting (CASY 2, Schärfe System) 
every 2-3 days 
• cell number was re-adjusted to 2x106 cells/ml by a partial medium change 
• a total medium change was performed once a week 
3.3.3 Freezing of cells/thawing of cells 
Freezing:  
• cells were trypsinized as described (adherent cells) or resuspended by pipetting 
(suspension cells) and counted (manual count with hemocytometer or CASY count)  
• the cells were pelleted by centrifugation (1200 rpm, 3 minutes, RT) 
• the cell pellets were resuspended in 800 µl cell freezing medium (Sigma C-6295) and 
transferred into cryotubes 
• the cryotubes were put on ice, transferred to an isopropanol container (“Mr. Frosty”, 
Nunc) and put into a -80°C freezer (this yields a slow cooling rate of -1°C/minute) 
• the next day, the cryotubes were transferred to a N2-storage tank (liquid phase storage) 
 
Thawing:  
• cryotubes were removed from the liquid nitrogen tanks and incubated for 
approximately 5 minutes at 37°C until the cell suspension is completely thawed (use a 
closed container due to the risk of cryovial disruption)  
• the cells were transferred to a 50 ml Falcon tube and pre-warmed medium was added 
drop-wise (first 3-4 ml) while swirling the tube frequently;  
• further medium was added to a final volume of 10 ml, and the cells were then pelleted 
(1200 rpm, 3 minutes, RT) 
• the pellet was resuspended in the desired volume and the cells were seeded into the 
appropriate flasks 
• after several hours/over-night incubation, the cells were inspected under the 
microscope for proper attachment/growth and a medium change was performed 
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3.3.4 Transient/stable transfection  
Transfection with Lipofectamine 2000 (Invitrogen) or Nanofectin (PAA):  
• approximately 300.000 cells were seeded into 6-well plates the day before transfection 
• 2-3 hours before addition of plasmid DNA, the cells were washed with PBS and 
Medium without antibiotics was added 
• the Lipofectamin (Nanofectin)-DNA complexes were prepared as follows:  
- 4 µg of plasmid DNA was diluted with 250 µl of serum-free DMEM 
- 10 µl of Lipofectamin 2000(Nanofectin) were diluted with 250 µl of serum-
free DMEM 
- DNA and Lipofectamin (Nanofectin) dilutions were combined, mixed well and 
incubated for 20-30 minutes at RT 
- the transfection mixture was added dropwise to the cells  
- after 4-6 hours, a medium change can be performed, fresh medium with 
antibiotics can be added 
- if transfection efficiency is very low, the ratio of DNA/Lipofectamine can be 
varied to optimize the outcome; this was rarely necessary for our purposes; 
• cells were analysed for expression of the transfected construct by western 
blotting/immunofluorescence after 48-72 hours 
• for immunofluorescence, the transfected cells were trypsinized, resuspended in fresh 
medium and seeded at the appropriate density onto glass coverslips 24 hours after 
transfection 
• for stable transfections, an aliquot (typically 1/3 of the cells) was seeded onto a 10 cm-
dish and, after letting the cells adhere overnight, selection for stable genomic 
integration of the transfected vector was performed by addition of the respective 
antibiotic to the culture medium  
- antibiotic concentrations have to be tested and optimised for every new cell 
line 
- routinely used antibiotic concentrations for our cell lines:  
G418 (neomycin resistance): 500-700 µg/ml 
Puromycin: 2 µg/ml 
Hygromycin: 10 µg/ml 
• medium was changed every 2nd day during the first week and every 2-4 days 
afterwards 
• after 2-4 weeks (depending strongly on the proliferation rate of the cells), colonies of 
antibiotic resistant cells were visible with the bare eye 
• single colonies were picked with cloning cylinders, trypsinized inside the cylinders, 
with one drop of 10X trypsin/EDTA, resuspended in 100 µl of medium and transferred 
to a 96well plate 
• single colonies were (if possible) expanded from the 96-wells to 24-wells and finally 
6-wells 
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• expression of the protein of interest was analysed by western blotting 
• several clones (if possible) with varying expression levels were further expanded in 
culture flasks or dishes and finally frozen down as working aliquots in liquid nitrogen 
 
Transfection with the calcium phosphate method:  
• the cells were seeded the day before transfection at approximately 30-50% density in 
100 mm plates 
• on the day of transfection, the medium was changed and the cells were incubated in 
fresh medium without antibiotics (Pen/Strep) for 3 hours 
• the 2M CaCl2 and 2x HBS solutions were thawed, 500 µl of 2xHBS were pipetted in a 
sterile tube 
• 20 µg of vector DNA were combined with sterile water (mix!) and 62 µl of the 2M 
CaCl2 solution (final volume 500 µl, mix again!) in a second tube 
• calcium phosphate-DNA complexes were prepared by slowly adding the CaCl2-DNA 
solution to the 2xHBS solution and continuously mixing the solution by bubbling air 
through it (good mixing is essential for the formation of a fine DNA-calcium 
phosphate precipitate, which then is essential for good transfection efficiency!!!)  
• the mixture appeared slightly opaque when addition of the DNA-solution was 
complete and was then incubated for 30 minutes at RT 
• the mixture was then vortexed and added dropwise to the plates 
• after over-night incubation, the medium was changed and the cells were incubated for 
another 24-36 hours  
• after this period, the plates were trypsinised and several dilutions (in the range from 
1:10 to 1:100, depending on the number of cells on the plate) were seeded in 100mm 
plates; after the cells had adhered, the proper antibiotic for selection was added (the 
calcium phosphate method was only used for stable transfection!) 
• clones were picked and analysed as described above 
3.3.5 Indirect immunofluorescence  
• cells were grown to approximately 50% confluency on glass coverslips (No.1 
thickness) in 6-well dishes 
• the cells were washed twice with 1.5 ml PBS 
• then, the cells were fixed by incubation with 1 ml 4% paraformaldehyde (PF) in PBS 
for 15 minutes 
- a 16% paraformaldehyde (PF) stock was incubated at 65°C for 5 minutes and 
then combined with an equal volume of 2X PBS and 2 volumes of PBS, 
yielding a 4% PF solution 
- the 16% PF stock was prepared as follows: 8 g PF were solubilized in ~40 ml 
milliQ-H2O; the solution was heated to ~60°C, and several drops of 1 M 
NaOH were added until the solution was almost clear; then, the solution was 
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cooled down to RT, brought to 50 ml, aliquoted and stored frozen at -20°C;  
• the 4% PF-solution was aspirated, and excess fixative is quenched by incubation with 
50 mM NH4Cl in PBS for 10 minutes 
• the cells were washed 3X with 1.5 ml PBS (time: 5 minutes total)  
• the cells were permeabilized with 1 ml 0.1% Triton X-100 in PBS for 5 minutes 
• the cells were washed 3X with 1.5 ml PBS (time: 5 minutes total) 
• while the 3rd washing solution was added, a small plastic plate was placed under the 
coverslip and the plate and the coverslip were arranged in a staggered fashion 
• the coverslip was then blocked by addition of 0.1 ml 5% FCS in PBS for 10 minutes 
• the blocking solution was aspirated, and 50-100 µl of the primary antibody solution 
(diluted in PBS containing 1% FCS) were added 
• a moist paper towel was placed on the lid of the 6-well to ensure a moist atmosphere 
and to prevent evaporation of the antibody solutions 
• the cells were incubated with the primary antibody for 1 hour (o/n incubation is also 
possible) 
• the cells were washed 3X with 2 ml PBS (time: 15 minutes total) 
• then, they were incubated for 1 hour with the secondary antibody diluted in PBS, 1 % 
FCS (for our AlexaFluor-488 and -596 conjugated antibodies, a standard dilution of 
1:600 was used) 
• the cells were washed 3X with 2 ml PBS (time: 15 minutes total) 
• to remove salts, the coverslip was finally dipped briefly into milliQ-H2O, excess water 
was removed with a paper towel and the coverslip was inversely mounted on a drop of 
Vectashield mounting medium on a clear glass slide 
• the coverslip was immobilised with nail polish and let dry  
• cells were analsyed at high magnification (63X, 100X) with a fluorescence 
microscope (Zeiss Axiovert) or a confocal microscope (LeicaTCS-NT or ZeissLSM 5) 
 
3.3.6 Fluorescence Recovery After Photobleaching (FRAP) 
• HeLa cells were transiently transfected with pEGFP-N3-Stomatin or pEGFP-N3-ST 
(1-262) as described using Lipofectamine 2000 (Invitrogen)  
• 12 hours after transfection, cells were seeded on 35mm glass-bottom dishes (MatTek 
Corp., Ashland, MA) and FRAP analysis was performed after another 24 hours, 
essentially as described (Goodwin and Kenworthy, 2005; Kenworthy et al., 2004) 
• Cells were washed with HBSS medium and mounted in prewarmed HBSS 
(supplemented with 25mM Hepes, pH 7.4) on a Zeiss LSM 510 Meta confocal 
microscope equipped with a stage heater (37°C)  
• Cells were imaged with a 63x NA1.4 Plan-Apochromat oil-immersion lens at 4-fold 
magnification  
• for quantitative FRAP, pre- and postbleach images were monitored with the 488 nm 
laser line of a 30mW Argon Laser set to 60% laser power at 1% transmission and a 
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confocal pinhole of 1.5 Airy units  
• photobleaching of a circular region of interest (ROI) with a diameter of 1.8 µm was 
performed by 12 bleach iterations with all Argon Laser lines set to 100% transmission  
• images were recorded with 2 s time lapse at a scan time of about 0.8 s  
• fluorescence intensity data of the whole cell ROI, the bleached ROI and a background 
ROI were quantified using the Physiology Evaluation Software Package (Carl Zeiss 
Microscopy, Jena, Germany)  
• recovery curves were bleach- and background-corrected and mobile fractions were 
calculated as described(Goodwin and Kenworthy, 2005) 
• for the calculation of the recovery halftime t1/2, the normalized and bleach-corrected 
recovery data were fitted to the following formula to estimate recovery kinetics:  
I (t) = a (1-exp (-kt))  
The recovery half-time was then calculated as t1/2=ln2/k. 
• for qualitative FRAP, the diameter of the bleach ROI was increased to 3.4 µm, the 
pinhole was set to 1 Airy unit and laser transmission was increased to 2-3% for pre- 
and postbleach images  
• postbleach images were acquired with 30 seconds time lapse,and 4-line-averaging was 
used to get high-quality pictures; the other settings were identical to those used in the 
quantitative experiments 
3.3.7 Live cell imaging  
Live cell imaging was performed as described in the FRAP method, with different settings for 
time lapse/laser intensity/pinhole, depending on the desired temporal resolution and quality of 
the single pictures and on the fluorescence of the analysed samples.  
In some experiments, lysosomes/late endosomes were stained with LysoTracker Red 
(Invitrogen) according to the manufacturer´s instructions. To increase the signal intensity and 
to enable reduction of laser power, the pinholes for green and red channel fluorescence were 
increased to 2 airy units if necessary.  
 
3.3.8 Induction of lipid droplets  
HeLa cells transiently transfected with the indicated GFP-fusion proteins were seeded onto 
glass coverslips 24 hours after transfection. The cells adhered overnight, subsequently 0.4 
mM oleic acid in 66.7 µM fatty-acid-free BSA (Brasaemle et al., 1997) were added to the 
medium to induce the formation of lipid droplets (LDs). After 24 hours, the cells were fixed 
with 4% paraformaldehyde and stained with NileRed as described (Umlauf et al., 2004).  
 
3.3.9 Blocking intracellular cholesterol transport with the aminosteroid U18666A  
A mixture of control HeLa cells and HeLa cells stably expressing the respective fusion 
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protein was seeded onto glass coverslips at about 50% density. Cells were adhering overnight 
and the indicated concentrations of U18666A were added from a 2 mg/ml stock solution in 
water. Accumulation of cholesterol in perinuclear vesicles was assessed by filipin staining as 
described (Kobayashi et al., 1999). The filipin stock solution was always prepared fresh, 
filipin was solubilized in DMSO at a concentration of 10 mg/mL. This stock was added to the 
primary and secondary antibody solution during the immunofluorescence staining prcedure at 
a dilution of 1/200.  
 
3.3.10 Uptake of fluorescent dextran 
• for uptake of fluorescent dextran, cells stably expressing SLP-1-GFP were seeded onto 
glass coverslips, let adhere and incubated in Medium with 1% FCS over night 
• the cells were incubated with Medium containing 5 mg/ml TRITC-Dextran (Sigma) 
for 10 minutes at 37°C 
• the TRITC-dextran was removed, and the cells were chased for the indicated time-
points with Medium without TRITC-dextran 
• then, the cells were immediately fixed with 4% paraformaldehyde and analysed by 
immunofluorescence 
 
3.3.11 Immunoelectron microscopy  
Only the seeding and fixing of the cells were done by me, the rest of the procedure, from 
embedding to sectioning to immunostaining were done by our collaboration partner Marianne 
Fliesser! 
 
• HeLa cells stably expressing SLP-1-GFP were grown on gridded Cellocate-coverslips 
(Eppendorf) 
• Cells strongly expressing SLP-1-GFP were selected and phase contrast and 
fluorescence images were recorded. Subsequently, the cells were fixed for 1 hour in 
0.1 M sodium phosphate buffer, pH 7.4, containing 4% paraformaldehyde and 0.2% 
glutaraldehyde, washed for 30 minutes with 0.1 M phosphate buffer and then 
incubated for 2 hours in 0.1 M phosphate buffer containing 50 mM glycine.  
• Embedding in LR white, trimming and thin-sectioning was essentially performed as 
described (Steiner et al., 1994).  
• Thin sections were blocked for 1 hour in phosphate buffered saline (PBS), pH 7.4, 
containing 0.05% Tween-20, 5% bovine serum albumin, and 1% goat serum.  
• Rabbit anti-GFP (Abcam) was diluted 1/500 in blocking buffer and thin sections were 
incubated for 2-3 hours at room temperature.  
• After washing 3 times with PBS, 0.05% Tween-20, the thin sections were incubated 
with a 10nm gold-conjugated goat anti-rabbit antibody (Biocell, diluted 1/40 in PBS, 
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pH 8.0, 0.05% Tween-20) for 2 hours.  
• Finally, the thin sections were washed 3 times with PBS, pH 8.0, 0.05% Tween-20, 
stained with 2% uranyl acetate for 1 hour and then analyzed with a Jeol 1200 EXII 
microscope. Anti-GFP signal was virtually eliminated by staining of thin sections with 
antibody saturated with a 10-fold excess of recombinant GFP (incubated for 2 hours at 
37°C), confirming the specificity of the observed signal.  
In a different set of experiments, the cells were fixed as described, but then embedded in Epon 
resin instead of LR white. This different embedding method allows for the use of OsO4 as 
contrasting agent, but is not feasible for immunostaining. Pictures with superior resolution of 
vesicle internal membranes and cytoskeletal structures were obtained from thin sections 
prepared with this method.  
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4 RESULTS 
4.1 SLP-1  
4.1.1 Subcellular localization of SLP-1  
The presented work represents the first detailed characterization of the SLP-1 protein. 
Because no antibody was available against human SLP-1 (although several attempts have 
already been made to obtain polyclonal antibodies against SLP-1 in our group; the reason for 
these failures could lie in the extremely good conservation of SLP-1 in mammals (see Figure 
7), I started with the construction of tagged SLP-1 protein fusions. We chose the small myc-
epitope to minimize the effects of the tag in respect to protein trafficking and the GFP-tag to 
enable live cell imaging of SLP-1. Because we were not successful in cloning a N-terminally 
tagged stomatin construct, we thought that N-terminal tagging of SLP-1 might also be 
problematic and started with C-terminal tags. We analysed several different cell types by 
transient and stable transfection. The results for HeLa cells, HepG2 cells and MDCK cells are 
shown in Figure 9A.  
The tagged SLP-1 protein was localized to perinuclear vesicles. No PM localization was 
observed in all tested cell types. In contrast to stomatin, SLP-1 did not translocate to the 
apical membrane upon polarization of MDCK cells (data not shown). The strictly perinuclear 
localization was observed in transient transfections and in stably transfected cell lines. Several 
clones expressing different amounts of either SLP-1-myc or SLP-1-GFP were analysed and 
all showed perinuclear staining. ELMI analysis showed that SLP-1 is predominantly found on 
the limiting membrane of multivesicular structures, already indicating that the perinuclear 
vesicles could be late endosomes (Figure 9B).  
4.1.2 SLP-1 is localized to the late endosomal compartment  
We next analysed the colocalization of SLP-1 with different marker proteins for subcellular 
compartments. Figure 10 shows the results for several late and early endosomal markers. 
SLP-1 showed good colocalization with the LE markers LAMP-2, Rab7, Rab9 and CI-M6PR, 
whereas there was only little colocalization with the early endosomal markers TfR and Rab5. 
No colocalization was observed with a golgi marker, GM130, and a peroxisomal marker, 
PMP70 (Figure 11). The next question was if the SLP-1-positive perinuclear structures are 
accessible to endocytosed TRITC-dextran as expected for late endosomes. Indeed, we 
observed co-localization of SLP-1-GFP with TRITC-dextran after a 30 minute chase after 
labeling, but no colocalization after 10 minutes of labeling (Figure 12).  
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Figure 9: SLP-1 is localized to perinuclear vesicles 
 
 
Subcellular fractionation experiments confirmed the localization of SLP-1 to endosomal 
fractions (Figure 13), but we were unable to properly separate early from late endosomes with 
these step gradient protocols. The colocalization with different markers was never perfect, we 
always observed a fraction of SLP-1 positive vesicles, which were negative for the marker. 
Co-localization was best with Rab7 and Rab9, where more than 50% of the vesicles were 
positive for both proteins. The late endosomal compartment is rather complex and 
heterogenous, as exemplified by the different staining pattern for LAMP-1/2 and CI-M6PR. 
All three proteins are widely used as LE markers, but they show only little overlap. CI-M6PR 
cycles between the Golgi apparatus and the LEs and stains a very restricted vesicle population 
around the MTOC, whereas LAMP-1/2 stains more peripheral LE vesicles and also 
lysosomes. The situation gets even more difficult when one considers the inhomogenous 
staining for SLP-1 on many vesicles (see Figure 32, Figure 36). This makes an unambiguous 
determination of colocalization difficult. SLP-1 seems to be broadly expressed on all late 
endosomal sub-compartments.  
 
Figure 9: (A) Localization of SLP-1-myc and 
SLP-1-GFP to perinuclear vesicles in different 
cell types (HeLa, HepG2, MDCK) Scale bar 
10µm. (B) Electron microscopy image of a 
HeLa cell stably expressing SLP-1-GFP. The 
insert shows a part of the cell at lower 
magnification, the position of the high 
magnification image is marked by the box. 
SLP-1 is detected on the limiting membrane of 
multivesicular structures around the nucleus. 
Scale bars: 200 nm, 1 µm (insert).  
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Figure 10: Late/early endosomal markers 
 
  
Figure 11: Golgi and peroxisome markers 
 
 
 
Figure 10: SLP-1 colocalizes with LE markers 
but not with EE markers. (A) HeLa cells stably 
expressing either SLP-1-GFP or SLP-1-myc 
were stained for different markers for late 
(LAMP-2, M6PR) or early endosomes (TfR). 
Significant colocalization was observed for LE
markers only. (B) HeLa cells stably expressing 
SLP-1-myc were transfected with the indicated 
GFP-Rab constructs. Colocalization with the 
LE markers GFP-Rab7 and GFP-Rab9 was 
observed, whereas the EE marker GFP-Rab5 
showed only minimal overlap. Scale bars 10 
µm. 
Figure 11: Double-staining with 
other organelle markers. HeLa 
cells stably expressing SLP-1-
GFP were co-stained with either 
the Golgi marker GM130 (upper 
panel) or the peroxisomal marker 
PMP70. No colocalization was 
observed for both markers.  
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4.1.3 Over-expressed SLP-1 interacts with endogenous stomatin  
As endogenous stomatin is also partially localized to LEs in different cell types, we next 
wanted to investigate if over-expressed SLP-1 co-localizes with endogenous stomatin. We 
performed transient transfections of HeLa cells with either SLP-1-GFP or SLP-1-myc and did 
double-stainings with the mouse monoclonal stomatin antibody GARP50 (Figure 14 A). We 
observed co-localization between SLP-1 and stomatin on late endosomes, and, importantly, 
we observed that the localization of endogenous stomatin changes if SLP-1 is over-expressed 
in the cells. Strong expression of SLP-1 results in reduced PM staining and increased LE 
staining for endogenous stomatin. This result could also be verified biochemically. We 
compared control HeLa cells with a clone stably expressing SLP-1-myc in subcellular 
fractionation experiments on Optiprep-gradients. As a marker for PM, we used alkaline 
phosphatase activity, and as LE marker, we performed western blotting with anti-LAMP-1 
antibody. The results are shown in Figure 14 B. In the clone stably expressing SLP-1-myc, 
stomatin is clearly reduced in the low-density fractions. Interestingly, SLP-1 and stomatin are 
detected in high-density endosomal fractions, but their distribution does not overlap perfectly. 
This indicates that the two proteins could occupy different subsets of late endosomes, but it 
could also be due to contamination of the endosomal fraction with PM components. The 
results that SLP-1 overexpression causes a redistribution of stomatin further indicated an 
interaction between SLP-1 and stomatin. We next performed co-immunoprecipitation 
experiments with an anti-GFP antibody to analyse if endogenous stomatin could be co-
precipitated with SLP-1. We also included two C-terminal truncations of SLP-1 to map the 
region of SLP-1, which is responsible for the interaction. Figure 15 shows the results of one 
such co-immunoprecipitation experiment.  
Endogenous stomatin is clearly co-precipitated with SLP-1-GFP and also with the two C-
terminal truncation mutants SLP-1(1-288)-GFP and SLP-1(1-224)-GFP. Therefore, the SPFH 
domain or the N-terminus of SLP-1 must be responsible for the interaction with stomatin, 
whereas the SCP-2/nsLTP domain and the linker region between the SPFH domain and the 
SCP-2 domain are not required for the interaction. The strongly reduced amount of co-
precipitated stomatin for SLP-1(1-224)-GFP is probably caused by the fact that this truncation 
mutant is mis-targeted to cytoplasmic aggregates and does barely reach the late endosomal 
compartment where it can interact with stomatin (see Figure 16).  
4.1.4 C-terminal truncation mutants  
To identify the regions which cause the targeting of SLP-1 to late endosomes, I constructed 
C-terminal truncation mutants. The first construct, SLP-1(1-288), where the entire C-terminal 
SCP-2 domain had been deleted, showed no difference compared to the full-length protein 
regarding its subcellular distribution. Further deleting the amino acids 225-288, however, had 
a strong impact on the localization (Figure 16+17).  
This SLP-1(1-224) construct seemed to be mis-targeted to cytoplasmic aggregates and 
filamentous structures and did not co-localize with LE markers any more. No colocalization 
Results 
PhD thesis   Mario Mairhofer 
 96 
 
was observed with ER and Golgi markers, either (Figure 17).  
Staining of cells expressing high amounts of SLP-1(1-224)-GFP with Nile Red revealed that 
the cytoplasmic aggregates strongly stain with this neutral lipid stain even in the absence of  
oleic acid (data not shown). 
 
Figure 12: Endocytosis of fluorescently labeled dextran 
 
Figure 12: The LEs containing SLP-1 are accessible to endocytosed fluid phase markers. HeLas stably 
expressing SLP-1-GFP were incubated with fluorescently labeled dextran (TRITC-Dextran) for 10 minutes and 
either fixed directly after the incubation or subjected to a 30 minute chase with medium without dextran. After 
the 30 minute chase, TRITC-Dextran was clearly detected in SLP-1-GFP positive vesicles (arrows in lower 
panel). Scale bar 10 µm.   
 
Figure 13: Subcellular fractionation 
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4.1.5 SLP-1 is excluded from lipid droplets (LDs) induced by feeding with oleic acid  
As it was recently shown that stomatin is targeted to LDs and because of the potential of SLP-
1 to function in lipid transfer/transport, we were interested if SLP-1 is also targeted to LDs. 
We transiently transfected HeLa cells with stomatin-GFP, SLP-1-GFP or with the truncation 
mutants SLP-1(1-288)-GFP and SLP-1(1-224)-GFP and induced the formation of LDs by 
addition of oleic acid. The results are shown in Figure 18.  
As expected, stomatin is targeted to LDs. Full-length SLP-1 and SLP-1(1-288)-GFP are not 
targeted to LDs and show no colocalization with NileRed-positive droplets, but instead retain 
their normal LE localization. The SLP-1(1-224)-GFP construct, however, is efficiently 
targeted to the membrane of LDs. These results show that the SPFH domain of SLP-1 has the 
potential to gain access to LDs, but the C-terminal region between amino acid 224 and 288 
inhibits this translocation. Of course, the LD localization of the SLP-1(1-224)-GFP construct 
could also be a consequence of the mistargeting, and correct targeting to LEs could make the 
translocation to LDs impossible. Nevertheless, these data strongly support the hydrophobic 
hairpin structure we assumed for the N-terminus of SLP-1 in analogy to stomatin. 
Additionally, I frequently observed that cells expressing high amounts of full-length SLP-1 
only contained rather small LDs compared to non-expressing cells. This indicates that SLP-1 
could act as a negative regulator of LD formation (possibly by mediating lipid transfer out of 
the LDs), but more quantitative data are necessary to confirm this notion.  
 
 
Figure 13 (previous page): SLP-1 is enriched in a crude endosomal fraction. Control HeLas and HeLas stably 
expressing SLP-1-GFP were grown in 15cm culture dishes and subjected to subcellular fractionation on 
sucrose step gradients as described in the Methods section. Aliquots of the PNS, the endosomal membrane 
fraction (EM) and the heavy membrane fraction (HM) were analysed by western blotting, silver staining and 
cholesterol/protein determination as described. SLP-1, stomatin, LAMP-2, flotillin-2 and Rab5 were all 
found to be enriched in the EM fractions. Silver staining revealed the different overall protein composition of 
the fractions. By analysing the cholesterol/protein ratio, the EM fraction was fount to be strongly enriched in 
cholesterol. Comparison of LAMP-1 in control HeLas and SLP-1-GFP expressing HeLas reveals that over-
expression of SLP-1 could affect the distribution of LEs in the subcellular fractionation experiment, probably 
by an effect on the cholesterol content.  
Results 
PhD thesis   Mario Mairhofer 
 98 
 
Figure 14: Overexpression of SLP-1 decreases PM stomatin 
 
 
4.1.6 The SLP-1(1-224) construct is targeted to lipid droplets  
A dominant-negative caveolin-3 (cav3DGV) mutant has been described, which is capable of 
disrupting cholesterol trafficking and is localized to small, cytoplasmic lipid droplets (Pol et 
al., 2001). We analysed if this protein colocalized with our myc-tagged SLP-1 constructs and 
observed almost perfect co-localization with SLP-1(1-224)-myc (Figure 17). The major 
difference was that ER staining was frequently observed for GFP-cav3DGV, but not for SLP-
1(1-224)-myc. As already outlined above, we did not observe ER localization for SLP-1(1-
224). Instead, we observed some colocalization of SLP-1(1-224) with the early endosomal 
marker Rab4 in the filamentous structures. Addition of oleic acid lead to the formation of 
large lipid droplets, which also contained GFP-cav3DGV.  
Figure 14: Over-expression of SLP-1 
causes a shift in stomatin localization 
from the plasma membranes to late 
endosomes. (A) HeLa cells were 
transiently transfected either with SLP-1-
GFP or SLP-1-myc and co-stained for 
stomatin. Cells expressing SLP-1 showed 
a reduction of stomatin signal at the PM 
compared to cells not expressing SLP-1. 
(B) Confirmation of this shift by 
subcellular fractionation on Optiprep 
gradients. Lysates of control HeLas and 
HeLas stably expressing SLP-1-myc were 
subjected to subcellular fractionation as 
described. Nineteen fractions were 
collected and analysed for alkaline 
phosphatase content (upper panel; black: 
control, grey: SLP-1-myc clone) as a PM 
marker and for the distribution of LAMP-
1, stomatin and SLP-1-myc by western 
blotting. Over-expression of SLP-1 
causes a reduction of the PM pool of 
stomatin and an increase in the more 
dense fractions.  
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Figure 15: Co-immunoprecipitation experiments 
 
 
 
 
Figure 16: Vesicular aggregates and tubular structures of SLP-1(1-224)-GFP 
 
Figure 16: HeLa cells stably expressing SLP-1(1-224)-GFP were analysed by confocal microscopy. A subset of 
cells showed very strong GFP-fusion protein expression, which was found on large cytoplasmic aggregates of 
smaller vesicles (A). Cells with a lower expression level frequently displayed tubular GFP-positive structures in 
the cytoplasm (B). Scale bars 10 µm.  
 
 
In double transfections of HeLa cells with GFP-cav3DGV and either SLP-1-myc, SLP-1(1-
288)-myc or SLP-1(1-224)-myc, which were treated with oleic acid to induce the formation of 
large lipid droplets, we observed perfect colocalization of SLP-1(1-224)-myc with the 
cav3DGV construct (Figure 19). Full-length SLP-1 and SLP-1(1-288) were excluded from 
these structures, STOM-GFP was not tested yet.  
 
 
Figure 15: Stomatin is co-precipitated with 
SLP-1 and two C-terminal truncation 
mutants.  
SLP-1-GFP and the two truncation mutants, 
SLP-1(1-288)-GFP and SLP-1(1-224)-GFP, 
were stably expressed in HeLa cells. 
Immunoprecipitations were performed with 
an anti-GFP antibody, and the samples were 
analysed for co-precipitation of endogenous 
stomatin by western blotting. As controls, 
HeLa cells and cells stably expressing EGFP 
were also analysed and did not yield a signal 
for stomatin under identical conditions (data 
not shown).  
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Figure 17: Co-staining of SLP-1(1-224) with different organelle markers 
 
Figure 18: SLP-1 on lipid droplets? 
 
Figure 18: Different GFP-tagged constructs were 
transiently expressed in HeLa cells and formation 
of large lipid droplets/bodies was induced by 
addition of oleic acid to the medium for 18-24 
hours (Brasaemle et al., 1997). Lipid bodies were 
stained with NileRed. Full-length SLP-1-GFP 
and SLP-1(1-288)-GFP do not localize to lipid 
bodies, whereas the truncation mutant SLP-1(1-
224)-GFP is clearly detected on the surface of 
large lipid droplets (visible as yellow rings). 
Scale bars: 10 µm.  
Figure 17: Co-staining of
SLP-1(1-224) with
different organelle
markersFigure 17: Hela 
cells stably expressing 
SLP-1(1-224)-myc were 
transiently transfected with 
different organelle markers 
(pEYFP-ER and pEYFP-
Golgi from Clontech, 
GFP-Rab4a and GFP-
Cav3DGV (Pol et al., 
2001). Only little 
colocalization was 
observed with ER-YFP 
and Golgi-YFP. Overlap 
was higher with the GFP-
Rab4a construct and 
almost perfect with GFP-
Cav3DGV.  
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Figure 19: Co-localization with Cav3DGV 
 
Figure 19: Co-localization of SLP-1(1-224)-myc and GFP-Cav3DGV on the surface of lipid droplets. HeLa cells 
stably expressing the indicated myc-tagged constructs were transiently transfected with GFP-Cav3DGV, and 
formation of lipid bodies was induced by treatment with oleic acid. GFP-Cav3DGV co-localizes with SLP-1(1-
224)-myc, but not with SLP-1-myc or SLP-1(1-288)-myc, as expected. Scale bars 10 µm.  
 
4.1.7 ELMI analysis of a clone stably expressing SLP-1(1-224)-GFP  
To gain further insights in the localization and trafficking of this mutant, we analysed cells by 
ELMI. As shown in Figure 20, we observed very strong signal in vesicular and tubular 
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structures.  
These pictures were taken from ultra-thin sections of cells embedded in LR white resin. This 
procedure allows efficient immunostaining, but the ultra-structure is not very well conserved. 
Several of the SLP-1(1-224)-GFP positive vesicles were found to have an “empty” 
appearance characteristic for lipid droplets, but a real identification was not possible. We 
therefore analysed the cells after embedding in Epon and staining with OsO4. This procedure 
yielded a superior conservation of the ultrastructure, but immunostaining was not possible 
(we tried de-osmiation and also to do a pre-embedding labeling, but were not successful up to 
now). 
Analysis of the Epon sections revealed that the SLP-1(1-224)-GFP clone contains many small 
LD structures. These structures often were aggregated and strongly reminded us of the 
cytoplasmic vesicle aggregates observed in fluorescence microscopy. In our opinion, these 
structures are induced by the over-expression of SLP-1(1-224)-GFP, although of course, we 
can not definitely proof that they are positive for SLP-1(1-224)-GFP. But this conclusion is 
supported by the fact that SLP-1(1-224)-GFP colocalizes with the LD markers NileRed and 
cav3DGV already in the absence of oleic acid and localizes to large LDs when oleic acid is 
added. During the analysis of the Epon sections, we found very interesting structures (Figure 
21). 
 
Figure 20: ELMI of SLP-1(1-224)-GFP I: immunolabeling 
 
Figure 20: Analysis of HeLa cells stably expressing SLP-1(1-224)-GFP by immuno-electron microscopy. Cells 
were fixed and processed for ELMI as described in the Methods section. Thin sections were immuno-stained 
with a polyclonal anti-GFP antibody and with gold-conjugated secondary antibodies (A: 5 nm, B: 10 nm gold). 
SLP-1(1-224)-GFP was detected in tubular structures and on the surface of larger vesicles, often with an 
“empty”, electron-translucent appearance. Scale bars: 200 nm.  
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Small vesicles were often observed close to the LD aggregates, which could represent 
transport intermediates on their way to/from LDs (Figure 21A). The formation and turn-over 
of LDs still remains enigmatic up to date. One theory is that LDs form from the ER 
membrane. Even less is known about the turn-over of this organelle. We observed some LDs, 
which seem to be surrounded by a vesicle containing electron-dense material (Figure 21B). 
Figure 21: ELMI II: Epon embedding  
 
Figure 21: ELMI analysis of HeLa cells stably expressing SLP-1(1-224)-GFP embedded in Epon resin. To 
achieve better conservation of vesicular ultra-structure, fixed cells were embedded in Epon, thin sections were 
cut and analysed under the electron microscope. Cells expressing SLP-1-GFP were also analysed, but no similar 
droplet aggregates or “enveloped” droplets were observed (data not shown). Scale bars: 200 nm.  
 
 
These structures could either represent LDs engulfed by e.g. lysosomes, or they could 
represent a LD which is forming in the interior. Our pictures could represent one of the first 
examples, where the digestion of a small LD structure inside a lysosome/late endosome is 
captured. The second possibility is also fascinating. If these structures represented LDs which 
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form out of a late endosomal/lysosomal structure, such a mechanism would be totally new. It 
is now well established that LDs are active organelles, which are connected not only to the 
ER, but also to other organelles by vesicular transport. Further work with this truncation 
mutant could clarify this issue. In a first step, it would be necessary to establish a proper pre-
embedding labeling procedure to be able to unambiguously identify the SLP-1(1-224)-GFP 
positive structures in Epon thin sections. With this information, we then could try to establish 
the mechanism, which leads to the formation of the observed, peculiar structures.  
 
4.1.8 SLP-1 and the C-terminal truncation mutants are localized to lipid rafts:  
As it is well established that stomatin and other proteins with SPFH domains are enriched in 
lipid rafts, we analysed if SLP-1 is also detected in these cholesterol-rich membrane domains. 
Figure 22 shows the results for flotation experiments with cells stably expressing SLP-1-GFP 
(A), SLP-1(1-288)-GFP and SLP-1(1-224)-GFP (B).  
Figure 22: SLP-1 is enriched in DRMs 
 
 
Figure 22: Lipid rafts/DRMs were 
isolated from the indicated stable clones 
as described in the Methods section. 
Cholesterol content was determined 
with the Infinity cholesterol reagent 
from ThermoElectron, protein content 
was determined with the Dc-Protein 
assay kit from BioRad. Equal volumes 
of the fractions were analysed by 
western blotting.  
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Full-length SLP1 and both truncations are strongly enriched in the low-density buoyant 
fractions compared to total protein content. The deletion of the SCP-2 domain does not have 
an effect on lipid raft association. This is in contrast to the situation regarding stomatin, where 
the outmost C-terminus is essential for lipid raft association(Umlauf et al., 2006). 
Surprisingly, also the SLP-1(1-224)-GFP construct, which shows defects in subcellular 
trafficking, is also strongly lipid raft associated. These data show that lipid raft association of 
SLP-1 must be mediated by its SPFH domain. A similar result has been obtained for flotillin-
1, where the isolated SPFH/PHB domain was also found to be raft-associated(Morrow and 
Parton, 2005). The distribution of stomatin in the gradients was not affected by the presence 
of SLP-1 (data for control HeLa cells not shown), which indicates that stomatin is a DRM-
protein independent of its subcellular localization.  
 
4.1.9 SLP-1 forms homo-oligomers  
To determine if SLP-1 also forms high-order oligomers like the related stomatin protein, we 
performed an equivalent equilibrium density gradient centrifugation assay as described for 
stomatin (Snyers et al., 1998). We prepared membranes from HeLa cells stably expressing 
SLP-1-GFP, lysed the membranes in a buffer containing 1% TX100 and loaded the detergent-
extract on top of a linear sucrose gradient from 5-25% sucrose. The whole gradient contained 
1% TX100 to keep the proteins properly solubilized. Figure 23 shows the results of a 
representative experiment for SLP-1-GFP.  
Figure 23: Analysis of SLP-1 oligomerization 
 
Figure 23: Analysis of SLP-1 oligomers by equlibrium density gradient centrifugation. Detergent extracts of 
HeLa cells and of the clone A2 stably expressing SLP-1-GFP were loaded on top of linear density gradients from 
5-25% sucrose and centrifuged at 200.000xg for 16-18 hours. Fractions were collected from the top and analysed 
by western blotting.  
 
Similar to stomatin, we observed a pool of SLP-1-GFP in the low-density fractions, which 
probably represents monomeric SLP-1-GFP or dimers. The shift between the monomeric 
stomatin pool and the monomeric SLP-1 pool can be explained by the GFP-tag, which almost 
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doubles the molecular weight of the monomers. Additionally, a very intense band was 
detected in the bottom fraction of the gradient. This fraction most probably represents a high-
molecular weight oligomeric complex of SLP-1. This complex is too heavy to be properly 
fractionated in the 5-25% gradient and therefore accumulates in the bottom fraction or gets 
pelleted. Protein aggregation could also be responsible for the observed signal in this fraction, 
but this should in principle also affect a similarly hydrophobic protein like stomatin. As seen 
in Figure 23, only a faint band is observed for stomatin in the bottom fraction in an analogous 
assay performed with control HeLa cells. The signal for stomatin in the bottom fraction 
slightly increases in the SLP-1-GFP expressing cells, but is in no relation to the fraction of 
SLP-1.  
Figure 24: Further evidence for oligomerization: Double transfections I 
 
Figure 24: Full-length SLP-1 co-localizes with the truncation mutants SLP1(1-288) and SLP-1(1-224) and 
corrects the trafficking defect observed with SLP-1(1-224). HeLa cells were transiently transfected with the 
indicated constructs and analysed by immunofluorescence microscopy. Almost perfect co-localization of SLP-1 
is observed with both truncation mutants. Cells expressing SLP-1(1-224)-GFP and SLP-1-myc at similar 
strength showed no filamentous structures and vesicle aggregates (see lower panel), but these structures were 
observed in cells only expressing the SLP-1(1-224)-GFP construct (data not shown).  
 
This result could also indicate the formation of hetero-oligomers. Further evidence for the 
formation of SLP-1 homo-oligomers comes from double-transfection experiments with 
different SLP-1 constructs. As already described, the SLP-1(1-224) truncation mutant is mis-
localized. Co-expression of wild-type SLP-1 can restore normal LE localization of this mutant 
(Figure 24). Perfect colocalization between SLP-1(1-224)-GFP or SLP-1(1-288)-GFP and 
wild-type SLP-1-myc was observed.  
 
4.1.10 N-terminal deletions of SLP-1 are targeted to the plasma membrane (PM)  
In addition to the previously described C-terminal truncations, we next analysed the effect of 
a deletion of the first 42 amino acids of SLP-1. As figure 25 shows, such a truncation mutant 
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is efficiently transported to the PM, whereas wild-type SLP-1 and the C-terminal truncations 
practically do not show PM localization.  
Figure 25: N-terminal deletions/point mutations of SLP-1 
 
 
Next, we analysed this sequence for putative subcellular targeting signals and found that it 
contains a GYXXΦ motif (GYRAL), which is well known in the context of late 
endosomal/lysosomal targeting of LAMP-1, LAMP-2 and CD63. This motif is highly 
conserved in mammalian SLP-1 homologues (see Figure 2). In a next step, we combined our 
C- terminal truncations with the N-terminal deletion and analysed the localization of the 
constructs. All constructs with the N-terminal deletion showed plasma membrane staining, 
and the SLP-1(43-224)-myc construct showed cytoplasmic aggregates and PM staining. 
These data clearly show that the N-terminus of SLP-1 is necessary for the targeting of the 
protein to internal membranes. We then sought to determine if it is really the tyrosine-based 
signal at the outmost N-terminus, which is responsible for the internal localization. We first 
constructed a deletion mutant where only the first 10 amino acids were missing (SLP-1(11-
397)-myc). Indeed, this construct also showed strong PM localization, which often appeared 
inhomogenously distributed. Finally, we targeted the tyrosine residue and mutated it to an 
alanine (SLP-1(Y7A)-GFP construct), and converted the hydrophobic amino acid at positon 
+2 after the tyrosine into a polar amino acid (SLP-1(L10S)-myc construct). These point 
mutations also caused a PM localization of the protein, which confirmed that the N-terminal 
GYRAL motif is indeed required for LE targeting of SLP-1. Three mechanisms could 
principally exist to direct SLP-1 to late endosomes: 1) the protein is directly transported to 
Figure 25: Comparison of 
different N- and C-terminal 
SLP-1 truncations/point 
mutations. HeLa cells were 
transiently transfected with 
the indicated constructs 
and analysed by confocal 
microscopy. N-terminal 
deletions of amino acids 1-
42 or 1-10 cause targeting 
of SLP-1 to the plasma 
membrane. Point mutations 
in the GYXXΦ motif 
(Y7→A and L10→S) have 
a similar effect. Scale bars: 
10 µm.  
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LEs from the TGN; 2) SLP-1 is first delivered to the PM and is efficiently endocytosed to 
LEs; 3) a combination of both mechanisms is operating.  
Figure 26: Inhibition of endocytosis and SLP-1 localization I: dynK44A 
 
Figure 26: Inhibition of clathrin-mediated endocytosis by expression of a dominant-negative dynamin mutant 
does not redirect SLP-1 to the plasma membrane. HeLa cells stably expressing dynK44A under the control of a 
tet-off promotor were transiently transfected with SLP-1-GFP. Expression of the mutant dynamin was induced 
12 hours after transfection by removal of tetracycline from the medium. Cells were analysed by confocal 
microscopy. No strong accumulation of SLP-1 at the plasma membrane was observed, although some changes in 
the distribution of SLP-1 were observed. The signal appeared more dispersed throughout the cytoplasm (section 
at 4.2 µm and lower panel), and very weak plasma membrane staining was observed in basal sections (lower 
panel). Scale bars 10 µm.  
 
To adress this question, we inhibited endocytosis from the PM by expression of dominant-
negative constructs. We either used a HeLa cell line, which stably expresses a dominant-
negative dynamin mutant (DynK44A) under the control of a tetracyclin-responsive promotor, 
or transiently over-expressed either the C-terminus of AP180 (AP180C construct) or the SH3 
domain of amphiphysin (AMPH-SH3). All these constructs target clathrin-mediated 
endocytosis(Snyers et al., 2003). No big effect (in regard to a strongly increased PM 
expression) was observed for all three experiments (see Figure 26 and 27). 
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Figure 27: Inhibition of endocytosis II: Amph-SH3, AP180C 
 
Figure 27: Inhibition of clathrin-dependent endocytosis with other constructs shows little effects on the 
subcellular distribution of SLP-1. HeLa cells stably expressing SLP-1-GFP were transiently transfected with the 
HA-tagged SH3 domain of amphiphysin or with the myc-tagged C-terminus of the adaptor protein AP180. Both 
constructs were previously shown to strongly inhibit clathrin dependent endocytosis. SLP-1 localization to 
perinuclear endosomes was not affected by expression of both constructs.  
 
Figure 28: Inhibition of endocytosis III: Cyclodextrin 
 
Figure 28: HeLa cells stably expressing SLP-1-GFP were treated with 10 mM methyl-beta-cyclodextrin for 30 
minutes at 37°C and were then analysed by immunofluorescence. MβCD had a strong effect on the distribution 
of SLP-1 and caused the dispersal of the signal throughout the cytoplasm and the appearance of weak plasma 
membrane staining. Treatment with mβCD caused rounding and detachment of a large proportion of the cells 
(right picture).  
 
These data rule out that the late endosomal localization of SLP-1 is caused by very efficient 
endocytosis via the clathrin-mediated “classic” endocytic pathway. As several clathrin-
independent pathways have recently been described especially for raft-associated proteins 
(Glebov et al., 2006), we still can not rule out that SLP-1 trafficks to LEs via the PM. 
In a different experiment, we treated SLP-1-GFP expressing cells with mβCD to achieve 
cholesterol depletion, which is known to inhibit both clathrin-dependent and –independent 
endocytosis. This treatment led to the detection of a clearly visible signal for SLP-1-GFP at 
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the PM (see Figure 28). But the treatment of the cells with ~10mM mβCD for 30 minutes also 
dramatically affected cell adherence and viability. Most cells remained only loosely attached 
to the substrate. Therefore, it is doubtable if this PM staining is only due to the inhibition of 
endocytosis. Treatment with lower doses of mβCD did not show this effect in SLP-1 
localization. Additionally, in most cells, the perinuclear signal still strongly dominated over 
the PM signal. In an independent experiment, we inhibited protein synthesis with 
cycloheximide and analysed if this treatment has any effect on the localization of the protein 
(data not shown). We found that the GFP-tagged SLP-1 protein is very stable in LEs and is 
still detected in strongly expressing cells after 72 hours of cycloheximide treatment. No PM 
localization was observed, although the amount of SLP-1-GFP was strongly reduced. This 
result indicates that LE targeting is not a mere consequence of a high expression level, which 
was also shown by the fact that we did not observe PM localization in transient transfections, 
also not in cells which show a low expression level. 
 
4.1.11 N-terminally GFP-tagged SLP-1 is partially localized to the PM  
During my work, I also cloned a N-terminally GFP-tagged SLP-1 variant to confirm the 
results obtained for the C-terminally tagged construct. Interestingly, this construct showed a 
clearly detectable PM signal besides a stronger LE signal in immunofluorescence (see Figure 
29).  
Figure 29: GFP-SLP-1 is mis-targeted to the PM 
 
Figure 29: The GFP-SLP-1 construct was transiently expressed in HeLa cells and surprisingly showed PM 
localization (upper picture). Co-expression of C-terminal tagged SLP-1-myc abolished the PM localization of 
GFP-SLP-1 (lower panel), which again indicates that SLP-1 forms oligomers. Scale bars 10 µm.  
 
Based on our results, which show the importance of the GYXXΦ signal at the outmost N-
terminus, we concluded that the bulky N-terminal GFP-tag probably reduces the accessibility 
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of this signal for adaptor proteins which mediate transport/sorting to LEs and cause a 
proportion of GFP-SLP-1 to be transported to the PM with the bulk flow. Co-expression of 
SLP-1-myc caused the PM signal for GFP-SLP-1 to vanish, therefore restoring normal LE 
localization (Figure 29) and almost perfect colocalization with SLP-1-myc. This result again 
indicates the formation of SLP-1 oligomers during biosynthesis.  
We next made use of the different SLP-1 constructs, which show at least partial PM 
localization to explore if SLP-1 also is inserted into the membrane via a hydrophobic hairpin 
as described for stomatin. If the hydrophobic hairpin conformation was correct, N- and C-
terminus of SLP-1 should reside in the cytoplasm.  
Figure 30: Both N- and C-termini of SLP-1 are cytoplasmic 
 
Figure 30: Analysis of N-
and C-terminally tagged 
SLP-1 constructs with PM 
localization. The SLP-
1(Y7A)-GFP and GFP-
SLP-1 constructs were 
transiently expressed in 
HeLa cells. Cells were 
analysed by indirect 
immunofluorescence with 
an anti-GFP antibody 
either with or without 
permeabilization. Without 
detergent, only the GFP-
signal was observed 
(except for some leaky 
cells, see middle panel), 
confirming the 
cytoplasmic localization of 
both termini.  
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The constructs which show PM localization should therefore only be detected after 
permeabilization of the cells and not without permeabilization. We used the GFP-SLP-1 
construct and the SLP-1(Y7A)-GFP construct, transiently transfected COS7 cells and then 
performed indirect immunofluorescence with an anti-GFP antibody on TX100-permeabilized 
and non-permeabilized cells (Figure 30).  
No signal was observed for both experiments without TX100 permeabilization (some “leaky” 
cells were observed, where some antibody could diffuse into the cytoplasm without TX100, 
see figure). These results confirm that the GFP-tag at the N-terminus and at the C-terminus is 
not exposed at the cell surface and rules out the possibility that SLP-1 could be a typeI 
transmembrane protein. Based on the similarities between the long hydrophobic membrane 
domains (same size, adjacient cysteine residues which can be palmitoylated, short strongly 
charged cytoplasmic N-terminus) and the already described possibility to localize to lipid 
droplets (transmembrane proteins are excluded from LDs), we conclude that SLP-1 is 
anchored to the membrane by an equivalent hydrophobic hairpin loop.  
 
 
4.1.12 Chimeric SLP-1/stomatin fusions confirm the LE targeting function of the N-
terminus  
Finally, I decided to construct a chimeric protein consisting of the N-terminus of SLP-1 
(amino acids 1-49) fused to the hydrophobic domain and the C-terminus of stomatin. The 
STOM (21-287)-GFP construct where the N-terminus of stomatin is deleted was cloned by 
Ellen Umlauf of our group recently. This construct was practically indistinguishable from the 
full-length stomatin-GFP construct in respect to subcellular localization, oligomerization and 
lipid raft association (Umlauf et al., 2004; Umlauf et al., 2006). Therefore, the N-terminus of 
stomatin is not essential for proper subcellular targeting of the protein. If I added the N-
terminus of SLP-1 to this construct, I would expect to see enhanced LE targeting of the 
resulting fusion protein. As a control, I also constructed fusions of STOM (21-287)-GFP with 
the point-mutated N-termini (Y7A, L10S) already described.  
The resulting fusion proteins were analysed by western blotting with an anti-GFP antibody 
and showed the expected sizes, with the expected size difference between the STOM (21-
287)-GFP construct and the SLP-1(1-49)STOM (21-287)-GFP construct. The two point-
mutated fusions had the same size as the wild-type SLP-1-STOM fusion (Figure 31 A). 
Transient transfections were analysed for the localization of the constructs (Figure 31 B), cells 
were co-stained with LysoTrackerRed to reveal acidic endosomes/lysosomes. The results 
were really striking. The STOM (21-287)-GFP construct showed the known distribution 
typical for stomatin (PM+LE staining). The fusion SLP-1(1-49)STOM (21-287)-GFP, 
however, did not show any PM localization any more and only showed perinuclear, vesicular 
staining as observed with SLP-1.  
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Figure 31: Fusion of the SLP-1 N-terminus to stomatin 
 
Figure 31: Fusion of the N- terminus of SLP-1 to stomatin. Deletion of the N-terminus of stomatin does not have 
an effect on the subcellular localization of the protein (PM and LE localization indistinguishable from wt 
stomatin, (Umlauf et al., 2004)). We constructed fusions of the entire N-terminus of SLP-1 (1-49) or of the N-
terminus carrying point mutations (Y7→A and L10→S) in frame with STOM (21-287)-GFP, transiently 
expressed them in HeLa cells and analysed expression by western blotting and immunofluorescence. The wild 
type N-terminus abolished PM localization of stomatin, which was restored when the GYRAL motif was 
mutated. Scale bars 10 µm.  
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Introduction of point mutations in the N-terminus of SLP-1 abolished the stringent LE 
targeting and restored the normal pattern for stomatin, with PM and LE signal. This result 
confirms that the N-terminus of SLP-1 is an efficient LE targeting signal. Targeting to LEs is 
most probably accomplished by direct trafficking from the TGN to LEs, because we did not 
observe cells with PM signal for the SLP-1(1-49)STOM (21-287)-GFP fusion. Alternatively, 
very efficient and quick internalization from the PM might also operate. The amino acids Y7 
and L10 are essential for proper function of the N-terminus as an endocytic targeting signal. 
This suggests that the N-terminus might also directly interact with a subunit of an adaptor 
complex as had already been described for other GYXXΦ motifs (Gough et al., 1999; Ihrke et 
al., 2004; Ohno et al., 1998). The analysis of interaction partners with this short, cytoplasmic 
stretch could yield interesting results on the transport machinery which is responsible for LE 
targeting of SLP-1.  
 
 
4.1.13 Live cell imaging reveals that SLP-1 on late endosomes is highly dynamic  
With our SLP-1-GFP construct, we were able to analyse the dynamics of SLP-1 in living 
cells. We used HeLa cells stably expressing high amounts of SLP-1-GFP and subjected the 
cells to time-lapse confocal microscopy. Most of the SLP-1-GFP-positive vesicles were found 
to reside close to the nucleus and to show brownian motion. But we also observed some 
vesicles which clearly showed directed movement to/from the cell periphery (Figure 32 A, 
Movie 1). In addition to the typical, perinuclear staining pattern known from fixed cells, we 
noted smaller vesicles, which moved at higher speed. These vesicles could either represent 
TGN-derived carriers or early endosomal carriers, which interact with the late endosomes. We 
frequently observed fusion events between these small SLP-1-GFP positive structures and 
large, LysoTrackerRed stained, larger structures (Figure 32 B, Movie 2).  
This population of small vesicles is probably missed in fixed cells, because these structures 
are indistinguishable from larger vesicles with an inhomogenous staining pattern for SLP-1. 
This inhomogenous, “patchy” staining of SLP-1 on large late endosomes was clearly 
confirmed by live cell imaging studies (Figure 32 A,B) and complicates the quantification of 
the degree of colocalization of SLP-1 with other marker proteins. Nevertheless, most of the 
SLP-1-GFP signal clearly resides on large, LysoTrackerRed-stained acidic vesicles, in line 
with a localization to late endosomes.  
The next step in the analysis of SLP-1 dynamics must clearly be to identify the origin/nature 
of the small, highly dynamic SLP-1-GFP vesicles, because these could be essential for the 
proposed function in lipid transport.  
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Figure 32: Live cell imaging of SLP-1-GFP 
 
Figure 32: Live cell imaging reveals the dynamic behavior of SLP-1-GFP. (A) HeLa cells stably expressing 
SLP-1-GFP were processed for live cell imaging as described in the Methods section. A freeze image of a cell is 
shown in the left panel. The boxed region was zoomed in and GFP-images were acquired every 0.65 seconds for 
about 3 minutes. The right panel shows images from the movie from time point 69 to 79 seconds. A large vesicle 
rapidly moving towards the cell periphery is marked by arrows. Please note the dotted distribution of the SLP-1-
GFP signal on the vesicle. In the complete movie, several vesicles rapidly moving to and from the cell periphery 
were observed. (B) Cells were co-stained with LysoTracker Red and analyzed by confocal live cell imaging. The 
left panel shows a freeze image of the cells, with the region analysed by live microscopy marked. The left panel 
shows overlays for SLP-1-GFP and LysoTrackerRed staining at different time points. Several big vesicles with 
small, dynamic SLP-1-GFP dots on their surface can be observed in the complete movie. Scale bar: 10 µm.  
 
 
4.1.14 SLP-1 induces the formation of enlarged, cholesterol-enriched vesicles if 
cholesterol efflux from LEs to the PM is blocked with the amino-steroid U18666A  
The unique domain structure of SLP-1 indicates that it could function in lipid 
transport/transfer. After we had discovered that the protein is localized to LEs, we decided to 
investigate if it could help the cells to overcome a blockade in cholesterol transport induced 
by U18666A when overexpressed. U18666A induces the accumulation of cholesterol in late 
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endosomes and is frequently used to artificially cause a so-called Niemann-Pick phenotype. 
This phenotype, which was first observed in fibroblasts derived from patients with the 
Niemann-Pick syndrome, a disease which affects the central nervous system, is characterized 
by the accumulation of cholesterol in late endosomes. Overexpression of MLN64, a 
cholesterol-binding late endosomal protein, inhibits cholesterol accumulation at low 
concentrations of U18666A(Alpy et al., 2001). We therefore wanted to analyse if SLP-1 has a 
similar effect. We treated control HeLa cells and HeLa cells stably expressing SLP-1-GFP 
with different concentrations of U18666A and analysed cholesterol accumulation by staining 
with filipin. No reduction of cholesterol accumulation was observed in cells over-expressing 
SLP-1-GFP (data not shown). Instead, we frequently observed the formation of enlarged, 
strongly filipin-stained structures in cells expressing SLP-1-GFP (Figure 33 A). These 
structures often had a diameter of up to 3 µm and were even visible in phase contrast. We 
next analysed if these enlarged vesicles were also present if the SCP-2 domain of SLP-1 is 
deleted. In cells expressing the SLP-1(1-288)-GFP construct, these enlarged structures were 
not observed. These data strongly indicate that SLP-1 might have a function in cholesterol 
transport and that the SCP-2 domain is required for this function. To get a quantitative picture 
of the situation, we analysed the SLP-1-GFP/SLP-1(1-288)-GFP and filipin-positive 
structures for maximal vesicle diameter. The results are shown in Figure 33 B. Cells 
expressing SLP-1-GFP contain significantly larger cholesterol-filled structures compared to 
cells expressing SLP-1(1-288)-GFP. These enlarged structures are not caused by the GFP-tag, 
because they were also observed in cells expressing SLP-1-myc (Figure 34).  
We next wanted to determine if these enlarged structures represent late endosomes/lysosomes 
as expected. We therefore performed a triple staining of filipin, SLP-1-GFP/SLP-1(1-288)-
GFP and the late endosomal marker LAMP-2. The results are shown in Figure 35.  
Because there are numerous reports that U18666A induces the accumulation of cholesterol in 
LAMP-1/2 positive late endosomes, we expected that the enlarged structures should be 
positive for LAMP-2. We were rather surprised to find that these structures only contain very 
little LAMP-2 (Figure 35A). In cells expressing SLP-1-GFP, the signal for filipin and LAMP-
2 was largely separated, and the structures with the strongest filipin staining showed only very 
little LAMP-2 signal (see arrows). Almost no colocalization of all 3 markers was observed. In 
cells expressing SLP-1(1-288)-GFP, however, we observed much better colocalization of 
filipin and LAMP-2 and also observed a higher fraction of vesicles clearly positive for all 3 
markers (Figure 35B). In control HeLa cells treated with U18666a, filipin and LAMP-2 
clearly co-localized, although not perfectly (Figure 36A). We then repeated the triple staining 
with SLP-1-GFP expressing cells and essentially got the same results. We could confirm that 
the enlarged structures contain only tiny amounts of LAMP-2 (Figure 36B). This means that 
they should be part of the late endosomal system, but they could represent a subcompartment, 
which is rather devoid of LAMP-2. In a live cell imaging experiment, we induced cholesterol 
accumulation and co-stained the cells with LysoTrackerRed. We again observed the enlarged 
structures in response to U18666A treatment in SLP-1-GFP positive cells.  
Results 
PhD thesis   Mario Mairhofer 
 117 
 
Figure 33: Influence on cholesterol distribution upon U18666A treatment 
 
Figure 33: Treatment of SLP-1-GFP expressing cells with the aminosteroid U18666A results in the formation of 
enlarged, cholesterol-rich vesicles. (A) Upper panel: Mixed SLP-1-GFP expressing and normal HeLa cells were 
grown in the absence of U18666A and stained with filipin to visualize cholesterol distribution. Weak filipin-
staining was detected on the plasma membrane and in the perinuclear region. Middle panel: Mixed SLP-1-GFP 
expressing and normal HeLa cells were treated with U18666A as indicated. In cells expressing SLP-1-GFP, 
enlarged, filipin-stained vesicles can be seen (arrows) that are surrounded by SLP-1-GFP. These filipin-stained 
vesicles are clearly larger than in normal, SLP-1-GFP-negative HeLa cells. Lower panel: Cells expressing SLP-
1(1-288)-GFP were treated with U18666A and analyzed equally. Small, filipin- stained, SLP-1(1-288)-GFP-
positive vesicles can be observed but not the enlarged vesicles. Scale bars: 10 µm. (B) Comparison of the 
maximum vesicle size of cells either expressing SLP-1-GFP or SLP-1(1-288)-GFP after treatment with 5 µg/mL 
U18666A for 24 hours. The diameter of the largest vesicular structures positive for the respective GFP-fusion 
protein and filipin was measured with the software of the Zeiss LSM microscope in 50 different cells, for each 
cell type. Diameters larger or smaller than 1.5 µm were scored. The relative results are shown in the diagram. 
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Figure 34: U18666A II 
 
Figure 34: Enlarged vesicles are also detected in cells expressing SLP-1-myc. Cells stably expressing SLP-1-
myc were treated with 3 µg/ml U18666A for 24 hours and analyzed by filipin staining. Two enlarged structures 
containing SLP-1-myc (green channel) and filipin (blue channel) were marked by arrows. These vesicles were 
also clearly visible in the phase contrast image. Scale bar: 10 µm. 
Figure 35: U18666A III 
 
Figure 35: Triple staining of cells treated with U18666A reveals a reduced co-localization of LAMP-2 with 
filipin and SLP-1-GFP in the large, cholesterol-rich vesicles. Cells stably expressing either (A) SLP-1-GFP or 
(B) SLP-1(1-288)-GFP were treated with 3 µg/ml U18666A for 24 hours. The cells were fixed and stained with 
filipin and anti-LAMP-2-antibody. (A) The enlarged, filipin-positive vesicles that are observed in cells 
expressing SLP-1-GFP (arrows) contain very little LAMP-2. (B) Co-localization of filipin, SLP-1(1-288)-GFP, 
and LAMP-2 can be clearly seen in a large part of the late endosomal compartment. Please compare the triple 
overlays in A and B. Scale bars: 10 µm.  
 
 
These large structures were clearly positive for LysoTrackerRed (Figure 36C), confirming 
their late endosomal origin. Several unanswered questions remain: 1) Why are the enlarged 
structures devoid of LAMP-2? Do they represent a LAMP-2-poor subcompartment of LEs?. 
2) Do these LAMP-2 poor structures exist before U18666A treatment? Do they specifically 
accumulate cholesterol stronger than other LEs? 3) Or is LAMP-2 sorted from the SLP-1-
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GFP-positive structures upon U18666A treatment? 4) Alternatively, the LAMP-2 signal could 
also simply be “diluted” when the vesicle gets bigger and bigger.  
At first, it would be important to find other marker proteins, which are enriched in these SLP-
1-GFP positive structures. This could help to precisely define the relationship of these giant 
vesicles to the late endosomal compartment. Next, analysis of the ultrastructure of these 
structures could provide interesting results (What is the ultrastructure of the interior of these 
vesicles? Are they MVBs or vacuoles?).  
Figure 36: U18666A IV 
 
Figure 36: The enlarged vesicles do contain small amounts of LAMP-2 and are acidic.(A) HeLa cells were 
incubated with 3 µg/ml U18666A for 24 hours and stained with filipin (blue) and anti-LAMP-2 antibody (red). 
LAMP-2 was detected in virtually all filipin-positive vesicles. (B) HeLa cells stably expressing SLP-1-GFP were 
treated equally and analyzed for filipin (blue), SLP-1-GFP (green), and LAMP-2 (red) staining. Three enlarged, 
SLP-1-GFP-positive vesicles were marked with arrows. These structures contained small but clearly detectable 
amounts of LAMP-2, indicating that they were derived from late endosomes. (C) Live cells expressing SLP-1-
GFP were treated with 10 µg/ml U18666A for 24 hours and stained with LysoTracker Red (LTR) as described. 
A cell showing the typical, enlarged structures is shown. Two enlarged, acidic vesicles clearly stained with LTR 
are marked with arrows. Scale bars: 10 µm. 
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4.2 Stomatin 
The function of stomatin, the founder member of the stomatin protein family, still remains 
enigmatic. Before I started with the project of the characterization SLP-1, I have tried to 
elucidate the function of stomatin in platelets and neutrophilic granulocytes. I decided to 
include these in large part biochemical data in my thesis because of the now apparent 
association of SLP-1 and stomatin in a high molecular weight complex. Because this complex 
formation is relevant for both proteins, the stomatin data will also be relevant for SLP-1.   
Additionally, I extended the work of the previous lab member and colleague, Ellen Umlauf, 
who had started the cell biological characterization of stomatin and constructed numerous 
stomatin point mutants and deletions with the aim of characterizing the oligomerization 
domain and possibly producing dominant-negative mutants which could reveal the function of 
the protein. She had clearly identified a region necessary for oligomerization and lipid raft 
association, but all her mutants did not show a clear phenotype in cell culture. In parallel to 
the characterization of SLP-1, I also constructed several stomatin point mutants, with a focus 
on amino acids conserved between the C. elegans homologue MEC-2 and stomatin, which 
were mutated in mec-2 alleles. Due to limitations in time, these novel constructs are not 
characterized in detail, but I am convinced that they will be very useful for the study of the 
function of stomatin in the future. Interestingly, two of these novel point mutations (S231A 
and S231E) apparently affect the interaction of stomatin with SLP-1.  
 
 
4.2.1 Immunofluorescence analysis of resting and activated platelets and PMNs reveals 
major changes upon activation  
Platelets and PMNs were isolated from whole blood as described, either activated or directly 
seeded onto coated coverslips. The distribution of stomatin was analysed by indirect 
immunofluorescence. The upper panel of Figure 37 shows the results for resting and activated 
platelets. In resting platelets, stomatin is detected in cytoplasmic puncta of variable size, 
which represent alpha-granules(Mairhofer et al., 2002). Activation with thrombin causes 
platelet spreading and fusion of alpha-granules with the plasma membrane. Stomatin is 
detected on the plasma membrane. The signal is strong at the tips of filopodia. A similar 
staining pattern was recently described for a toxin which binds to cholesterol(Heijnen et al., 
2003). This staining pattern is also interesting, because we have observed an enrichment of 
stomatin in platelet-derived microvesicles, and these microvesicles could form by shedding 
from the tips of the filopodia. Activation with a peptide mimicking the effect of thrombin 
action (TRAP peptide) showed the same results. The lower panel of Figure 37 shows the 
results for isolated PMNs.  
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Figure 37: Immunofluorescence images of platelets and neutrophils 
 
Figure 37: Immunofluorescence images of platelets and neutrophils. Platelets and Neutrophils were isolated from 
whole blood as described in the Methods section and seeded onto poly-L-lysine–coated coverslips. Cells were 
either fixed immediately or activated with the indicated agonists for 5 minutes at 37°C. Immunofluorescence was 
performed with the anti-stomatin-antibody GARP50. Please note the dramatic shape change of platelets and the 
characteristic filopodia seen after activation.  
 
In resting PMNs, stomatin is detected in cytoplasmic granules as expected(Feuk-Lagerstedt et 
al., 2002). Please note the lobes of the nucleus, which are clearly visible. No plasma 
membrane staining was observed in resting PMNs. Activation with PMA caused a 
translocation of stomatin to the plasma membrane. Again, stomatin staining was visible in 
tiny filopodia. Activation with the chemotactic peptide fMLP caused random polarization of 
the adherent PMNs. The outer right picture in the lower panel of Figure 37 shows a polarized 
neutrophil cell with the leading edge and the trailing edge strongly stained for stomatin. This 
staining may not represent true polarization of the stomatin signal, but could also be caused 
by an accumulation of stomatin-positive granules close to the membrane.  
 
4.2.2 2D-PAGE analysis of platelet lipid rafts reveals major differences between raft 
fractions isolated with different detergents  
During my diploma thesis, we established a method for the isolation of lipid rafts from 
platelets with the detergent CHAPS instead of Triton X-100, which is routinely used for this 
purpose. For the hydrophobic membrane protein stomatin, detergent lysis with CHAPS leads 
to an increased proportion of total stomatin in the low-density, buoyant lipid raft fractions. 
Several other proteins were also detected in the CHAPS lipid raft fractions, but not in the 
Triton X-100 lipid raft fractions (GLUT3, CD9, CD36). Figure 38 shows a comparison of 
TX100 and CHAPS flotation assays analysed by 1D-PAGE and western blotting/silver 
staining.  
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Figure 38: Platelet lipid rafts isolated with different detergents: 1D PAGE 
 
Figure 38: Comparison of platelet lipid rafts/DRMs isolated with different detergents. Platelets were lysed with 
either 1% TritonX-100 or 1% CHAPS as described, and DRMs were isolated by step density gradient 
centrifugation. Equal volumes of density gradient fractions were analysed by silver staining (A, B). (C) 
represents a comparison of the pooled raft fractions (label F) and the non-floating dense fractions (label D). 
Differences in protein content are clearly visible. The most striking difference is the reduction of actin in the 
CHAPS raft fractions.  
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We then developed a 2D-PAGE method suitable for lipid raft fractions to be able to analyse 
these differences in more detail. Figure 39 shows a comparison of TX100 and CHAPS lipid 
raft fractions analysed by 2D-PAGE. Major differences are clearly visible in the two spot 
patterns. Most striking is the strong reduction of actin (and actin-associated cytoskeletal 
proteins) in the CHAPS raft fractions. But although the cytoskeleton content of the raft 
fractions is decreased, the complexity is increased compared to the TX100 raft fractions. This 
means that CHAPS lysis is less stringent and probably results in the isolation of much more 
proteins in the low-density buoyant fractions.  
 
 
 
Figure 39: Platelet lipid rafts isolated with different detergents: 2D PAGE 
 
Figure 39: Analysis of TritonX-100 and CHAPS lipid rafts by 2D-PAGE. Lipid raft fractions were isolated and 
2D-PAGE was performed as described in the Methods section. 2D-PAGE analysis revealed that CHAPS rafts 
contain much more different proteins than TritonX-100 rafts. Regions with the biggest differences are encircled.  
 
 
 
As the value of the isolation of detergent-resistant membranes was strongly doubted recently 
(see introduction), we decided to return to the more stringent TX100 raft isolation procedure 
for a more detailed proteomic analysis of platelet lipid rafts. We therefore compared lipid raft 
fractions isolated either from resting platelets or from thrombin-activated platelets and looked 
for differences in the protein patterns. Figure 40 shows the silver-stained polyacrylamide gels. 
Regions with big differences in the spot pattern are encircled. 
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Figure 40: 2D-PAGE analysis of resting and activated platelets 
 
Figure 40: Comparison of TritonX-100 rafts from resting and activated platelets. Lipid raft fractions of resting 
and activated platelets were analysed by 2D-PAGE and silver staining for mass spectroscopy. Regions with big 
changes are encircled. Spot numbers refer to  
 
 
Table 1 on the next page summarizes the results from this analysis. Due to the high costs of 
mass spectroscopic protein identification on a service basis, only a subset of spots was 
analysed by MALDI-TOF or MS2-ESI. As expected, numerous cytoskeletal proteins were 
identified in the lipid raft fractions. These cytoskeletal proteins also account for the major 
differences between resting and activated platelets, which probably only reflects the changes 
in actin-associated proteins in response to platelet activation. Therefore, these changes 
probably do not represent activation-induced changes in lipid raft composition, which we 
were looking for. But in addition to these cytoskeletal proteins, we also identified several new 
platelet lipid raft proteins which could be involved in cellular signalling (InsP4 binding 
protein, zinedin, 14-3-3 subunits, Galpha i). 
Additionally, there must without doubt be some connection between lipid rafts and the 
cytoskeleton, which is sensitive to CHAPS lysis but remains intact when TX100 is used. Due 
to the small proportion of signalling proteins, we did not procure this proteomic approach any 
further. Instead, we focused on the analysis of the stomatin protein by 2D-PAGE.  
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Table 1: Platelet lipid raft proteins identified in this work:  
Spot # 
Increase with 
activation Protein (s)  Identification remarks 
1 yes talin MALDI   
2 yes CD 61 MALDI glycosylated 
3 yes CD 41 MALDI glycosyl. 
gamma-Fibrinogen MALDI 
secreted upon 
activation 
InsP4 binding protein MS/MS GTPase activating  
alpha-actinin MS/MS actin bundling protein 
4 yes zinedin MS/MS   
5 no CD 36 MALDI, WB glycosyl. 
filamin A  MS/MS only fragment 
6 yes gelsolin MS/MS   
vimentin MS/MS intermediate filament 
7 no tubulin MS/MS   
8 yes 
ATP synthase beta 
subunit MALDI mitochondrial 
9 no flotillin-2 WB   
10 no flotillin-1 WB 3 spots 
11 decrease beta-actin WB major spot 
12 no G alpha i WB   
13 no VDAC2 MS/MS mitochondrial protein 
14 no VDAC1 MS/MS mitochondrial protein 
tropomyosin 4 MS/MS   
15 yes beta-tropomyosin MS/MS   
16 no CapZ beta MS/MS actin filament capping 
17 no stomatin MALDI, WB focuses poorly 
18 no VDAC3 MS/MS mitochondrial protein 
14-3-3 zeta 
MALDI, 
MS/MS   
14-3-3 eta MS/MS   
14-3-3 tau MS/MS   
14-3-3 gamma MS/MS   
19 yes 14-3-3 beta MS/MS   
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4.2.3 Stomatin phosphorylation in response to platelet activation? 
To analyse if stomatin is modified in response to platelet activation, we analysed lipid raft 
fractions from resting or activated platelets by western blotting. As a positive control, we 
included the lyn tyrosine kinase, which is strongly phosphorylated upon platelet activation. 
Figure 41A shows the western blots for lyn in resting and activated lipid raft samples. A shift 
towards the more acidic end of the gradient is clearly visible.  
Figure 41B shows a comparison of the spot pattern of stomatin in resting or activated 
platelets. In resting platelets, we observed 3 major spots for stomatin. The outer right spot is 
close to the theoretical pI (7.81) for stomatin. The two other spots are shifted to the more 
acidic region. The increments perfectly match the expected shift for two additional negative 
charges. These shifts could be explained by two phosphorylation events, but also de-
amination of basic amino acids could account for it. In activated platelets, we clearly observed 
a shift of stomatin to the more acidic region of the gel. This clearly supports a possible 
phosphorylation of stomatin in response to platelet activation. The three spots in resting 
platelets could be explained by slight activation of the platelets during the isolation procedure, 
which is frequently observed.  
Figure 41: Western blot analysis of 2D-PAGE gels 
 
Figure 41: Lipid raft fractions of resting and thrombin-activated platelets were analysed by 2D-PAGE and 
western blotting with anti-lyn kinase and anti-stomatin antibodies. The lyn kinase shows a strong shift of the 
signal to the acidic region, which fits well to the described phosphorylation of the protein upon platelet 
activation. Stomatin also shows a shift to the acidic region.  
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4.2.4 Mass spectroscopic analysis of stomatin from platelet lipid rafts for post-
translational modifications  
Because we were unable to get properly focused stomatin spots in silver-stained 2D-gels 
(increasing the sample amount resulted in poor focusing and smears of stomatin instead of 
sharp, discrete spots), we went back to 1D-PAGE to prepare samples for mass spectroscopy. 
Lipid rafts of resting and activated platelets were prepared as described, the lipid raft fractions 
were analysed by 1D-PAGE and silver staining. The stomatin bands were excised, trypsin 
digested and analysed by LC-MS/MS. Neutral loss scanning was performed to identify 
peptides which could be phosphorylated. During this work, the described phosphorylation of 
stomatin on Ser-9 could be confirmed (Salzer et al., 1993), but no further phosphorylation 
sites could be detected. Instead, three peptides were identified, which show a neutral loss as 
observed for phosphopeptides, but the characteristic dehydroalanine residues which are 
observed after elimination of H3PO4 from the peptide were not found. The post-translational 
modification observed was characterized by addition of a molecular mass of ~96 to the 
peptide, which was lost in MS2. The MS2 and MS3 spectrum of the unmodified and modified 
peptide were virtually identical. No PTM with these characteristics has been described up to 
now. Recently, O-sulfonation of serine and threonine has been described(Medzihradszky et 
al., 2004). This modification is characterized by the neutral loss of SO3 and does not leave a 
“mark” on the backbone. But the mass difference to the unmodified peptide also should be 
+80 and not +96 as in our case. Therefore, we could not identify the nature of the PTM on the 
three stomatin peptides. It could either be a novel, yet uncharacterized modification, which of 
course would be very interesting. Additionally, either non-covalent, tightly bound H3PO4 or 
covalently bound persulfonate could explain the observed behaviour. The detailed MS data 
are given in Appendix 2. As these cryptic PTMs were observed in samples from resting and 
activated platelets, they do not account for the observed shift in the 2D-PAGE experiments. 
We aim at a collaboration with an expert in PTMs to resolve these issues. In addition to these 
LC-MS/MS data, we also got some hints on possible PTMs from MALDI-TOF data. Two 
peptides with a mass difference of +80 characteristic of phosphorylation were observed. One 
contained the well-known serine-9, whereas the other contained serine-231 as the only 
possible phosphorylation site. These data were the starting point for the generation of 
stomatin point mutants, which either inhibit phosphorylation (S231A) or mimick 
phosphorylation (S231E). Although the phosphorylation of stomatin at position 231 is still 
only hypothetic, these point mutations showed very interesting effects.  
 
4.2.5 Point mutations at serine-231 show effects on stomatin trafficking  
Because serine-231 was identified as a potential new phosphorylation site in a MALDI-TOF 
experiment, I constructed point mutations which either abolish a possible phosphorylation 
(S231A) or should mimick permanent phosphorylation (S231E). Independent of the putative 
phosphorylation, this region of stomatin seems to be very important for the function of the 
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protein because numerous point mutants at conserved positions have been described for the C. 
elegans homologues MEC-2 and UNC-1. Therefore, I decided to construct numerous different 
point mutants and started with serine-231. At first, both the S231A and S231E mutant seemed 
to show no difference to wild-type stomatin. A more detailed analysis revealed that the myc-
tagged S231A mutant was reduced in the perinuclear region compared to wild-type stomatin 
and the S231E mutant. This was very obvious when we transiently transfected cells stably 
expressing SLP-1-GFP with these constructs. As seen in Figure 42, wild-type stomatin is 
detected on the PM and in late endosomes, where it colocalizes with SLP-1. The S231E 
mutant was barely detectable at the PM and colocalized perfectly with SLP-1-GFP, whereas 
the S231A mutant did not colocalize with SLP-1 at all, but remained exclusively at the PM. In 
cells stably expressing only the respective myc-tagged constructs, the situation was as 
follows: wt stomatin and S231E were practically indistinguishable, both showing PM and LE 
staining. The S231A mutant, however, only showed PM staining, which indicates a reduced 
rate of internalization of this point mutant. As a next step, I re-cloned these constructs into the 
pEGFP-N3 vector. With these GFP-tagged constructs, I created stably expressing cell lines. 
When I analysed the resulting stable clones by immunofluorescence, I got very surprising 
results. The S231A mutant showed ER localization in one of the stable clones, whereas it 
showed normal PM localization in others. The localization was correlated with the level of 
expression, the clone with the strongest expression showed the ER labeling.  
 
Figure 42: Stomatin point mutations I 
 
Figure 42: Point mutations at 
serine 231 strongly influence 
co-localization of stomatin 
with SLP-1. HeLa cells stably 
expressing SLP-1-GFP were 
transiently transfected with 
wt stomatin-myc (upper 
panel), with ST (S231E)-myc 
(middle panel) or with ST 
(S231A)-myc (lower panel). 
The wild-type stomatin 
construct partially co-
localizes with SLP-1, the 
S231E mutant almost 
perfectly co-localizes with 
SLP-1 and shows practically 
no PM localization, whereas 
the S231A construct shows 
only PM localization and 
does not co-localize with 
SLP-1.  
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I then repeated transient transfections with the S231A-myc construct and also observed 
obvious ER staining in cells with a very high expression level of the construct. Therefore, we 
concluded that the targeting of the S231A construct to the PM can probably be rescued by the 
endogenous stomatin protein at moderate expression levels of the mutant. Consequently, we 
performed transient transfections in A431 cells, which only express minimal amounts of 
stomatin. We observed ER localization of the S231A-GFP construct in virtually all cells.  
 
Figure 43: ER localization of S231A 
 
Figure 43: GFP-tagged wild type stomatin and point mutants at S231 were either transiently or stably expressed 
in A431 and HeLa cells and analysed by immunofluorescense. In A431 cells, which express no endogenous 
stomatin, the S231A mutant accumulates in the ER. In HeLa cells, the subcellular localization depends on the 
expression level of the mutant. At high expression, we observe ER localization, whereas we observe perinuclear 
and weak PM staining at lower expression levels. The C-terminally truncated point mutant ST (1-262)(S231A), 
which should be unable to oligomerize (Snyers et al., 1998), does not show ER localization even at high 
expression levels.  
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Figure 43 shows the described results from stable and transient transfections of the GFP-
tagged constructs in HeLa and A431 cells. Additionally, I also combined the S231A point 
mutation with a truncation after amino acid 262. This construct, ST (1-262)(S231A)-GFP, 
differed from the full length construct, because it was transported to the PM without any 
problem. No ER localisation was observed in contrast to the full-length ST (S231A)-GFP 
construct. The truncation after amino acid 262 abolishes the formation of high-order stomatin 
oligomers and lipid raft association of stomatin (Umlauf et al., 2006). In my opinion, the 
formation of oligomers between mutant stomatin (S231A) and endogenous wild-type stomatin 
is responsible for the observed, apparently contradictory results. If enough endogenous 
stomatin is present, the mixed oligomers of mutant and wt stomatin can be transported to the 
plasma membrane. If the mutant form dominates, the oligomers are not transport-competent 
and accumulate in the ER. Additionally, the mutant form seems to inhibit the endocytosis of 
stomatin oligomers. A truncated, monomeric variant is transported to the PM without any 
problems. This truncation probably is not functional and is transported with the bulk of other 
membrane proteins, whereas the transport of stomatin oligomers seems to be regulated. The 
question if oligomers already form in the ER will be addressed with the stable clone which 
shows ER localisation.  
The S231E mutant also showed some special characteristics when tagged with GFP. In many 
cells, we observed filamentous structures of S231E-GFP, often several µm in length. These 
structures are aligned along actin filaments as shown by costaining with fluorescent phalloidin 
(Figure 44), whereas they did not colocalize with tubulin.  
These filamentous structures could represent linear arrays of vesicles, which are transported 
along actin filaments. The questions, which remain are: Are these vesicles transported to the 
cell periphery/PM or are they internalized? Are these filaments a mere consequence of the 
strong overexpression of the GFP-tagged construct or do they represent functional transport 
intermediates? Live cell imaging and FRAP analysis can perhaps help to clarify these 
questions in the future.   
 
 
4.2.6 A non-oligomeric, not raft associated stomatin truncation mutant shows 
enhanced plasma membrane motility in a FRAP assay  
With the possibility to do live cell imaging with the newly acquired Zeiss LSM Meta confocal 
microscope, we decided to analyse the motility of full-length stomatin-GFP and compare it to 
the truncation mutant ST (1-262)-GFP. Both GFP fusions were cloned by Ellen Umlauf. 
FRAP was performed with transiently transfected HeLa cells as described. The results are  
depicted in Figure 45.  
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Figure 44: Tubular structures of S231E 
 
Figure 44: Transient transfections of HeLa cells with St (S231E)-GFP show filamentous, GFP-positive 
structures. HeLa cells were transiently transfected with St (S231E)-GFP and were co-stained with 
AlexaFluor596-conjugated phalloidin to stain actin filaments or with an anti-tubulin antibody.  
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Figure 45: FRAP analysis of stomatin mobility 
 
Figure 45: HeLa cells transiently expressing full-length StomGFP and the truncation mutant ST (1-262)GFP, 
respectively, were subjected to FRAP analysis. (A) Qualitative FRAP. A ROI of 3.4 µm diameter was bleached 
and the recovery of StomGFP or ST (1-262)GFP in the plasma membrane after 30 and 120 s is shown. Bars = 10 
µm. (B) Quantitative FRAP. The recovery curves show the mean intensity ± SD from 7 cells, each. (C) 
Comparison of the mobile fractions Mf and the recovery halftimes t1/2 for StomGFP and ST (1-262)GFP 
calculated from the recovery data as described in Materials and Methods. Mean values for Mf and t1/2 (n=7, 
respectively), error bars represent +/- one standard deviation. The paired Student’s t test was used to assess the 
statistical significance of the differences between the results for StomGFP and ST (1-262)GFP.  
 
 
Wild-type stomatin diffuses relatively slow, and a large fraction is immobilised, probably 
through an interaction with the cytoskeleton. The truncation mutant ST (1-262)-GFP shows 
faster diffusion as revealed by the reduced recovery half-time t1/2, and the mobile fraction is 
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also significantly higher. Because ST (1-262)-GFP is non-oligomeric and not raft associated, 
we cannot determine precisely if raft association or oligomerization is responsible for the 
slow diffusion velocity and high immobile fraction. During her PhD thesis, Ellen Umlauf 
constructed several point mutations, which have different effects on oligomerization and raft 
association. Some of these mutants were already cloned as GFP fusion proteins, but the 
expression and localization of the fusion proteins had not be verified yet. I analysed several of 
these mutants by transient transfection into HeLa cells. The results are shown in Figure 46.  
 
 
Figure 46: Further candidates for FRAP analysis 
 
 
Figure 46: Three mutated GFP-tagged constructs, which had been constructed by E. Umlauf, were tested for 
proper expression and PM localization to find out if they are feasible for FRAP analysis. All 3 constructs work 
and show PM localization, although the PM staining is weak in the P269A construct.  
 
 
All three tested constructs showed PM and LE localization and can therefore be used for 
FRAP analysis in the future. The PM signal for the P269A mutant, however, was rather low 
and LE localization dominated. The F268A and P269A point mutations could be very 
interesting, because F268A is monomeric and not raft-associated, whereas P269A is also 
monomeric, but localized to lipid rafts (Umlauf et al., 2006).  
If these constructs showed differences in respect to diffusion speed and immobile fraction 
(compared to each other and wt stomatin), one should be able to separate the contributions of 
oligomerization and lipid raft association to the diffusional behaviour of stomatin-GFP. 
Another issue for future FRAP experiments would be the comparison of the lateral mobility 
of stomatin at the PM and in the ER (S231A-GFP construct).  
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Figure 47: Alignment of the human stomatin family, MEC-2 and UNC-1 
 
 
Figure 47: Multiple sequence alignment of human stomatin family proteins and of C. elegans MEC-2 and UNC-
1 proteins. The alignment was computed with the ClustalW programme (http://www.ebi.ac.uk/clustalw/). 
Identical and similar amino acids were coloured with boxshade 
(http://www.ch.embnet.org/software/BOX_form.html). Point mutations identified in functional screens in C. 
elegans or in steroid resistant nephrotic syndrome patients or created in-vitro through site-directed mutagenesis 
are coloured in red. Details about the point mutations are given in  
Table 2.  
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Table 2: Point mutations in the SFPH domain of stomatin family proteins 
mutation commentary origin reference
W184JA
P199JG
E209JK
E211JK
S230JA defective targeting J ER
Y251JA E. U., unpublished
T265JA
I266JA
V267JA
F268JA
P269JA
L270JA
P118JL
R138JQ
D160JG
R168JH
V180JM
R238JS
R291JW defective targeting J LEs
P134JS abolishes cholesterol binding C. elegans mec-allele u274 Huber et. al., 2006
R184JC touch sensitivity --- mec-allele u64
V190JM touch sensitivity -- mec-allele u224
S200JF touch sensitivity - mec-allele u306
A204JT mec-alleles e75 + u284 Gu et al., 1996
A207JT touch sensitivity --- mec-allele u28 Zhang et al., 2004
A234JV touch sensitivity -- mec-allele u227
R239JH mec-allele e1608
G243JE mec-allele u7
T246JI mec-allele u750
A296JV touch sensitivity --- mec-allele u144
E297JK mec-allele u318
E299JK touch sensitivity - mec-allele e1514 Huang et al., 1995
A304JT mec-allele u243
A306JT mec-allele u24
E314JK mec-allele u217
A320JV mec-allele u311
A325JT mec-allele u43
P357JL touch sensitivity --- mec-allele u130
P357JS touch sensitivity --- mec-allele u132
E60JK loss of function C. elegans unc-allele n774
A121JT unc-allele e114
T183JR dominant negative allele unc-allele n494 Park & Horvitz, 1986 Rajaram et al., 1998
G187JE unc-allele e580 Rajaram et al., 1998
K189JR+
A212JV
intragenic revertant of the 
dominant e1598 allele unc-allele e1598n1201
Park & Horvitz, 1986 
Rajaram et al., 1998
R252JC unc-alleles hs1+hs4
L257JI unc-allele hs5
T267JI unc-allele hs2
P273JS unc-allele hs3
cold-sensitive alleles
defective oligomerization 
Ellen Umlauf (E.U), 
unpublished data
Mario Mairhofer, 
unpublished data 
in vitro mutation, 
overexpression
steroid-resistant nephrotic 
syndrome
U
N
C
-1
Table 1: Point mutations in the PHB domain of stomatin family proteins: 
Umlauf et al., 2006
Roselli et. al., 2004
Zhang et al., 2004
Huang et al., 1995
Zhang et al., 2004
Zhang et al., 2004
Rajaram et al., 1998
Rajaram et al., 1998 
Hecht et al., 1996
ST
O
M
A
TI
N
PO
D
O
C
IN
M
EC
-2
defective oligomerization and 
lipid raft association
defective oligomerization 
defective oligomerization
defective PM targeting 
defective targeting J ER
Abbreviations: ER...endoplasmatic reticulum; PM...plasma membrane 
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4.2.7 Further point mutations introduced into stomatin  
As outlined in Figure 47 and  
Table 2, a great number of point mutations in the PHB domain of stomatin are known, either 
from unc- and mec-alleles in C. elegans or from patients with steroid-resistant nephrotic 
syndrome, which is caused by alterations in the podocin protein. The majority of these point 
mutations affect amino acids conserved from the C. elegans protein to human stomatin or 
from podocin to stomatin. Based on these findings, I began to construct several novel point 
mutations in the human stomatin sequence, with the hope that these mutants would cause a 
defect either in stomatin localization or function. The aim was to create a dominant-negative 
mutant, which would show a distinct phenotype when introduced to cultured cells. This aim 
proved difficult, because the precise function of the protein is still not clear and the point 
mutations did not directly affect the vitality or appearance of the cells. Nevertheless, I think 
that this approach can yield valuable results in the future. I identified two mutations (E210K 
and E212K) which apparently affect the subcellular trafficking of stomatin and cause an 
accumulation in intracellular compartments (Figure 48).  
 
Figure 48: Stomatin point mutants II 
 
 
Recently, a point mutation in MEC-2, which abolishes cholesterol binding, was 
Figure 48: Point mutations in stomatin, 
which correspond to mutations found in the 
mec-2 gene, show effects on the subcellular 
targeting of stomatin. The region around 
amino acid 212, which is well conserved 
between MEC-2 and stomatin and seems to 
be important for MEC-2 function, was 
targeted by site-directed mutagenesis in the 
human stomatin protein. Double serine 
mutants (S214, S231) were also cloned. 
Pictures represent the results from transient 
transfections into HeLa cells. St (E210K) 
and St (E212K) show no PM labeling. 
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described(Huber et al., 2006). As already mentionned in the introduction, results from Ellen 
Umlauf (in collaboration with Dr. Christoph Thiele, MPL Dresden) confirmed that stomatin 
also binds a photo-activatable cholesterol derivative efficiently. This point mutation would be 
the next target if I were able to continue with this strategy. For the analysis of functional 
consequences of the point mutations, it would be important to seek collaborations with groups 
which are able to analyse the activity of cation channels by patch-clamp analysis or the 
activity of the GLUT-1 glucose transporter, as a function for stomatin in the regulation of 
cation channels and glucose transport seems very likely in the light of recent results (Price et 
al., 2004; Zhang et al., 2001; Huber et al., 2006).  
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5 DISCUSSION 
5.1 SLP-1 function 
As already outlined in the introduction, the SLP-1 protein had been identified and cloned 
several years ago by our group based on its similarity to the stomatin protein (Seidel and 
Prohaska, 1998). After compiling its complete sequence (and although there had been a 
mistake in sequencing, which led to a wrong stretch of  ~35 amino acids), it was quickly 
realized that SLP-1 is the human orthologue of the C. elegans UNC-24 protein, sharing the 
unique, bipartite structure with a SPFH-domain and a SCP-2/nsLTP domain. When the unc-
24 locus had been sequenced by Barnes et al. in 1996(Barnes et al., 1996), they already 
postulated a function for UNC-24 in lipid transport, but further evidence for this function had 
not been presented yet. Meanwhile, several members of the SPFH protein family had been 
implicated in the formation/stabilization/organization of cholesterol- and sphingolipid-
enriched membrane domains, so-called “lipid rafts”(Bickel et al., 1997; Lang et al., 1998; 
Mairhofer et al., 2002; Salzer and Prohaska, 2001). Interesting new findings from C. elegans 
(Sedensky et al., 2004; Sedensky et al., 2001) led us to the conclusion that the human SLP-1 
protein could also function in a complex with stomatin analogous to the UNC-1/UNC-24 
complex in the worm and that a detailed characterization of the human SLP-1 could also help 
to shed light on the function of stomatin. We therefore attempted a first cell biological 
characterization of the human SLP-1 protein. Based on the C. elegans data, we expected SLP-
1 to be localized to the PM and were really surprised to find this protein to be exclusively 
localized to perinuclear organelles (Figure 9). Different constructs with C-terminal tags (GFP, 
myc, HA) all yielded identical results and showed this late endosomal localization, in 
transient as well as stable expression. Also, variation of the expression level did not show an 
effect on the subcellular distribution of SLP-1, therefore we can out-rule that the LE 
localization is an artefact caused by the over-expression of the protein. To identify the 
essential regions for this targeting, we started with the construction of an array of truncation 
mutants. Quickly, we realized that the C-terminal SCP-2/nsLTP domain is not required for the 
transport to LEs (truncation mutant SLP-1(1-288) was indistinguishable from the wild type 
protein in respect to subcellular localization), whereas deletion of the linker region between 
the SPFH domain and the SCP-2/nsLTP-domain (a sequence with no detectable homology to 
any other human protein, and also only poorly conserved between C. elegans and human) 
clearly showed an effect (SLP-1(1-224), see Figure 16). This truncation most probably gets 
mis-localized to early endosomes and cytoplasmic lipid aggregates (some co-localization with 
Rab4a, co-localization with cav3DGV and NileRed staining of the cytoplasmic aggregates, 
see Figure 17).  
The late endosomes play a crucial role in subcellular cholesterol trafficking, but the precise 
Discussion 
PhD thesis   Mario Mairhofer 
 139 
 
mechanisms, which are responsible for the release of LDL-derived cholesterol and subsequent 
transport to the plasma membrane are very incompletely understood. Some “key players” 
have been identified (NPC-1 and 2), but the whole picture is incomplete. Because cholesterol 
homeostasis is very important for cell survival, one also has to be aware that several different 
mechanisms of cholesterol transport from/to late endosomes might co-exist and be partially 
redundant. Based on the enrichment of SLP-1 in cholesterol-rich lipid rafts and on its 
localization to late endosomes, we hypothesized that it could also take part in cholesterol 
efflux from LEs to the PM. For another late endosomal cholesterol-binding protein named 
MLN64, which is also an integral membrane protein with a C-terminal cholesterol binding 
domain, it was recently shown that over-expression of the protein released the block of 
cholesterol efflux from LEs in Niemann-Pick fibroblasts as well as in U18666A-treated cells 
(Alpy et al., 2001). The synthetic amino-steroid U18666A causes cholesterol accumulation in 
LEs similar to the phenotype observed in Niemann-Pick fibroblasts (Kobayashi et al., 1999; 
Liscum and Faust, 1989). Because we did not have NPC fibroblasts, we decided to explore 
the potential effect of SLP-1 on cholesterol efflux from LEs in cells treated with U18666A. 
We soon realized that SLP-1 does not seem to mediate cholesterol efflux from LEs because 
we could not reduce the accumulation of cholesterol by (transient or stable) over-expression 
of SLP-1. Instead, we observed that over-expression of SLP-1 rather induces the formation of 
enlarged, cholesterol-rich LEs (Figure 33), but only when normal cholesterol efflux from LEs 
was blocked. The observed structures were clearly bigger than in control HeLa cells, and the 
cells expressing SLP-1 contained numerous of these enlarged organelles. The SCP-2/nsLTP 
domain of SLP-1 was required to trigger this effect, because deletion of this domain abolished 
the formation of the enlarged vesicles. So, insted of having a function in cholesterol efflux 
from LEs (as was our initial hypothesis), SLP-1 could rather mediate cholesterol 
accumulation. When we tried to characterize these cholesterol-rich, enlarged structures in 
more detail, we observed that they were only weakly stained with the LE marker LAMP-2, 
although it was described that U18666A triggers cholesterol accumulation in LAMP-1 and 
LAMP-2-positive vesicles (Umeda et al., 2003; Watari et al., 2000). In cells expressing the 
truncation mutant SLP-1(1-288)-GFP, we observed the expected accumulation of cholesterol 
in LAMP-2 positive vesicles. SLP-1 is broadly distributed throughout the late endosomal 
compartment, partially co-localizing with different markers. If cholesterol efflux from late 
endosomes is blocked, cholesterol accumulation is enhanced in LE vesicles which carry full-
length SLP-1 compared to untransfected cells and cells carrying C-terminal truncation 
mutants. These enlarged structures only contain low amounts of LAMP-2, which indicates 
that a shift of the cholesterol accumulation away from strongly LAMP-2 positive vesicles 
takes place. The SCP-2 domain is essential for this redistribution. As already mentioned 
above, this effect of SLP-1 on cholesterol distribution was only observed under conditions 
where the efflux of cholesterol from LEs was blocked. Nevertheless, we think that SLP-1 
could have a function in cholesterol transport in unperturbed cells as well.  
Because of its unique, bipartite structure, SLP-1 is a candidate for a role in lipid transport. 
Recently, stomatin was found to localize to lipid droplets under certain conditions, especially 
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when the protein was overexpressed or when newly synthesized proteins were accumulated in 
the ER by treatment with brefeldin A(Umlauf et al., 2004). We hypothesized that SLP-1 could 
also be targeted to LDs and probably act in lipid transfer to/from these organelles. 
Surprisingly, over-expressed SLP-1 was strictly excluded from the LDs (see Figure 18 and 
Figure 19). Only the C-terminal truncation mutant SLP-1(1-224)-GFP could be detected on 
LDs. This finding confirms that SLP-1 is anchored to the cytoplasmic leaflet of the membrane 
via its long hydrophobic domain at the N-terminus (and probably a lipid anchor like 
palmitate). Nevertheless, it also raises the question why this certain truncation can be 
translocated to LDs. The biogenesis of LDs is still a matter of controversy. Several different 
theories exist, the most popular being the idea that LDs form in the cytoplasmic leaflet of the 
ER as lipids and certain proteins accumulate in bulges and finally pinch off , forming an 
organelle surrounded only by a lipid monolayer. ELMI analysis has revealed that also 
“mature” LDs still are in tight contact with the ER. When we first observed the tubular 
structures positive for SLP-1(1-224) in the cells, we immediately thought that these might 
represent ER tubules and that the truncation gets somehow stuck in biosynthetic transport. But 
we never observed co-localization of  SLP-1(1-224) with ER markers (neither with ER-YFP 
nor with calnexin). We also compared the localization of SLP-1(1-224) with Cav3DGV, a 
mutated caveolin construct, which localizes to LDs and induces imbalances in intracellular 
lipid transport. In double transfections, we observed almost perfect co-localization of SLP-
1(1-224) and Cav3DGV, in cells fed with/without oleic acid (without oleic acid: Figure 18, 
lowest panel, Figure 19 with oleic acid). The only difference was that Cav3DGV often was 
clearly detected on the ER around the nucleus, whereas this localization was not observed for 
SLP-1(1-224). In our opinion, this data suggests that SLP-1(1-224) is not transported to the 
LD surface via the ER, but probably via a different organelle system. ELMI analysis of cells 
stably expressing SLP-1(1-224)-GFP revealed numerous interesting ultrastructures in these 
cells. Of special interest are the structures in the Epon-embedded samples. There, we could 
luckily depict intermediates in the formation/degradation of LDs (see Figure 21). These 
structures look like hybrid organelles between lysosomes and LDs and could represent either 
LDs which were engulfed by lysosomes or LDs budding from electron-dense multi-vesicular 
organelles (the latter would be my favourite option, but the first option would be interesting as 
well). We also observed later/earlier stages, where the LD is only surrounded by a distinct 
bilayer. Comparison of light and electron microscopy results strongly indicates that the LD 
aggregates observed in ELMI are positive for SLP-1(1-224). The definitive proof is still 
missing, because our attempts to perform immunodetection on the Epon-embedded cells 
(preembedding immunolabeling or removal of OsO4 prior to immunolabeling) were not 
successful. For me, it is clear that SLP-1(1-224) is on the surface of the characteristic LD 
aggregates. For the “intermediates”, the evidence is not so compelling. But a point is that 
these structures were only observed in the cells expressing SLP-1(1-224) and not in cells 
expressing full-length SLP-1 (data not shown). This indicates that these structures could be 
induced by the overexpression of this construct. As already mentioned, overexpression of 
Cav3DGV disturbes intracellular cholesterol homeostasis(Pol et al., 2001). The SLP-1(1-224) 
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construct could have a similar effect. Therefore, it could be interesting to follow the 
subcellular transport of (radio- or fluorescence-)labelled lipids in control cells and in cells 
expressing SLP-1(1-224). Because the vesicular aggregates induced by SLP-1(1-224) are 
likely to be somehow related to LDs (ELMI results and results after induction of LDs with 
oleic acid), we think that there is a good chance that this truncation will affect lipid 
trafficking.  
A more detailed analysis of the tubular structures and the vesicle organelles will be necessary 
to pin down such an effect. And, of course, cooperation with Marianne Fliesser on ELMI of 
cells expressing these constructs should be continued to improve our understanding of these 
interesting ultrastructures.  
 
5.2 Subcellular targeting of SLP-1 
During my PhD thesis, I could show that the overexpressed SLP-1 protein is exclusively 
localized to late endosomes in different cell types (see Figure 9 and Figure 10). This LE 
localization was found in transient and stable transfection experiments, at variable expression 
levels and with different tags (GFP, myc-tag, HA-tag). The next step was to investigate which 
regions of SLP-1 are responsible for this LE targeting. For stomatin, which is localized to the 
PM and to LEs, a specific LE targeting signal might exist, but is not absolutely necessary. The 
LE localization could also be the consequence of bulk membrane endocytosis. For LE 
localization without PM localization, as is the case for SLP-1,  it is necessary that a trafficking 
signal is present, which specifically directs transport to LEs and not to the PM via the 
constitutive biosynthetic/secretory pathway. Analysis of the protein sequence of SLP-1 
revealed a tyrosine-based GYXXφ motif at the N-terminus of SLP-1. Similar motifs at the 
cytoplasmic C-terminus of LAMP proteins are necessary for the targeting of the LAMPs to 
LEs/lysosomes (Gough et al., 1999; Guarnieri et al., 1993). We constructed several 
truncations at the N-terminus and found out that N-terminal deletions cause that SLP-1 is 
transported to the PM (Figure 25). Similar to stomatin, a combined localization to perinuclear 
vesicles and the PM was observed in deletions of amino acids 1-50 and 1-10. Therefore, we 
could conclude that the first 10 amino acids are required for correct LE targeting (amino acid 
sequence MLGRSGYRAL). In the next step, we introduced point mutations into the GYXXφ-
motif and replaced tyrosine 7 with an alanine (Y7A construct) and the hydrophobic amino 
acid at position +2, leucine-10, with a more polar serine (L10S construct). Both point 
mutations caused transport of the protein to the PM (see Figure 25) and therefore confirmed 
the functionality of the GYRAL motif at the N-terminus of SLP-1. In a different experiment, 
we exchanged the N-terminus of stomatin for amino acids 1-50 of SLP-1. The resultant 
chimeric protein showed exclusive localization to perinuclear organelles and colocalized with 
LysoTrackerRed (see Figure 31). When the point mutations (Y7A and L10S) were present in 
the SLP-1 N-terminus, the localization changed to PM and LEs and was practically 
indistinguishable from wt stomatin or from the original ST (21-287)-GFP construct. In the 
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SLP-1 protein, however, other sequences also seem to be necessary for proper subcellular 
targeting. As already outlined, the region between amino acid 224 and 288 also is necessary 
for correct LE targeting. Combinations of N- and C-terminal truncations revealed that N-
terminal truncations always induced PM localization of the construct, independent of the C-
terminal truncations. This suggests that the GYRAL motif at the N-terminus of SLP-1 is 
necessary, but not sufficient for LE targeting (because SLP-1(1-224) truncations are also 
mislocalized), although it was shown to be sufficient in a SLP-1/stomatin chimeric protein. 
Finally, I tried to clarify if SLP-1 is transported to LEs via very efficient endocytosis from the 
PM or via a direct transport pathway from the TGN. I tried to inhibit clathrin-dependent 
endocytosis by expressing either a dynamin mutant (dynK44A), a fragment of AP-180 
(AP180-C) or the SH3 domain of amphiphysin (Amph-SH3), but I could not observe big 
effects on the subcellular localization of SLP-1. Therefore, I can conclude that SLP-1 is not 
transported to LEs via clathrin-dependent endocytosis from the PM. A non-clathrin-dependent 
mechanism would still be possible. Direct transport of proteins to LEs has been described to 
be mediated by the AP-3 complex. The µ-subunits of different AP complexes have been 
shown to interact directly with short tyrosine-based sorting signals(Ihrke et al., 2004; Ohno et 
al., 1998; Rous et al., 2002). Our current working hypothesis is that the GYRAL motif could 
directly interact with AP-3 and therefore mediate direct targeting to LEs. This putative 
interaction could be confirmed by yeast two-hybrid screens or immunoprecipitation assays. In 
my opinion, there must be an interaction partner, which binds to/recognizes the GYRAL 
motif in the N-terminus.  
 
5.3 The interaction between SLP-1 and stomatin 
As already outlined, we started with the hypothesis that human SLP-1 and stomatin could 
form a complex as described for C. elegans UNC-24 and UNC-1. This assumption was found 
to hold true, because we could show that endogenous stomatin is co-immunoprecipitated with 
over-expressed SLP-1 (Figure 15) and that SLP-1 causes a change in stomatin localization 
(Figure 14). Based on these results, we assume that hetero-oligomeric complexes of SLP-1 
and stomatin can form. A future goal is to confirm the existence of hetero-oligomers in vivo 
by FRET experiments, but this method still has to be established in our laboratory. CFP- and 
YFP-tagged SLP-1 and stomatin constructs were cloned, and the FRET analysis can perhaps 
be done in collaboration with experts in this field. A very important question to be solved is: 
Are the hetero-oligomers of SLP-1 and stomatin also present in unperturbed cells (without 
overexpression of one or both binding partners)? To adress this question, it is necessary to 
first get a good antibody against endogenous SLP-1. Then, different cell lines and tissues can 
be investigated, and the relative amounts of SLP-1 and stomatin can be compared. From 
microarray and northern blot data, we must expect that the expression level of SLP-1 is 
considerably low compared to stomatin in most tissues. Nevertheless, a non-stoichiometric 
incorporation of SLP-1 into bigger oligomeric complexes could still have a profound impact 
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on the subcellular localization of the complex. Another question is where these hetero-
oligomers might form. For stomatin, we know that oligomer formation starts early in the 
biosynthetic pathway, probably at the ER membrane shortly after biosynthesis. Further 
experiments will be necessary to adress these interesting questions.  
 
5.4 FRAP experiments with stomatin 
As shown in Figure 45, deletion of the outmost C-terminus of stomatin has an impact upon 
the diffusional properties of the protein. The mobile fraction Mf as well as the diffusion speed 
(as measured by the recovery half-time t1/2) both increase when amino acids 263-287 are 
deleted. This region of the protein is also essential for both oligomerization(Snyers et al., 
1998) and lipid raft association(Umlauf et al., 2006) of stomatin. During her work, my 
colleague Ellen Umlauf has constructed several point mutations in this region and has shown 
that one of these mutants, P269A, only interferes with oligomerization and not with lipid raft 
association. This mutant could be used to investigate which of these two properties of 
stomatin has a bigger influence on the diffusion properties. Lipid raft association was recently 
shown not to have a big impact on the diffusional properties of several proteins(Kenworthy et 
al., 2004), therefore I would expect that it is the oligomerization, which causes the slow 
diffusional speed of the protein. Concerning the low mobile fraction of wild-type stomatin, 
experiments with agents which cause depolymerization of the cytoskeleton (e.g. cytochalasins 
or latrunculin A) could be very interesting. An interaction of stomatin with the cytoskeleton 
has been proposed almost ten years ago(Snyers et al., 1997), but an experimental proof is still 
missing. The high fraction of immobile stomatin in the plasma membrane again indicates a 
link to the cytoskeleton, but further experiments are necessary. The FRAP assay could be very 
useful for the confirmation of a (direct or indirect) link to the cytoskeleton, because 
depolymerization of, for example, cortical actin could result in a substantial increase of the 
mobile fraction of stomatin. To investigate the role of lipid raft association and 
oligomerization, one could immediately start with the existing, GFP-tagged point mutants 
(see Figure 46) and analyse them in FRAP experiments.  
 
5.5 New stomatin point mutations 
As already mentioned, I started with the construction of several new stomatin point mutants, 
either based on described mutations in the C. elegans MEC-2/UNC-1 protein ( 
Table 2) or targeting residues with potential PTMs (eg.serine 231).  
Especially the serine 231 point mutants gave very interesting results, although the putative 
phosphorylation still has to be confirmed. The S231A point mutant obviously gets stuck in the 
ER early during biosynthesis (Figure 43). This blockade can be overcome by formation of 
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oligomers with endogenous stomatin, depending on the expression level in HeLa, the mutated 
protein either localizes to the ER (high expression level) or can be transported to the PM (low 
expression level). In A431 cells, which only have very low levels of endogenous stomatin, I 
only observed ER localization. Interestingly, a combination of this point mutation with the C-
terminal truncation, which abolishes oligomerization (deletion 263-287) yields a construct 
which can be properly transported to the PM and does not accumulate in the ER. This 
indicates that only the oligomeric S231A mutant is not transport-competent for exit from the 
ER, but the monomeric mutant can be transported. Of course, biochemical analysis of the 
oligomerization state of the mutants should be done to complement the cell biological data. 
The S231E mutant, which was designed to mimick permanent phosphorylation at this 
position, also showed some interesting features. Upon strong overexpression, this mutant was 
detected on long, filamentous structures in the cells, which most likely represent bundles of 
actin filaments (Figure 44). The localization of the mutant to these structures could, of course, 
represent an artefact of over-expression. But it could also indicate that this mutant is more 
efficiently recruited to transport vesicles travelling along cytoskeletal structures. Another 
difference to the wild-type protein was observed if this mutant was co-expressed with SLP-1. 
The S231E mutant showed perfect co-localization with SLP-1 on late endosomes, whereas 
wild-type stomatin only showed partial co-localization and also strong PM staining (Figure 
42). We hypothesize that S231E can be internalized more rapidly than the wild-type stomatin 
protein, whereas the S231A mutant, when targeted to the PM, is only internalized to a very 
low extent. Irrespective of phosphorylation at serine 231, this region seems to be very 
important for proper function and targeting of stomatin. This is also reflected by the many 
point mutants discovered in this region ( 
Table 2). Secondary structure prediction programs suggest a very long alpha-helical structure 
for this region, which could be involved in oligomerization and protein-protein interactions. 
The outmost 25 amino acids are necessary for oligomerization of stomatin, but a second 
region must also be involved to give rise to stable, large oligomers (>12 subunits). Because 
three consecutive peptides in this region showed the cryptic PTM described in the Results 
section, we decided to target S214 according to S231 and constructed the S214A and S214E 
mutants. A detailed analysis of these mutants and of the double mutants (S214,231A, 
S214,231E) is still missing, but the effects described above seem to be specific for position 
S231. But two other mutants, E210K and E212K, converting the negative charge to a positive 
one, were shown to profoundly impact stomatin trafficking. In my first transient transfection 
experiments with these constructs, I did not observe PM localization, but only localization to 
cytoplasmic vesicles or aggregates (see Figure 48). Therefore, the subcellular trafficking of 
these mutants seems to be defective. Further experiments are necessary to confirm this result, 
especially derivation of stable clones and biochemical analysis.  
The stomatin mutants constructed in this thesis, in my opinion, could be very useful for the 
elucidation of the true function of the stomatin protein. The approach to introduce point 
mutants has been started several years ago in our laboratory, and the outmost C-terminus was 
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analysed by an alanine scanning mutagenesis approach. Several point mutants which are 
defective in oligomerization or lipid raft association were identified. But the subcellular 
localization of all these constructs was practically indistinguishable from the wild-type 
protein, and clearly visible phenotypes caused by the over-expression of the mutants could 
also not be identified. Now, we have several candidate mutants, which show effects on the 
subcellular trafficking of the protein. Stable over-expression in different cell lines and 
accurate analysis of these cells by different means (e.g. fluorescence microscopy, ELMI) will 
show if the expression of these mis-targeted proteins has any effect on the cells, for example 
in respect to lipid transport, and could help to identify the processes where stomatin is 
involved.  
 
5.6 Outlook 
The molecular function of the members of the human stomatin protein family still remains 
largely obscure. Nevertheless, a basic function can be assumed for these enigmatic membrane 
proteins. The kidney-specific member podocin is mutated in steroid-resistant nephrotic 
syndrome (NPHS2)(Boute et al., 2000), SLP-3 knockout mice show defects in 
mechanosensation(Wetzel et al., 2007) and SLP-2 knockout mice are not viable (data 
presented in poster sessions by two different groups). In my thesis, I have tried to expand our 
knowledge about the least characterized human family member, SLP-1. I am sure that the 
mouse knockout for SLP-1 will soon be reported, and I am really curious to see if there is a 
phenotype. Also, crossing of the newly available SLP-3 -/- animals with the stomatin -/- 
animals(Zhu et al., 1999) could lead to interesting insights. As we still assume an important 
function for the stomatin protein, it might happen that the phenotype is only apparent when 
SLP-3 cannot compensate for the loss of stomatin. For me, the function of the stomatin family 
proteins lies somewhere in the field of lipid transport, membrane domain formation and 
modification of membrane properties. The oligomeric properties of the stomatin family 
proteins and the organization in lipid rafts make them ideal candidates for scaffolding proteins 
on the inner leaflet of the PM. A similar function has been described for the related flotillins, 
which are essential for proper insulin signalling. An involvement in any signalling pathway 
has not yet been reported for stomatin, but this possibility should not be forgotten. With the 
first commercial antibodies available now, the protein might become a useful marker protein 
for lipid raft domains in cell types or tissues expressing low levels of other markers, and this 
more wide-spread use might also lead to unexpected new discoveries. Modern molecular 
biological methods like siRNA should be implemented as soon as possible for all family 
proteins, because they provide a quick method to screen for the pathways where the proteins 
could be involved. Of course, good antibodies for all 5 family members are needed for this 
task, but these reagents will hopefully be available soon. A focus must be put on the analysis 
of lipid/cholesterol distribution and lipid raft formation in the cells. For SLP-1, the proposed 
lipid binding ability of its SCP-2 domain should be tested in vitro after bacterial expression 
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and purification of this domain, and methods to analyse subcellular cholesterol transport have 
to be established to analyse SLP-1 function in vivo.  
As the interest in SPFH family proteins continuously increases(Browman et al., 2007; 
Morrow and Parton, 2005), I am optimistic that the field will advance and draw more 
attention in the next years. As exemplified by podocin, which was basically unknown until 
Boute et al. described the mutations which cause NPHS2, a single “breakthrough paper” in a 
high-impact journal can persistantly boost research in a field. Up to now, more than 230 
publications dealing with podocin have been published. The recent article in Nature 
describing “A stomatin domain protein essential for touch sensation in the mouse”(Wetzel et 
al., 2007) hopefully will promote research on stomatin and the other family members, because 
there are still plenty of open questions to be solved.  
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7 ABBREVIATIONS 
AAA  ATPase associated with various cellular activities 
AFM atomic force microscopy 
AP alkaline phosphatase 
APCs antigen presenting cells 
APS ammoniumperoxodisulfate 
ASIC acid sensing ion channel 
BAP37 B cell receptor associated protein of 37 kDa 
BHK baby hamster kidney cells 
BSA bovine serum albumine 
BSE Bovine spongiform encephalopathy, mad cow disease 
C. briggsae nematode closely related to C. elegans 
C. elegans  nematode caenorhabditis elegans 
C. remanei nematode, more distantly related to C. elegans 
cAMP cyclic adenosine monophosphate, stress signal 
CD cluster of differentiation, surface antigens recognized by monoclonal antibodies 
CI-M6PR cation-independent mannose-6-phosphate receptor 
CJD Creutzfeldt-Jakob disease 
CNS central nervous system 
COX cyclooxygenase 
CTB cholera toxin B 
DEG/ENaC degenerin/epithelial sodium channel family 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DRMs detergent resistant membranes 
DTT dithiothreitol 
E. coli full name Escherichia coli, bacterium 
ECS epidermal cell surface 
EDTA ethylenediamine tetraacetic acid 
EEs early endosomes 
ELMI electron microscopy 
EMBL european molecular biology laboratories 
ER endoplasmic reticulum 
ESA epidermal surface antigen 
EST expressed sequence tag 
FCS fetal calf serum 
FRAP Fluorescence Recovery After Photobleaching 
FRET Fluorescence Resonance Energy Transfer 
GABA gamma-aminobutyric acid, neurotransmitter 
GFP  green fluorescent protein 
GLUT glucose transporter 
GM130 golgi membrane protein of 130 kDa 
GPI glycosylphosphatidylinositol anchor 
GUVs giant unilamellar vesicles 
HA influenza haemagglutinin 
HDAC histone deacetylase 
HepG2 cells hepatic cancer cell line 
Hfl high frequency of lysogenization 
HRP horseradish peroxidase 
IEF iso-electric focusing 
IP  immunoprecipitation 
LAMP lysosome associated membrane protein 
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LAT linker of activated T cells 
LDs lipid droplets/bodies 
LEs  late endosomes 
MALDI-TOF matrix-assisted laser desorption ionization-time of flight, mass spectroscopy method 
MDCK cells Madine-Darby canine kidney cells 
MEC nematode with mechanosensory defect 
MS mass spectroscopy 
MTOC microtubule-organizing center 
MW molecular weight 
NBD Nitro-benzoxadiazole, fluorophore 
NMR nuclear magnetic resonance 
nsLTP non-specific lipid transfer protein, synonymous with SCP-2, competing designation 
OHSt overhydrated hereditary stomatocytosis, rare anemia 
PAGE polyacrylamide gel electrophoresis 
PC12 rat cancer cell line derived from pheochromocytoma (adrenal gland), model for neuronal differentiation 
PCR polymerase chain reaction 
PDB protein data bank 
PHB prohibitin 
PIP phosphatidylinositol phosphate 
PLAP placental alkaline phosphatase 
PM  plasma membrane 
PMP70 peroxisomal membrane protein of 70 kDa 
PTMs  post-translational modifications 
PVP  poly-vinylpyrrolidone 
RIPA radioimmunioprecipitation assay 
RNA ribonucleic acid 
ROI region of interest 
RT room temperature 
S. cerevisiae saccharomyces cerevisiae, brewer´s little helper & budding yeast 
SAGE serial analysis of gene expression 
SCP-2 domain sterol carrier protein 2 domain 
SDS sodium dodecyl sulfate 
siRNA short interfering RNA 
SL sphingolipid 
SLP stomatin like protein 
SPFH stomatin/prohibitin/flotillin/HflK/C protein superfamily 
SRO stomatin related olfactory 
SSU suppressor of stomatin uncoordination 
STL C. elegans stomatin-like  
STO C. elegans stomatin 
STOML stomatin-like 
STORP stomatin-related protein 
TCR T cell receptor 
TEMED tetramethylethylendiamine 
TfR transferrin receptor, CD71 
TIM translocase inner mitochondrial membrane 
TRITC tetramethyl-rhodamine isothiocyanate, fluorophore 
TRP  transient receptor potential 
UAC cells umbilical amniotic cells, epithelial cell line 
UNC uncoordinated nematode 
UTR untranslated region (of mRNA) 
VA volatile anesthetic 
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8 APPENDIX 
Mass spectrometry data for three stomatin peptides with a kryptic modification:  
 
1: Peptide AMAEAEASR 
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2: Peptide VIAAGEMNASR 
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3: Peptide EASMVITESPAAL 
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